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   and	   (c)	  10	  μg/mL	  
cholera	   toxin	   subunit	   B-­‐Alexa	   Fluor	   647	   (CTB-­‐AF647)	   conjugates,	   and	   (d)	   a	  
merged	   image	   of	   those.	   Green,	   red,	   and	   purple	   fluorescence,	   respectively,	  
represent	  G7-­‐AF488-­‐NH2,	  TF-­‐AF546,	  and	  CTB-­‐AF647.	  Images	  e,	  f,	  g,	  and	  h	  are	  a	  
data	  set	  of	  Rat2	  cells	  at	  the	  same	  condition	  with	  KB	  cells.	  Note	  that	  dendrimers	  
are	  colocalized	  intracellularly	  with	  CTB	  in	  both	  cell	  lines.	  Bar:	  10	  μm.	  ................	  33	  
	  
Figure	  2.8.	   Confocal	   images	   of	   (a)	   C6	   cells	   having	  GM1-­‐pyrene	   (blue)	   treated	  with	  
Cholera	   toxin	   subunit	   B	   (CTB)-­‐AF647(red),	   (b)	   C6	   cells	   without	   GM1	   treated	  
with	   CTB,	   (c)	   C6	   cells	   having	   GM1-­‐pyrene	   (blue)	   treated	  with	   G7-­‐NH2-­‐AF488	  
(green)	   PAMAM	   dendrimer,	   and	   (d)	   C6	   cells	   without	   GM1	   treated	   with	   G7	  
dendrimer.	  All	   incubations	  were	  for	  1	  h.	  CTB	  is	  internalized	  only	  when	  GM1	  is	  
present	  in	  the	  cell	  membrane.	  G7-­‐NH2	  dendrimer	  is	  internalized	  independent	  of	  
the	  presence	  of	  GM1	  in	  the	  cell	  membrane.	  ........................................................................	  34	  
	  
Figure	  2.9.	  Confocal	  images	  of	  KB	  cells	  coincubated	  for	  1	  h	  with	  (a)	  100	  nM,	  (b)	  200	  
nM,	  and	  (c)	  400	  nM	  G7-­‐AF488-­‐NH2	  and	  1	  μM	  G5-­‐6T-­‐Ac.	  Image	  d	  shows	  KB	  cells	  
incubated	   with	   1	   μM	   G5-­‐6T-­‐Ac	   only.	   Note	   that	   red	   fluorescence	   should	   be	  
detected	  if	  G7-­‐AF488	  NH2	  induces	  diffusion	  of	  G5-­‐6T-­‐Ac	  into	  the	  cells.	  However,	  
no	  noticeable	  signal	   from	  G5-­‐6T-­‐Ac	   is	  observed.	  First	  row,	  green	   fluorescence	  
channel	   detecting	   G7-­‐AF488-­‐NH2;	   second	   row,	   red	   fluorescence	   channel	  
detecting	  G5-­‐6T-­‐Ac;	  and	  third	  row,	  DIC	  images	  of	  each	  sample.	  Bar:	  50	  μm.	  .....	  36	  
	  
Figure	   3.S1.	   	   HeLa	   Cell	   Viability	   after	   3-­‐hour	   transfection	   incubation:	   	   Polyplex	  
preparation:	   40,000	   cells/	   well	   were	   plated	   and	   incubated	   overnight	   in	   96-­‐
wells	   plate.	   Wells	   were	   rinsed	   with	   PBS	   containing	   Ca2+	   and	   Mg2+.	   10	   μL	  
Polyplexes	   at	   N:P	   ratio	   5:1,	   10:1	   and	   20:1	   containing	   0.08	   μg	   of	   Molecular	  
Beacon	  were	   then	  added	   to	  90	  μL	  SFM.	   	  3	  hours	  post-­‐transfection	  media	  was	  
removed	  and	  added	  to	  a	  replicate	  96	  wells	  plate.	  The	  media	  was	  then	  used	  for	  
the	  LDH	  assay	  and	  the	  cells	  were	  used	  for	  the	  XTT	  assay.	  	  XTT	  assay:	  Cells	  were	  
rinsed	  with	  PBS	  containing	  Ca2+	  and	  Mg2+.	  50	  μL	  of	  PBS	  containing	  divalent	  ions	  
was	  then	  added	  to	  cells	  and	  followed	  by	  	  50	  μL	  XTT	  working	  solution.	  The	  plate	  
was	  then	  incubated	  at	  37	  °C	  for	  4	  hours	  before	  it	  was	  measured.	  	  LDH	  assay:	  50	  
μL	  of	  supernatant	  was	  incubated	  with	  50	  μL	  of	  the	  LDH	  working	  solution.	  The	  
plate	   was	   then	   incubated	   at	   37	   °C	   for	   20	   minutes	   and	   then	  
measured……………………………………………………………………………………………………51	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  Figure	  3.S2.	  	  Molecular	  Beacon	  stability	  analysis.:	  	  The	  experiment	  was	  carried	  out	  
in	  a	  96-­‐well	  plate.	  Each	  well	  contained	  0.08	  µg	  of	  molecular	  beacon	  diluted	  in10	  
μL	   water	   solution.	   Molecular	   beacon	   solution	   was	   then	   added	   to	   wells	  
containing	  90	  μL	  of	  water	  or	  PBS	  at	  pH	  2,	  5	  and	  7.4	  without	  S1	  nuclease	  or	  in	  S1	  
nuclease	  buffer	  with	   S1	  nuclease.	   The	  plate	  was	   read	   at	   excitation	  of	   485/20	  
nm	  and	  emission	  of	  528/20	  nm.	  Based	  on	   this	  study	   it	   can	  be	  concluded	   that	  
molecular	   beacon	   is	   stable	   at	   acidic	   and	   neutral	  
pH………………………………………………………………………………………………………………55	  
	  
Figure	   3.S3.	   A	   shows	   the	   order	   and	   relative	   durations	   of	   the	   4	   phases	   in	   the	  
experiment.	  B	  summarizes	  the	  pressure	  settings	  at	  the	  different	  phases.	  C	   is	  a	  
graphic	   representation	   of	   the	   pressure	  
settings……………………………………………………………………………………………………….56	  
	  
Figure	  3.1.	  Two-­‐color	   flow	  cytometry	  of	  PI	  uptake	   (y-­‐axis)	   vs	  MB	   fluorescence	   (x-­‐
axis)	   in	  HeLa	  cells	  after	  3	  h	  polyplex	  exposure	  followed	  by	  9	  h	   incubation.	   	  PI	  
uptake	   is	   used	   to	   indicate	   cell	   plasma	   membrane	   permeability	   and	   MB	  
fluorescence	  is	  used	  to	  indicate	  cytosolic	  nuclease	  activity.	  ......................................	  63	  
	  
Figure	   3.2.	   Cell	   plasma	  membrane	   currents	   induced	   by	   exposure	   of	   HeLa	   cells	   to	  
SFM	   solutions	   of	   jetPEI,	   B-­‐PEI,	   G5	   PAMAM,	   and	   L-­‐PEI	   polymers	   and	  
polymer/DNA	   polyplexes.	   	   	   Only	   the	   jetPEI	   polymer	   and	   polyplex	   exhibits	  
evidence	   for	  membrane	  porosity	   that	   is	   significantly	   different	   from	  SFM	  only	  
controls.	  .............................................................................................................................................	  66	  
	  
Figure	  3.S4.	  	  Cell	  membrane	  permeability	  induced	  by	  polyplex	  exposure	  in	  ECS…...66	  
	  
Figure	  3.3.	  Two-­‐color	  flow	  cytometry	  of	  RFP	  expression	  (y-­‐axis)	  vs	  MB	  fluorescence	  
(x-­‐axis)	  in	  HeLa	  cells	  after	  3	  h	  polyplex	  exposure	  followed	  by	  33	  h	  incubation.	  	  
RFP	  expression	  is	  used	  as	  the	  marker	  of	  transfected	  pDNA	  expression	  and	  MB	  
fluorescence	  is	  used	  to	  indicate	  cytosolic	  nuclease	  activity.	  ......................................	  67	  
	  
Figure	  3.4.	  Two-­‐color	  flow	  cytometry	  of	  DNA	  uptake	  (y-­‐axis)	  vs	  MB	  fluorescence	  (x-­‐
axis)	  in	  HeLa	  cells	  after	  3	  h	  polyplex	  exposure	  followed	  by	  9	  h	  incubation.	  	  DNA	  
uptake	   is	   measured	   using	   a	   rhodamine	   labeled	   DNA	   plasmid	   and	   MB	  
fluorescence	  is	  used	  to	  indicate	  cytosolic	  nuclease	  activity.	  ......................................	  70	  
	  
Figure	  3.5.	  Fluorescence	  of	  MB	  after	  complexing	  as	  a	  10:1	  N:P	  polyplex	  with	  B-­‐PEI,	  
G5	  PAMAM,	  jetPEITM	  or	  L-­‐PEI	  followed	  by	  cytosolic	  nuclease	  treatment	  (5	  μg	  of	  
cytosolic	  extract).	   	  Fluoresence	  of	  MB	  treated	  with	  cytosolic	  nuclease	  and	  MB	  
only	  in	  water	  included	  as	  controls.	  ........................................................................................	  72	  
	  
Figure	   3.S5:	   	   Fluorescence	   of	   MB	   a)	   after	   treatment	   with	   S1	   nuclease	   b)	   after	  
complexing	   as	   a	   10:1	  N:P	  polyplex	  with	  L-­‐PEI,	  B-­‐PEI,	  G5	  PAMAM,	  or	   jetPEITM	  
	   xi	  
followed	  by	  S1	  nuclease	  treatment	  	  c)	  controls	  of	  	  MB	  and	  polyplex	  with	  no	  S1	  
nuclease	  added…………………………………………………………………………………………...73	  
	  
Figure	   3.6.	   Confocal	   fluorescence	  microscopy	   of	   HeLa	   cells	   exposed	   to	   polyplexes	  
consisting	  of	  MB	  (to	  measure	  nuclease	  activity),	  Rhodamine-­‐labeled	  plasmid	  (to	  
measure	   DNA	   uptake)	   and	   polymer	   in	   a	   10:1	   N:P	   ratio	   for	   3	   h	   followed	   by	  
another	  9	  h	   incubation.	   	  Nuclease	  cleaved	  MB	   is	   shown	   in	  green,	  DNA	  uptake	  
shown	  in	  red	  and	  DAPI-­‐stained	  cell	  nuclei	  are	  shown	  in	  blue.	  .................................	  76	  
	  
Figure	   3.7.	   Agarose	   gel	   electrophoresis	   showing	   DNA	   cleavage	   pattern	   of	   HeLa	  
cytoplasm	  treated	  pDNA	  and	  S1	  nuclease	  treated	  pDNA.	  ...........................................	  78	  
	  
Figure	   4.S1.	   Circular	   plasmid	   map	   pGL4.51	   employed	   in	   the	   presented	   study.	  
Courtesy:	  Promega	  Corporation…………………………………………………………………..88	  
	  
Figure	  4.1.	  	  Agarose	  gel	  electrophoresis	  showing	  the	  DNA	  cleavage	  pattern	  of	  HeLa	  
cytosol	   and	   S1	   nuclease	   treated	   luciferase	   pDNA.	   Lanes	   1	   and	   8)	   10	   kB	  DNA	  
ladder.	  Lane	  2)	  pDNA	  in	  water.	  	  Lane	  3)	  pDNA	  treated	  with	  cells	  only	  cytosol	  in	  
water.	   	   Lane	  4)	  pDNA	   treated	  with	   cytosol	   in	  water	   from	  cells	   exposed	   to	  G5	  
polyplexes.	  Lane	  5)	  pDNA	  treated	  with	  S1	  nuclease	  in	  S1	  nuclease	  buffer.	  	  Lane	  
6)	  pDNA	  treated	  with	  S1	  nuclease	  in	  water.	   	   In	  lanes	  3-­‐6,	  both	  the	  nicked	  and	  
linear	  topology	  of	  the	  plasmid	  can	  be	  seen…………………………………………………..	  92	  
	  
Figure	  4.2.	  Endonuclease	  treatment	  of	  6.4	  kB	  linear	  plasmid	  (LP).	  	  Lanes	  1	  and	  10;	  
10	  kB	  DNA	  ladder.	  	  	  Lane	  2)	  	  pDNA	  in	  water.	  	  Lane	  3)	  	  LP	  in	  water.	  	  	  Lanes	  4,	  6,	  
8)	  pDNA	  treated	  with	  SacI,	  DraIII	  and	  StuI,	  respectively.	  	  	  Lanes	  5,	  7,	  9)	  	  LP	  
treated	  with	  SacI,	  DraIII	  and	  StuI,	  respectively………………………………………….....	  93	  
	  
Figure	  4.3.	  Heat	  maps	  showing	   frequency	  of	  cuts	  on	   the	   luciferase	  pDNA	  resulting	  
from	  the	  S1	  nuclease	  digest	   in	  water.	   	  White	  color	   indicates	  the	  percentage	  of	  
plasmids	  cut	  is	  between	  zero	  and	  the	  lower	  part	  of	  the	  cut	  range	  listed.	  	  Black	  
color	   indicates	   the	   percentage	   cut	   is	   the	   maximum	   value	   for	   that	   cut	   range.	  	  
Greyscale	  	  indicates	  cut	  percentages	  between	  these	  extrema.	  	  Panel	  A	  shows	  the	  
full	  range	  of	  labile	  sites,	  Panel	  B	  represents	  labile	  regions	  that	  have	  frequency	  
of	  cuts	  between	  25-­‐45%	  (showing	  ~15	  most	  cut	  regions).	  	  Panel	  C	  shows	  ~top	  
5	   cut	   regions	  between	  28-­‐45%.	   	  The	   luciferase	   functional	  map	   is	   provided	   in	  
registry	  with	  the	  heat	  map	  to	  facilitate	  comparison	  of	  cuts	  sites	  to	  the	  different	  
regions	  of	  the	  plasmid.	  ................................................................................................................	  97	  
	  
Figure	  4.4.	  Heat	  maps	  showing	  frequency	  of	  cuts	  on	  the	  luciferase	  plasmid	  resulting	  
from	  cytosolic	  nuclease	  treatments.	  	  White	  color	  indicates	  the	  percentage	  of	  cut	  
is	  between	  zero	  and	  the	  lower	  part	  of	  the	  cut	  range	  listed.	  	  Black	  color	  indicates	  
the	   percentage	   of	   cut	   is	   the	   maximum	   value	   for	   that	   cut	   range.	   	   Greyscale	  
indicates	  cut	  percentages	  between	  these	  extrema.	  	  Panels	  A,	  B	  and	  C	  show	  labile	  
cut	   regions	   for	  G5	  polyplex-­‐treated	   cell	   cytosol	   treatment.	   Panel	  A	   shows	   the	  
full	  range	  of	  labile	  sites,	  Panel	  B	  represents	  labile	  regions	  that	  have	  a	  frequency	  
	   xii	  
of	  cuts	  between	  41-­‐65%	  (showing	  ~15	  most	  cut	  regions).	  	  Panel	  C	  shows	  ~top	  
5	  cut	  regions	  between	  52-­‐65%.	  	  Panels	  D,	  E	  and	  F	  represent	  cells-­‐only	  cytosol	  
treatment.	  Panel	  D	  shows	  the	  full	  range	  of	  labile	  sites,	  Panel	  E	  represents	  labile	  
regions	  that	  have	  a	  frequency	  of	  cuts	  between	  50-­‐75%	  (showing	  ~15	  most	  cut	  
regions)	  and	  Panel	  F	  shows	  ~top	  5	  cut	  regions	  between	  59-­‐75%.	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  99	  
	  
Figure	   4.5.	   Heat	   map	   comparison	   between	   cytosol	   nuclease	   samples	   and	   S1	  
nuclease.	   (A)	   	   G5	   polyplex-­‐treated	   cytosol	   cut	   regions	   with	   41-­‐65%	   cuts	   (B)	  
cells-­‐only	   cytosol	   cut	   regions	   with	   50-­‐75%	   cuts	   (C)	   S1	   nuclease	   cut	   regions	  
with	  25-­‐45%	  cuts.	  ......................................................................................................................	  105	  
	  
Figure	  6.1.	  Below	  are	  CAD	  representations	  of	  the	  polycarbonate	  attachment	  with	  the	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  polymers	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  nucleic	  acid	  delivery:	  Membrane	  






In	  order	   to	  optimize	  the	  design	  of	  gene	  delivery	  vector	  systems	  using	  polycationic	  
polymers,	  their	  internalization	  pathway	  needs	  to	  be	  extensively	  studied.	  	  In	  chapter	  
2,	  Generation	  7	  (G7)	  poly(amidoamine)	  (PAMAM)	  dendrimers	  (G7-­‐NH2)	  with	  amine	  
termination	  were	  prepared	   to	   investigate	  polymer/cell	  membrane	   interaction.	   	  C6	  
cells	   were	   employed	   in	   this	   experiment	   because	   of	   their	   unique	   characteristic	   of	  
inherently	  lacking	  GM1	  but	  still	  possessing	  downstream	  requirements	  for	  successful	  
GM1	  mediated	  endocytosis.	  	  This	  resulted	  in	  the	  reported	  binary	  experiment	  where	  
C6	  cells	  without	  and	  with	  GM1	  did	  not	  show	  differential	  G7-­‐NH2	  uptake	  supporting	  
the	  hypothesis	   that	  GM1	  mediated	  endocytosis	   is	  not	   the	  primary	  pathway	   for	  G7-­‐
NH2	   internalization.	   	   In	   addition	   to	   understanding	   uptake	   mechanisms,	   efforts	   to	  
improve	  the	  polymer-­‐based	  vector	  systems	  have	  assumed	  that	  cells	  play	  a	  passive	  
role	  and	  don’t	  actively	  respond	  to	  these	  polymer	  vector	  systems.	  	  In	  chapter	  3,	  I	  will	  
show	  how	  cells	  respond	  to	  different	  polymer	  systems	  by	  activating	  different	  levels	  
of	  cytosolic	  nucleases	  and	  how	  this	  nuclease	  activity	  can	  be	  measured	  with	  the	  help	  
of	  Molecular	  Beacon	  (MB).	  	  We	  also	  learn	  that	  membrane	  porosity	  is	  not	  the	  reason	  
for	   nuclease	   activation.	   This	   nuclease	   activation	   decreases	   gene	   expression,	  
ultimately	  decreasing	  polymer	  efficiency.	  	  In	  doing	  this,	  I	  show	  that	  it	  is	  possible	  to	  
screen	  multiple	  polymer-­‐based	  vector	  systems,	  thereby	  increasing	  the	  probability	  of	  
identifying	  and	  designing	  an	  efficient	  polymer	  vector	   system.	   	   	   In	   chapter	  4,	   I	  will	  
concentrate	  on	  DNA	  degradation	  characteristics	  of	  these	  cytosolic	  nucleases.	  	  High-­‐
throughput	   sequencing	  was	   used	   to	   identify	   and	   quantify	   degradation	   patterns	   of	  
these	  cytosolic	  nucleases	  on	  a	  plasmid.	  	  We	  will	  also	  see	  that	  S1	  nuclease	  (a	  known	  
nuclease)	  has	  similar	  degradation	  pattern	  as	  cytosolic	  nucleases.	  	  Designing	  polymer	  
vector	  systems	  that	  protect	  these	  labile	  sites	  on	  DNA	  can	  improve	  gene	  expression.	  
In	  chapter	  6,	   invention	  of	  The	  Endocutter,	  a	  gastrointestinal	  device	   that	  cuts	  clots,	  
cuts	  costs	  and	  saves	  lives	  is	  described.	   	  This	  device	  was	  designed	  to	  be	  compatible	  
with	   both	   single	   and	   dual	   channel	   endoscope	   for	   easy	   adaptation.	   	   Endocutter	   is	  
easy	  to	  use	  and	  has	  been	  shown	  to	  be	  safe	  and	  efficient	  in	  removing	  blood	  clots	  both	  
in-­‐vitro	  and	  in-­‐vivo	  systems	  (http://www.youtube.com/watch?v=gxnB_kuzOsQ	  )	  
	  




1.1 Nucleic	  Acid	  Delivery	  Systems	  
	  
Nucleic	   acid	   transfection	   and	   expression	   play	   an	   important	   role	   in	   everyday	  
molecular	  biology	  experiments.	  [1]	  Delivery	  of	  oligonucleotides,	  including	  antisense	  
DNA	   	   (asDNA),	   silencing	   RNA	   (siRNA),	   and	   plasmid	   DNA	   (pDNA)	   is	   a	   promising	  
strategy	   in	   the	   field	   of	   medicine	   with	   possible	   applications	   including	   diagnosis,	  
vaccines	   and	   disease	  management.[2]	   The	   big	   range	   of	   applications	   and	   potential	  
impact	  on	   common,	   life	   threatening	  diseases	   like	  diabetes	  mellitus	   and	  metastatic	  
neoplasm,[2]	   led	   to	   a	   predicted	   pharmaceutical	   industry	   of	   $16.8	   billion/year	   by	  
2020-­‐2025;[3]	  however,	  almost	  15	  years	  after	  this	  prediction	  gene	  therapy	  is	  only	  a	  
small	  fraction	  of	  this	  multi-­‐billion	  dollar	  market	  projection.	  Despite	  the	  outstanding	  
promise	  of	   this	   technology,	   there	  are	  no	  FDA-­‐approved	  vector	   systems	   for	  nucleic	  
acid	   delivery	   in	   humans.	   This	   lack	   of	   market	   availability	   and	   penetration	   arises	  
primarily	   because	   of	   safety	   and	   efficiency	   issues	   for	   current	   nucleic	   acid	   delivery	  
systems.[4,	   5]	   	   In	   addition	   to	   gene	   therapy,	  many	  other	  nucleic	   acid	  manipulation	  
techniques	  like	  asDNA	  and	  siRNA	  can	  greatly	  benefit	  from	  safe	  and	  efficient	  delivery	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systems.[2,	   4]	   There	   are	   two	   categories	   of	   nucleic	   acid	   delivery	   systems	   but	   they	  
each	  have	  their	  tradeoffs:	  
1.1.1 Viral	  Based	  Systems	  
	  Viral	   based	   systems	   are	   good	   at	   providing	   gene	   expression.	   However,	   they	   pose	  
significant	  health	  and	  safety	  concerns	  because	  of	   their	  use	  of	   infective	  viruses	   like	  
adenoviruses,	   retroviruses,	  etc.[6,	  7]	  Viral	  based	  vector	  systems	   take	  advantage	  of	  
the	   virus’s	   inherent	   ability	   to	   transfect	   cells.	   	   These	   systems	   are	   composed	   of	   a	  
benign	  part	  of	  the	  viral	  genome	  in	  conjunction	  with	  the	  transgene	  to	  help	  facilitate	  
transgene	  expression	  into	  the	  host	  cell.	  This	  technique	  has	  various	  caveats:	  
1.1.1.1 The	  target	  locus	  of	  the	  host’s	  genome	  where	  the	  transgene	  is	  integrated	  
cannot	  be	  confidently	  predetermined.[7]	  If	  the	  target	  locus	  expresses	  an	  
important	  transcript	  then	  the	  integration	  can	  lead	  to	  a	  nonfunctional	  transcribe	  
which	  ultimately	  can	  lead	  to	  a	  precarious	  state	  for	  the	  host.	  
1.1.1.2 The	  viral	  based	  system,	  like	  any	  other	  system	  that	  utilizes	  foreign	  agents,	  can	  
lead	  to	  activation	  of	  the	  host’s	  immune	  response.	  Not	  only	  can	  that	  lead	  to	  a	  
potentially	  fatal	  immune	  hyper-­‐reaction	  in	  the	  host,	  but	  can	  also	  block	  future	  
gene	  therapy	  treatment	  with	  the	  same	  agent.	  [7]	  	  
1.1.2 Non-­‐Viral	  Based	  Systems	  
Non-­‐viral	   based	   systems,	   because	   of	   their	   small	   size	   and	   lack	   of	   traditional	  
immunogenic	  epitopes,	  lack	  non-­‐specific	  immune	  responses.	  However	  they	  are	  not	  
as	  efficient	  for	  gene	  expression	  as	  viral	  based	  systems.	  [8,	  9]	  	  Some	  examples	  of	  non-­‐
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viral	  based	  systems	  are	  electroporation,	  gene	  gun,	  and	  cationic	  polymeric	  systems	  
such	   as	   PAMAM	   dendrimer	   and	   PEI	   (Poly(ethyleneimine)),	   and	   lipids.	   Non-­‐viral	  
systems	  are	  efficient	  at	  delivering	  the	  transgene	  into	  the	  cells	  and	  can	  also	  protect	  
the	   nucleic	   acid	   from	   cytosolic	   degradation,	   but	   they	   lack	   a	   dedicated	   transport	  
mechanism	   within	   cells	   that	   leads	   to	   their	   inefficiency	   in	   providing	   transgene	  
expression.	   [8,	  9]	   	  Additionally,	   they	   lack	   the	  ability	   to	   integrate	   the	  gene	   into	   the	  
host’s	  genome.	  [9]	  	  
1.1.2.1 Low	  Transgene	  Expression	  with	  Non-­‐Viral	  Vector	  Systems	  
A	   polycationic	   polymer	   like	   the	   PAMAM	   dendrimer	   can	   provide	   a	   high	   level	   of	  
customization	  with	  its	  defined	  molecular	  architecture	  and	  high	  surface	  moieties	  to	  
volume	   ratio,	   without	   activating	   an	   aggressive	   immune	   response.	   [10-­‐13]	   This	  
makes	  it	  an	  optimum	  vector	  system.[9,	  14]	  Many	  studies	  have	  investigated	  cellular	  
uptake	   mechanism	   for	   viral	   and	   non-­‐viral	   vector	   systems.[15-­‐17]	   They	   both	   are	  
thought	  to	  enter	  via	  energy	  dependent	  endocytosis	  pathways	  that	  can	  lead	  to	  their	  
localization	  inside	  an	  endosome.	  [8,	  18]	  Before	  these	  endosomes	  become	  lysosomes,	  
the	   two	   vector	   systems	   are	   thought	   to	   escape	   via	   different	   mechanisms.	   Viral	  
systems	  have	  a	  dedicated	  mechanism	  to	  transfer	  nucleic	  acid	   into	  the	  nucleus,	  but	  
polyplexes	   are	   not	   known	   to	   have	   such	   a	   mechanism.	   [19]	   This	   is	   thought	   to	  
contribute	   to	   the	   inefficiency	   of	   non-­‐viral	   systems	   in	   providing	   transgene	  
expression.	  This	  problem	  has	  been	  studied	   for	  several	  years,	  but	  researchers	  have	  
always	   attributed	   it	   to	   the	  uptake	  mechanism	  and	   endosomal	   escape.	   [19]	  Recent	  
work	  by	  Lechardeur	  et	  al.	  [20]	  and	  Pollard	  et	  al.	  [21]	  argues	  otherwise.	  Their	  studies	  
show	   that	   cytosolic	   nucleases	   contribute	   to	   degradation	   of	   transported	   DNA	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lowering	   overall	   expression	   of	   transgene.	   Chapter	   2	   will	   concentrate	   on	   PAMAM	  
dendrimer	  interaction	  with	  cell	  plasma	  membrane	  and	  test	  a	  specific	  internalization	  
pathway	  PAMAM	  dendrimer	  proposed	  to	  be	  active	  for	  uptake	  into	  cells.	  In	  chapter	  
3,	   I	   will	   identify	   and	   evaluate	   effects	   of	   cytosolic	   nuclease	   activity	   on	   gene	  
expression	  and	  also	  how	  choice	  of	  polymer	  used	  in	  polyplexes	  relates	  to	  the	  activity.	  
In	   chapter	   4,	   I	   will	   characterize	   cytosolic	   nucleases	   and	   use	   sequencing	   to	   study	  
their	  degradation	  sites	  on	  a	  plasmid	  DNA.	  	  
1.2 The	  Role	  of	  Ganglioside	  GM1	  in	  Cellular	  Internalization	  Mechanisms	  
of	  Poly(amidoamine)	  Dendrimers	  (Chapter	  2)	  
In	  order	   to	  optimize	  the	  design	  of	  gene	  delivery	  vector	  systems	  using	  polycationic	  
polymers,	  their	  internalization	  pathway	  needs	  to	  be	  extensively	  studied.	  [10,	  12,	  16,	  
17]	   PAMAM	   dendrimer,	   with	   their	   defined	  molecular	   architecture	   and	   controlled	  
synthesis,	   provide	   a	   unique	   opportunity	   for	   understanding	   these	   specific	  
internalization	  pathways	   in	  great	  detail.[11,	  13,	  22]	  There	  are	  studies	   in	   literature	  
supporting	  the	  hypothesis	  that	  PAMAM	  dendrimer	  are	  internalized	  via	  polycationic	  
endocytosis	  mechanisms	  such	  as	  clathrin	  and	  GM1	  mediated	  endocytosis.	  [23]	   	  But	  
there	   are	   many	   also	   contradictory	   and	   inconclusive	   experiments	   existing	   in	  
literature.	   [24-­‐28]	   In	   the	   first	   chapter	   I	  will	   present	   a	   binary	  way	   to	   address	   this	  
hypothesis.	  This	  study	  showed	  that	  polycationic	  polymer,	  contrary	  to	  some	  studies	  
in	  literature,	  does	  not	  internalize	  via	  GM1	  mediated	  endocytosis.	   	   	  Additionally	  this	  
study	  was	  repeated	  with	  polyplexes	  where	  the	  hypothesis	  had	  been	  shown	  to	  stay	  
true.	   [29]	   This	   conclusion	   helped	   narrow	  down	  possible	   internalization	   pathways	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for	   PAMAM	  dendrimers,	   informing	   better	   design	   for	   novel	   polymer	   based	   nucleic	  
acid	  delivery	  systems.	  	  
1.3 Polyplex-­‐Induced	  Cytosolic	  Nuclease	  Activation	  leads	  to	  Differential	  
Transgene	  Expression	  (Chapter	  3)	  
Nucleic	   acid	   delivery	   based	   therapeutics	   like	   DNA,	   asDNA,	   siRNA	   are	   severely	  
limited	   by	   absence	   of	   safe	   and	   efficient	   delivery	   systems.	   Non-­‐viral	   nucleic	   acid	  
delivery	  systems	  like	  PAMAM	  dendrimers	  and	  other	  provide	  certain	  advantages	  like	  
low	   toxicity,	   high	   surface	  moieties	   to	   volume	   ratio	   but	   don’t	   provide	   the	   level	   of	  
efficiency	   viral	   systems	   do.	   As	   mentioned	   above,	   this	   low	   efficiency	   has	   been	  
attributed	   to	   uptake	   mechanisms,	   endosomal	   escape	   and	   nuclear	   transport	   by	  
polymer	   systems.	   [8,	   15-­‐17]	   In	   studying	   the	   above-­‐mentioned	   bottlenecks,	   it	   is	  
assumed	  that	  1)	  cells	  do	  not	  actively	  respond	  to	  the	   introduction	  of	  polymer/DNA	  
complexes	   (polyplexes),	   and	   2)	   if	   a	   cell	   does	   respond	   it	   responds	   in	   a	   fashion	  
independent	  of	  polymer	  employed.	  In	  chapter	  3,	  I	  will	  address	  our	  hypothesis	  that	  
polyplexes	  induce	  a	  cellular	  response	  (cytosolic	  nucleases),	  which	  in	  turn	  decreases	  
the	  downstream	   transgene	  expression..	  And	  how	  nuclease	  activation	   is	  dependent	  
on	  the	  polymer	  employed	  to	  make	  polyplexes.	  This	  knowledge	  can	  help	  in	  designing	  
efficient	  polymeric	  nucleic	  acid	  delivery	   system	   that	  decreases	   cytosolic	  nucleases	  
activation	  leading	  to	  increase	  in	  downstream	  gene	  expression.	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1.4 Quantification	  of	  Cytosolic	  Plasmid	  DNA	  Degradation	  Using	  High-­‐
Throughput	  Sequencing:	  	  Implications	  for	  Gene	  Delivery	  (Chapter	  4)	  
Hypothesis	   tested	   in	   this	   chapter:	   S1	   nuclease	   type	   nucleases	   are	   part	   of	   the	  
cytosolic	   nuclease	   milieu	   and	   cytosolic	   nucleases	   attack	   certain	   plasmid	   regions	  
more	   than	   others.	   High-­‐throughput	   sequencing	   is	   employed	   to	   study	   the	  
downstream	  effects	  of	  nuclease	  activation	  on	  the	  transported	  DNA.	  High-­‐throughput	  
sequencing	  was	  used	  in	  this	  study	  to	  identify	  and	  quantify	  labile	  sites	  on	  a	  plasmid	  
DNA.	   S1	   nuclease	   was	   used	   in	   this	   study	   to	   both	   validate	   sequencing	   data	  
comparison	  with	  published	  agarose	  gel	  work	  but	  also	  because	  of	   interest	   in	  better	  
understanding	  of	   the	   S1	  nuclease	  plasmid	  DNA	  cleavage	  pattern.	  High-­‐throughput	  
sequencing	   not	   only	   provided	   more	   labile	   sites	   than	   previously	   known	   but	   also	  
provided	   information	   regarding	   relative	   degree	   of	   degradation	   for	   labile	   site	   and	  
their	   location	   on	   the	   plasmid.	   This	   study	   can	   help	   in	   designing	   efficient	   polymer	  
vector	   systems	   that	   protect	   these	   labile	   sites	   from	   degradation	   and	   in	   turn	  
improving	  expression.	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Chapter	  2	  
The	  Role	  of	  Ganglioside	  GM1	  in	  Cellular	  Internalization	  
Mechanisms	  of	  Poly(amidoamine)	  Dendrimers#	  
2.1 Abstract	  
In	  this	  chapter,	  the	  hypothesis	  that	  GM1	  medicated	  endocytosis	  plays	  an	  important	  
role	   in	   polyplex	   cellular	   internalization	   was	   addressed.	   Generation	   7	   (G7)	  
poly(amidoamine)	   (PAMAM)	   dendrimers	   with	   amine,	   acetamide,	   and	   carboxylate	  
end	   groups	   were	   prepared	   to	   investigate	   polymer/cell	   membrane	   interactions	   in	  
Vitro.	  G7	  PAMAM	  dendrimers	  were	  used	  in	  this	  study	  because	  higher-­‐generation	  of	  
dendrimers	  are	  more	  effective	  in	  permeabilization	  of	  cell	  plasma	  membranes	  and	  in	  
the	   formation	   of	   nanoscale	   holes	   in	   supported	   lipid	   bilayers	   than	   smaller,	   lower-­‐
generation	   dendrimers.	   Dendrimer-­‐based	   conjugates	   were	   characterized	   by	   1H	  
NMR,	  UV/vis	  spectroscopy,	  GPC,	  HPLC,	  and	  CE.	  Positively	  charged	  amine-­‐terminated	  
G7	  dendrimers	  (G7-­‐NH2)	  were	  observed	  to	  internalize	  into	  KB,	  Rat2,	  and	  C6	  cells	  at	  
a	   200	   nM	   concentration.	   By	   way	   of	   contrast,	   neither	   negatively	   charged	   G7	  
carboxylate-­‐terminated	   dendrimers	   (G7-­‐COOH)	   nor	   neutral	   acetamide-­‐terminated	  
G7	  dendrimers	   (G7-­‐Ac)	  associated	  with	   the	   cell	  plasma	  membrane	  or	   internalized	  
under	  similar	  conditions.	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  performed	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  by	  me.	  	  	  
	  
G7-­‐NH2	   dendrimers	   colocalized	   with	   CTB;	   however,	   experiments	   with	   C6	   cells	  
indicated	   that	   internalization	   of	   G7-­‐NH2	  was	   not	   ganglioside	   GM1	   dependent.	   The	  
G7/CTB	  colocalization	  was	  thus	  ascribed	  to	  an	  artifact	  of	  direct	  interaction	  between	  
the	  two	  species.	  The	  presence	  of	  GM1	  in	  the	  membrane	  also	  had	  no	  effect	  upon	  XTT	  
assays	   of	   cell	   viability	   or	   lactate	   dehydrogenase	   (LDH)	   assays	   of	   membrane	  
permeability.	  
2.2 Introduction	  
Polycationic	   polymers	   such	   as	   poly(lysine)s,	   poly(ethyleneimine)s,	  
diethylaminoethyl-­‐dextrans,	   and	   poly(amidoamine)	   (PAMAM)	   dendrimers	   have	  
demonstrated	   great	   potential	   to	   be	   exploited	   as	   gene	   transfer	   and	   drug	   delivery	  
vectors.(1-­‐9)	   Among	   those	   polycationic	   polymers,	   PAMAM	   dendrimers	   have	  
attracted	   great	   scientific	   interest	   in	   the	   biomedical	   applications	   due	   to	   their	  
excellent	  water-­‐solubility	  and	  well-­‐defined	  structure,	  molecular	  weight,	  and	  surface	  
end	  groups.	   	  Demonstrated	  utility	  for	  practical	  applications,	  coupled	  with	  excellent	  
monodispersity	   and	   chemical	   versatility,	   make	   PAMAM	   dendrimers	   an	   ideal	  
material	  for	  exploring	  polymer-­‐membrane	  interactions	  in	  greater	  detail.(6,	  8-­‐10,	  13,	  
15)	  
The	  internalization	  mechanism	  of	  amine-­‐terminated	  PAMAM	  dendrimers	   into	  cells	  
has	   been	   explained	   as	   polycation-­‐mediated	   endocytosis	   or	   leaky	   endocytosis.(10-­‐
14)	   In	   particular,	   co-­‐localization	   studies	   with	   using	   choleratoxin	   subunit	   B	   (CTB)	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suggested	   that	   	   ganglioside	  GM1	  played	  a	  major	   role	   in	   the	   initial	   interaction	  with	  
the	   cell	  membrane	  and	   the	   subsequent	   internalization	  process	   for	  EA.hy	  926	  cells	  
and	   Chinese	   hamster	   ovary	   (CHO)	   cells.(16)	   Furthermore,	   inhibition	   of	  
internalization	   by	   methyl-­‐β-­‐cyclodextrin	   (MβCD)	   suggested	   that	   a	   lipid-­‐raft	  
mediated	  process	  may	  be	  a	  primary	  pathway	  for	  PAMAM	  dendrimer	  internalization	  
into	  the	  cells.	  	  Subsequent	  studies	  with	  HeLa	  and	  HepG2	  cells	  did	  not	  show	  an	  effect	  
from	  MβCD	  but	  instead	  increased	  uptake	  and	  transfection	  efficiency	  were	  observed	  
as	   a	   function	   of	   caveolin	   1	   expression.(17)	   These	   results	   were	   particularly	  
interesting	   in	   light	  of	  other	  studies	  that	  had	  identified	  an	  “adsorptive”	  endocytosis	  
that	  might	  involve	  a	  specific	  membrane	  component	  for	  B16f10	  melanoma	  cells(18)	  
which	   are	   also	   known	   to	   contain	   GM1.(19)	  However,	   the	   generality	   of	   a	   caveolae-­‐
based	   endocytosis	   mechanism	   is	   called	   into	   question	   by	   studies	   on	   Caco-­‐2	   cells	  
which	   support	   a	   clathrin-­‐based	   mechanism,	   not	   a	   caveolae-­‐mediated	  
mechanism.(20)	  In	  addition,	  studies	  on	  A549	  cells	  indicate	  the	  process	  is	  not	  either	  
clathrin	  or	  caveolae	  based.(21)	  	  
An	   alternative	   to	   endocytic	  mechanisms	   of	   uptake	   is	   direct	   physical	   disruption	   of	  
the	   membrane	   and	   the	   formation	   of	   nanoscale	   holes	   causing	   plasma	   membrane	  
permeability.	   	   AFM	   observations	   have	   revealed	   that	   polycationic	   polymers	   cause	  
nanoscale	  hole	  formation,	  expansion	  of	  pre-­‐existing	  defects,	  or	  membrane	  thinning	  
depending	  on	  physical	  properties	  of	  polymers	  such	  as	  structure,	  size,	  and	  terminal	  
groups,	   as	   well	   as	   membrane	   composition	   and	   phase.(6,	   9,	   22-­‐25)	   	   Particularly,	  
efficiency	   of	   hole	   formation	   in	   supported	   lipid	   bilayers	   induced	   by	   PAMAM	  
dendrimers	  was	  concluded	  to	  be	  proportional	  to	  molecular	  weight	  (G7	  >	  G5	  >	  G3)	  as	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well	   as	   terminal	   end	  groups	   (amine	  >	   acetamide;	   i.e.	   charged	  >	  uncharged)	  of	   the	  
dendrimers.	   	   Recent	   studies	   across	   a	   broad	   variety	   of	   cationic	   nanomaterials	  
suggests	   that	  surface	  area	   is	   the	  single	  best	  correlate.(26)	  This	  observation	  agrees	  
with	   in	   vivo	   studies	   carried	   out	   by	   Oberdörster	   et	   al.(27)	   AFM	   studies	   using	  
supported	   lipid	   bilayers	   were	   consistent	   with	   our	   in	   vitro	   results	   exploring	   cell	  
membrane	   permeability	   and	   dendrimer	   internalization.(6,	   8,	   9)	   	   Employing	   two	  
tumor	   cell	   lines,	   KB	   and	   Rat2,	   cytosolic	   enzyme	   (LDH	   and	   luciferase)	   leakage,	  
dendrimer	  internalization,	  and	  small	  molecule	  diffusion	  in	  and	  out	  of	  the	  cells	  were	  
observed	  as	  a	  result	  of	  incubation	  with	  positively	  charged	  G7	  PAMAM	  dendrimers	  as	  
illustrated	   in	   Figure	   2.1.	   	   We	   thus	   concluded	   that	   the	   cellular	   level	   data	   for	   the	  
interaction	   of	   cationic	   PAMAM	   dendrimers	   with	   cell	   membranes	   was	   consistent	  
with	  induction	  of	  nanoscale	  hole	  formation	  and	  that	  this	  process	  may	  be	  related	  to	  
the	   internalization	   of	   these	   materials	   into	   the	   cell	   and/or	   the	   membrane	  
permeability	  measured	  by	  dye	  diffusion	  and	  LDH	  assays.(6,	  8,	  9)	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Figure	  2.1.	  Schematic	  diagram	  of	  the	  proposed	  nanoscale	  hole	  formation	  mechanism	  
induced	   by	   positively	   charged	   PAMAM	   dendrimers.	   	   The	   data	   supporting	   this	  
schematic	  summary	  is	  presented	  in	  this	  paper	  as	  well	  as	  in	  our	  previous	  reports.	  
	  
Considering	   the	   recent	   reports	   on	   endocytic	   internalization(16-­‐21)	   and	   nanoscale	  
hole	   formation,(6,	   8,	   9,	   26)	   we	   decided	   to	   investigate	   the	   role	   of	   GM1	   in	   the	  
interaction	  of	  PAMAM	  dendrimers	  with	  cells.	   	  Experiments	  were	  designed	  probing	  
the	   roles	  of	  GM1	   in	  endocytosis	  and/or	  nanoscale	  hole	   formation.	   	  Experiments	   to	  
test	   other	   key	  hypothesis	   such	   as	   clathrin	  pathways	  were	   also	   explored.	   	   For	   this	  
study,	  G7	  PAMAM	  conjugates	  were	  chosen	  because	  of	  their	  effectiveness	  in	  terms	  of	  
both	   endocytosis	   and	   cell	   membrane	   disruption	   and	   because	   they	   had	   been	  
observed	   to	   cause	   membrane	   permeability	   even	   at	   4	   ºC.(6,	   8,	   9,	   28,	   29)	   	   Three	  
different	   types	   of	   G7	   PAMAM	   dendrimer-­‐AlexaFluor®488	   conjugates	   (amine,	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acetamide,	  and	  carboxylate	  terminated)	  were	  synthesized	  and	  characterized	  (Figure	  
2.2).	   	   The	   conjugates	   were	   then	   tested	   in	   vitro	   to	   explore	   dendrimer/cell	  
interactions.	  	  The	  key	  findings	  in	  this	  paper	  are:	  	  1)	  no	  evidence	  is	  found	  for	  a	  GM1	  
dependence	   of	   G7	   PAMAM	   dendrimer	   with	   respect	   to	   internalization	   via	  
endocytosis	  or	  nanoscale	  hole	  formation	  2)	   	  the	  presence	  of	  GM1	  in	  the	  membrane	  
does	  not	  play	  a	  role	  in	  cell	  viability	  assays	  as	  measured	  by	  XTT	  	  3)	  	  the	  presence	  of	  
GM1	  in	  the	  membrane	  does	  not	  play	  a	  role	  in	  plasma	  membrane	  permeability	  assays	  
as	  measured	  by	  LDH.	  
	  
	  
Figure	   2.2.	   Synthetic	   routes	   for	   G7	   PAMAM	   dendrimer	   conjugates	   with	   various	  
surface	  end	  groups.	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2.3 Experimental	  Methods	  
2.3.1 Materials	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
G7	  and	  G5	  PAMAM	  dendrimers	  were	  synthesized	  at	   the	  Michigan	  Nanotechnology	  
Institute	  for	  Medicine	  and	  Biological	  Sciences	  and	  purified	  using	  ultrafiltration	  and	  
dialysis	  before	  use.	  	  Alexa	  Fluor®488	  carboxylated,	  succinimidyl	  ester	  (AF488)	  was	  
supplied	  by	  Molecular	  Probes	   (Eugene,	  OR)	  and	  used	  without	   further	  purification.	  	  
Tranferrin	  from	  human	  serum	  labeled	  by	  AlexaFluor®546	  (TF-­‐AF546),	  recombinant	  
cholera	  toxin	  subunit	  B-­‐Alexa	  Fluor®647	  conjugate	  (CTB-­‐AF647),	  and	  LysoTracker®	  
Red	   DND-­‐99	   (LysoTracker)	   were	   provided	   by	   Molecular	   Probes.	   	   Methyl-­‐β-­‐
cyclodextrin	   (MβCD),	   and	   GM1-­‐pyrene	   were	   purchased	   from	   Sigma-­‐Aldrich	   (St.	  
Louis,	  MO)	  and	  used	  without	   further	  purification.	   	  Materials	   for	  native	  PAGE	  were	  
obtained	  from	  Invitrogen.	  	  All	  other	  chemicals	  were	  acquired	  from	  Aldrich	  and	  used	  
as	  received.	   	  Water	  used	  in	  this	  work	  was	  purified	  by	  Milli-­‐Q	  Plus	  185	  system	  and	  
had	  a	  resistivity	  higher	  than	  18.0	  MΩ/cm.	  	  	  
	  
2.3.2 Preparation	  of	  PAMAM	  Dendrimer	  Conjugates	  and	  Their	  Surface	  
Modification	  	  
Two	  milligrams	  of	  AF488	  (6.20	  μM,	  5	  times	  excess	  to	  G7)	  dissolved	  in	  400	  μL	  DMSO	  
were	  conjugated	  to	  68	  mg	  of	  the	  purified	  G7	  PAMAM	  dendrimers	  (1.25	  μM)	  under	  
the	  presence	  of	  2	  mL	  of	  1	  M	  NaHCO3	  at	  room	  temperature	  for	  48	  hrs.	  	  The	  resulting	  
reaction	  mixture	  was	  then	  dialyzed	  in	  water	   for	  2	  days	  and	  lyophilized	  for	  2	  days,	  
followed	  by	  5	  times	  of	  ultrafiltration	  with	  water	  using	  an	  80,000	  molecular	  weight	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cut-­‐off	   membrane	   at	   21	   °C,	   5000	   rpm	   for	   30	   min	   each.	   	   Sixty	   milligrams	   of	   a	  
yellowish	  powder	  (G7-­‐AF488-­‐NH2)	  were	  finally	  obtained	  (yield:	  86%).	  	  The	  average	  
number	  of	  AF488	  dye	  molecules	  present	  was	  determined	  by	   1H	  NMR	  and/or	  GPC.	  	  
The	   materials	   used	   in	   these	   studies	   varied	   from	   2.4	   –	   4	   AF488	   per	   dendrimer.	  	  
Twenty-­‐two	  milligrams	  of	  G7-­‐AF488-­‐NH2	  were	  allowed	  to	  react	  with	  12	  μL	  of	  acetic	  
anhydride	  (50%	  mol	  excess	  to	  the	  conjugate)	  in	  1.5	  mL	  MeOH	  as	  a	  solvent	  at	  room	  
temperature	  for	  24	  hrs.	  	  The	  reaction	  mixture	  was	  then	  purified	  by	  ultrafiltration	  at	  
the	   same	   condition	   above	   with	   PBS	   (w/o	   Ca2+,	   Mg2+)	   and	   water	   subsequently	   5	  
times	  for	  each.	  	  After	  lyophilization	  for	  2	  days,	  16.25	  mg	  of	  a	  yellowish	  powder	  (G7-­‐
AF488-­‐Ac)	  was	  obtained	   (yield:	  63%).	   	  Twenty	  milligrams	  of	  G7-­‐AF488-­‐NH2	  were	  
also	  allowed	  to	  react	  with	  11	  mg	  succinic	  anhydride	  (50%	  excess	  to	  the	  conjugate)	  
in	   1.5	   mL	   DMSO	   at	   room	   temperature	   for	   24	   hrs	   followed	   by	   ultrafiltration	   and	  
lyophilization	   at	   the	   same	   condition	   used	   for	   preparation	   of	   G7-­‐AF488-­‐Ac.	   	   A	  
yellowish	   powder	   (18.8	   mg)	   was	   obtained	   (G7-­‐AF488-­‐COOH,	   yield:	   67%).	   	   The	  
synthetic	  routes	  for	  the	  three	  different	  conjugates	  are	  summarized	  in	  Figure	  2.2.	  	  In	  
addition,	   G5	   PAMAM	   dendrimers	   used	   in	   the	   XTT	   assay	   (Figure	   2.3)	   were	   also	  
conjugated	   with	   6-­‐carboxy-­‐tetramethylrhodamine	   (6-­‐TAMRA)	   followed	   by	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2.3.3 Characterization	  of	  the	  Prepared	  PAMAM	  Based	  Conjugates:	  UV/Vis	  and	  
1H	  NMR	  Spectroscopy	  
UV/Vis	   spectra	   of	   the	   G7	   PAMAM	   conjugates	   were	   measured	   on	   Perkin	   Elmer	  
UV/Vis	   spectrometer	  Lambda	  20	   (Wellesley,	  MA).	   	  Molar	  extinction	  coefficients	  of	  
the	   dendrimer	   conjugates	   were	   also	   calculated	   by	   plotting	   maximum	   absorbance	  
values	  against	  conjugate	  concentrations	  at	  20,	  40,	  60,	  80,	  and	  100	  μg/mL	  using	  the	  
Lambert-­‐Beer	   law	   (Table	   2.1).	   	   1H	  NMR	   spectra	  were	   also	   taken	   in	  D2O	   and	  were	  
used	   to	  provide	   integration	   values	   for	   structural	   analysis	   using	   a	  Bruker	  AVANCE	  
DRX	  500	  instrument.(31)	  	  
Table	  2.1.	  Molar	  extinction	  coefficients,	  molar	  masses,	  and	  polydispersity	  indices	  of	  
G7	  conjugates	  
	  
a	  Molar	   extinction	   coefficients	   were	   obtained	   from	   the	   Lambert-­‐Beer	   equation	   by	   plotting	   λmax	   against	   corresponding	  
concentrations	   of	   a	   conjugate	   (20,	   40,	   60,	   80,	   and	   100	  μg/mL).	  R2	  values	   of	   the	   linear	   regressions	  were	   0.9966-­‐0.999.	   The	  
coefficients	   were	   calculated	   on	   the	   basis	   of	   UV	   characteristic	   peaks	   of	   conjugated	   AF488	  at	   497	   nm.	   b	  Calculated	   from	   the	  
measured	   molecular	   weight	   of	   starting	   G7-­‐NH2	  by	   assuming	   that	   the	   G7	   PAMAM	   dendrimers	   have	   4	   AF488	   moieties	   per	  
dendrimer	  and	  427	  surface	  terminal	  groups	  according	  to	  the	  previously	  reported	  curve	  fit	  (30).	  Measured	  by	  GPC	  (Mn,	  Number	  
average	  molecular	  weight;	  Mw,	  Weight	  average	  molecular	  weight).	  d	  Obtained	  from	  HPLC	  chromatograms.	  
	  
2.3.4 Characterization	  of	  the	  Prepared	  PAMAM	  Based	  Conjugates:	  GPC	  and	  
HPLC	  
The	   molar	   mass	   moments	   and	   molar	   mass	   distribution	   of	   each	   polymer	   sample	  
were	  measured	  using	  gel	  permeation	  chromatography	  (GPC).	  	  The	  number	  average	  
molecular	  weight	  (Mn)	  and	  polydispersity	  index	  (PDI),	  a	  commonly	  used	  measure	  of	  
the	  breadth	  of	   the	  molar	  mass	  distribution	  defined	   as	   the	   ratio	   of	   the	  weight	   and	  
number	   average	   molecular	   weights	   (Mw/Mn),	   of	   individual	   samples	   are	   listed	   in	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Table	   2.1.	   	   GPC	   experiments	   were	   performed	   using	   an	   Alliance	   Waters	   2690	  
separation	  module	   (Waters	   Corp.,	  Milford,	  MA)	   equipped	  with	   a	  Waters	   2487	  UV	  
absorbance	   detector	   (Waters	   Corp.),	   a	  Wyatt	   Dawn	  DSP	   laser	   photometer	   (Wyatt	  
Technology	  Corp.,	  Santa	  Barbara,	  CA),	  an	  Optilab	  DSP	  interferometric	  refractometer	  
(Wyatt	  Technology	  Corp.),	  and	  TosoHaas	  TSK-­‐Gel	  Guard	  PHW	  06762	  (75×7.5	  mm,	  
12	  µm),	  G	  2000	  PW	  05761	  (300	  ×	  7.5	  mm,	  10	  µm),	  G	  3000	  PW	  05762	  (300	  ×	  7.5	  
mm,	  10	  µm),	  and	  G	  4000	  PW	  (300	  ×	  7.5	  mm,	  17	  µm)	  columns.	  	  A	  detailed	  procedure	  
of	  the	  GPC	  measurement	  was	  described	  elsewhere.(9,	  31)	  	  
The	  reverse-­‐phase	  (RP)	  HPLC	  system	  (Beckman	  Coulter,	  Fullerton,	  CA)	  consisting	  of	  
a	  System	  GOLD	  126	  solvent	  module,	  a	  model	  507	  autosampler	  equipped	  with	  a	  100	  
μL	  loop,	  and	  a	  model	  166	  UV	  detector	  were	  used	  in	  this	  study	  as	  well.	  	  A	  Jupiter	  C5	  
silica-­‐based	   RP-­‐HPLC	   column	   (250	   ×	   4.6	   mm,	   300	   Å)	   was	   purchased	   from	  
Phenomenex	  (Torrance,	  CA).	   	  Two	  Phenomenex	  Widepore	  C5	  safety	  guards	  (4	  ×	  3	  
mm)	  were	  also	  installed	  ahead	  of	  the	  Jupiter	  column.	  	  The	  mobile	  phase	  for	  elution	  
of	   G7-­‐AF488	   dendrimer	   conjugates	   with	   different	   terminal	   groups	   was	   a	   linear	  
gradient	   beginning	   from	   100:0	   (v/v)	   water/acetonitrile	   (ACN)	   to	   50:50	   (v/v)	  
water/ACN	  at	  a	  flow	  rate	  of	  1	  mL/min	  for	  40	  min.	  	  Trifluoroacetic	  acid	  (TFA)	  at	  0.14	  
wt	  %	  concentration	  in	  water	  as	  well	  as	  in	  ACN	  was	  used	  as	  counter-­‐ions	  to	  make	  the	  
dendrimer	  surfaces	  hydrophobic.	   	  All	  the	  samples	  were	  dissolved	  into	  the	  aqueous	  
mobile	  phase	  (water	  containing	  0.14%	  TFA)	  at	  the	  concentration	  of	  1	  mg/mL.	  The	  
detection	  of	  eluted	  samples	  was	  performed	  at	  210	  nm.	  	  The	  analysis	  was	  performed	  
using	  Beckman's	  System	  GOLD	  Nouveau	  software.(32)	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2.3.5 Characterization	  of	  the	  Prepared	  PAMAM	  Based	  Conjugates:	  Capillary	  
Electrophoresis	  (CE)	  
An	   Agilent	   Technologies	   (Waldbronn,	   Germany)	   CE	   instrument	   was	   used	   in	   this	  
work.	  Unmodified	  quartz	  capillaries	  were	  purchased	   from	  Polymicro	  Technologies	  
(Phoenix,	   AZ,	   USA).	   	   The	   voltage	  was	   kept	   at	   20	   kV.	   	   On-­‐capillary	  UV	   diode-­‐array	  
detection	  was	  used,	  operating	  at	  wavelengths	  of	  210	  nm,	  250	  nm,	  280	  nm	  and	  495	  
nm.	  	  Samples	  were	  introduced	  by	  hydrodynamic	  injection	  at	  a	  pressure	  of	  50	  mbar.	  	  
For	   analysis	   of	   G7-­‐AF488	   conjugates	   with	   amino	   and	   acetamide	   terminal	   groups,	  
silanized	  capillaries	  (i.d.	  100	  µm)	  with	  total	  length	  of	  48.5	  cm	  and	  effective	  length	  of	  
40	   cm	  were	   employed	   following	   previous	   literature.(33)	   	   G7-­‐AF488-­‐NH2	   and	   G7-­‐
AF488-­‐Ac	   conjugates	   were	   dissolved	   in	   pH	   2.5	   phosphate	   buffer	   and	   the	   sample	  
solutions	   were	   adjusted	   to	   pH	   2.5	   using	   0.1	   M	   phosphoric	   acid	   to	   give	   a	  
concentration	   of	   1	   mg/ml.	   	   All	   the	   conjugates	   contained	   0.05	   mg/mL	   2,3-­‐
diaminopyridine	  (2,3-­‐DAP)	  as	  an	  internal	  standard.	  	  	  
For	   analysis	   of	   G7-­‐AF488	   conjugate	   with	   carboxyl	   terminal	   groups,	   bare	   silica	  
capillaries	   (i.d.	   75	  µm)	  with	   total	   length	   of	   64.5	   cm	   and	   effective	   length	   of	   56	   cm	  
were	   used	   for	   the	   characterization	   of	   G7-­‐AF488-­‐COOH	   conjugates.	   	   The	   capillary	  
temperature	  was	  maintained	  at	  20	  °C.	  	  Before	  use,	  the	  uncoated	  silica	  capillary	  was	  
pretreated	  by	   rinsing	  with	  1	  M	  NaOH	   (15	  min),	   deionized	  water	   (Purchased	   from	  
Agilent)	   (15	   min)	   and	   running	   buffer	   (15	   min).(33)	   	   Before	   each	   injection,	   the	  
capillary	  was	  rinsed	  with	  a	  similar	  sequence	  of	  each	  eluent.	   	  20	  mM	  borate	  buffer	  
(pH	   8.3)	   was	   used	   as	   the	   running	   buffer.	   	   G7-­‐AF488-­‐COOH	   conjugates	   were	  
dissolved	  in	  the	  running	  buffer	  and	  the	  sample’s	  pH	  was	  adjusted	  to	  8.3	  with	  20	  mM	  
	   20	  
sodium	   tetraborate	   solution	   to	   get	   a	   final	   concentration	   of	   1	   mg/mL.	   	   4-­‐
Methoxybenzyl	  alcohol	  (MBA)	  (0.05	  mg/mL)	  was	  used	  as	  a	  neutral	  marker.	  	  
2.3.6 Cell	  Lines	  
The	   KB,	   Rat2,	   and	   C6	   cell	   lines	  were	   purchased	   from	   the	   American	   Type	   Culture	  
Collection	  (ATCC,	  Manassas,	  VA)	  and	  grown	  continuously	  as	  a	  monolayer	  at	  37	  °C,	  
and	  5%	  CO2.	  	  The	  KB	  cells	  were	  grown	  in	  RPMI	  1640	  medium	  (Mediatech,	  Herndon,	  
VA).	   The	   Rat2	   and	   C6	   cells	   were	   grown	   in	   Dulbecco’s	   modified	   Eagle’s	   medium	  
(DMEM,	   Gibco,	   Eggenstein,	   Germany).	   	   The	   RPMI	   1640	   and	   DMEM	   media	   were	  
supplemented	  with	  penicillin	  (100	  units/mL),	  streptomycin	  (100	  μg/mL),	  and	  10%	  
heat-­‐inactivated	  fetal	  bovine	  calf	  serum	  (FBS)	  before	  use.	  	  	  
2.3.7 XTT	  Cytotoxicity	  Assay	  
Cytotoxicity	   of	   the	   dendrimer	   conjugates	   used	   in	   this	   study	   was	   assessed	   by	   the	  
overall	   activity	   of	   mitochondrial	   dehydrogenase	   by	   2,3-­‐bis(2-­‐methoxy-­‐4-­‐nitro-­‐5-­‐
sulfophenyl)-­‐2H-­‐tetrazolium-­‐5-­‐carboxanilide	   (XTT)	   assay	   (Cell	   Proliferation	   Kit	   II,	  
Roche	  Molecular	  Biochemicals,	  Mannheim,	  Germany).	  	  KB,	  Rat2,	  and	  C6	  cell	  lines	  (at	  
a	  concentration	  of	  5	  ×	  104	  cells/well)	  were	  prepared	  as	  monolayers	  in	  96	  well	  plates,	  
followed	   by	   incubation	  with	   dendrimers	   in	   phosphate	   buffered	   saline	   (PBS)	  with	  
Ca2+	  and	  Mg2+	  at	  37	  °C	  under	  5%	  CO2	  for	  4.5	  hrs	  (2	  h	  for	  C6	  cells).	  	  Polymer	  solutions	  
(supernatants)	   were	   then	   removed,	   followed	   by	   washing	   with	   PBS	   twice.	  	  
Mitochondrial	   activities	  of	   the	   cells	  were	   spectrophotometrically	  measured	  at	  492	  
nm	  using	  a	  Spectra	  Max	  340	  ELISA	  Reader	  (Molecular	  Devices,	  Sunnyvale,	  CA).	  	  Cell	  
viability	  was	  then	  calculated	  based	  on	  optical	  density	  (OD)	  from	  untreated	  cells.	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2.3.8 LDH	  Membrane	  Permeability	  Assay	  
Membrane	  permeability	  was	  tested	  via	  lactate	  dehydrogenase	  (LDH)	  leakage	  using	  
the	   LDH	   assay	   kit	   (Promega,	   Madison,	  WI).	   	   	   The	   activity	   of	   LDH	   in	   extracellular	  
media	   is	   taken	   as	   a	   measure	   of	   membrane	   porosity.	   	   C6	   cells	   were	   seeded	   at	   a	  
density	  of	  5	  ×	  104	  cells/well	  in	  96	  well	  plates	  for	  overnight	  incubation	  at	  37	  °C	  and	  
5%	  CO2.	  	  Dendrimers	  diluted	  in	  100	  μL	  PBS	  (w/	  Ca2+,	  Mg2+)	  was	  added	  at	  specified	  
concentrations	  into	  the	  96	  well	  plates	  and	  incubated	  at	  37	  °C	  and	  5%	  CO2	  for	  2	  hrs	  
after	  which	   the	  supernatant	  was	  removed	  and	  50	  μL	  was	   taken	   for	   the	  LDH	  assay	  
(throughout	   the	   experiment	   boundary	   wells	   were	   not	   used).	   	   LDH	   activity	   was	  
spectrophotometrically	  measured	  at	  490	  nm	  using	  an	  ELISA	  reader.	  	  
2.3.9 Confocal	  Laser	  Scanning	  Microscopy	  (CLSM)	  
A	   concentration	   of	   1	   ×	   105	   cells/mL	   of	   KB	   and	   Rat2	   cells	  was	   seeded	   on	  MatTek	  
glass	  bottom	  petri	  dishes	  (35	  mm)	  and	  incubated	  at	  37	  °C	  under	  5%	  CO2	  for	  24	  hrs.	  	  
The	   cell	   culture	   medium	   was	   removed	   and	   2	   mL	   of	   each	   dendrimer-­‐AF488	  
conjugates	  in	  PBS	  (w/	  Ca2+,	  Mg2+)	  solution	  was	  added	  into	  the	  appropriate	  dish.	  	  The	  
dishes	  were	  incubated	  with	  added	  solutions	  either	  at	  37	  °C	  under	  5%	  CO2	  for	  1	  hr	  or	  
at	  4	  °C.	  	  For	  the	  low	  temperature	  experiment,	  cells	  were	  pre-­‐incubated	  at	  4	  °C	  for	  10	  
min	   before	   adding	   the	   dendrimer	   solutions.	   	   The	   conjugate-­‐containing	   solutions	  
were	  removed	  and	  the	  resulting	  cell	  monolayer	  was	  washed	  with	  PBS	  at	  least	  three	  
times.	   	  Cells	  were	  fixed	  with	  2%	  formaldehyde	  in	  the	  PBS	  (w/	  Ca2+,	  Mg2+)	  at	  room	  
temperature	  for	  10	  min,	  followed	  by	  washing	  with	  PBS	  twice.	  	  	  
For	  co-­‐localization	  studies	  of	  dendrimers	  with	  CTB	  and	  transferrin	  on	  KB	  and	  Rat2	  
cells,	   dendrimer	   solutions	   were	   pre-­‐mixed	   with	   markers,	   resulting	   in	   final	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concentrations	  of	  200	  nM,	  10	  µg/mL,	  and	  50	  µg/mL	  for	  G7-­‐AF488-­‐NH2,	  CTB-­‐AF647,	  
and	  TF-­‐AF546,	  respectively.	   	  The	  mixed	  solutions	  were	  then	  added	  to	  KB	  and	  Rat2	  
cells	  and	  the	  cells	  were	  incubated	  at	  37	  ºC,	  5%	  CO2	  for	  1	  hr.	  	  	  
For	   co-­‐localization	   studies	   of	   CTB	   and	   G7-­‐NH2	  dendrimers	   on	   C6	   cells,	   cells	  were	  
seeded	   in	   Fisherbrand	   2	  well	  microscope	   cover	   glass	   #	   1.5	   at	   2.5	   ×	   105	   cells/mL	  
density,	  with	  1	  mL	  complete	  media	  in	  each	  well.	  	  Cells	  were	  allowed	  to	  attach	  to	  the	  
surface	  for	  4	  hrs	  after	  which	  wells	  were	  washed	  with	  PBS	  (w/	  Ca2+,	  Mg2+)	  and	  then	  
overnight	   incubated	  with	  media	   (w/o	   serum)	   containing	   GM1-­‐pyrene.	   	   Cells	  were	  
then	  treated	  with	  5	  μg/mL	  CTB-­‐AF647	  for	  1	  hr	  or	  500	  nM	  G7-­‐AF488-­‐NH2-­‐	  for	  2	  hrs,	  
washed	  with	  PBS,	  and	  imaged	  in	  PBS	  solution.	  
For	  co-­‐incubation	  of	  KB	  cells	  with	  G7-­‐AF488-­‐NH2	  and	  fully	  acetylated	  G5	  PAMAM-­‐6-­‐
TAMRA	  conjugates	  (G5-­‐6T-­‐Ac),(34)	  KB	  cells	  were	  incubated	  with	  100,	  200,	  and	  400	  
nM	  G7-­‐AF488-­‐NH2	  at	  37	  ºC	  for	  30	  min	  followed	  by	  addition	  of	  1	  μM	  G5-­‐6T-­‐Ac	  with	  
additional	  incubation	  for	  30	  min.	  
Confocal	   and	   differential	   interference	   contrast	   (DIC)	   images	   were	   taken	   on	   an	  
Olympus	  FV-­‐500	  confocal	  microscope	  using	  either	  a	  60X,	  1.5	  NA	  or	  a	  100X,	  1.4	  NA	  
oil	  immersion	  objective.	  	  For	  the	  confocal	  images	  using	  three	  different	  AlexaFluors,	  
the	  488	  nm	  line	  of	  an	  argon	  ion	  laser	  (for	  dendrimer	  conjugates),	  543	  nm	  line	  of	  a	  
HeNeG	  laser	  (for	  transferrin	  and	  LysoTracker),	  or	  633	  nm	  line	  of	  a	  HeNeR	  laser	  (for	  
cholera	   toxin)	   was	   used	   for	   excitation	   and	   the	   emission	   was	   filtered	   at	   505-­‐525,	  
560-­‐600,	  660	  IF	  nm,	  respectively.	  	  Percentages	  of	  overlapping	  between	  two	  markers	  
in	  the	  confocal	  images	  were	  quantified	  using	  Metamorph	  offline	  software	  version	  6-­‐
3r7	  provided	  by	  Molecular	  Devices	  (Downingtown,	  PA).	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2.4 Results	  
2.4.1 Synthesis	  and	  Characterization	  of	  G7	  PAMAM/AlexaFluor	  488	  
Conjugates	  with	  Various	  Surface	  End	  Groups	  
G7	   PAMAM	   dendrimers	   were	   conjugated	   with	   AF488	   dye	   to	   allow	   confocal	   laser	  
scanning	  microscopy	  (CLSM)	  studies.	  	  AF488	  was	  chosen	  for	  this	  study	  because	  this	  
fluorophore	   is	   known	   to	   exhibit	   brighter	   fluorescence	   and	   greater	   photostability	  
than	  other	  spectrally	  similar	  fluorophores	  (300%	  more	  photostable	  than	  fluorescein	  
(FITC)	  at	  90	  sec.	  exposure)	  as	  well	  as	  greater	  pH	  insensitivity	  between	  pH	  4.0	  and	  
10.0.(35)	   	  The	  synthesis	   scheme	   for	   the	  conjugates	   is	   illustrated	   in	  Figure	  2.2.	   	   1H	  
NMR	  spectra	  for	  all	  three	  conjugates	  are	  provided	  in	  Figure	  2.S1.	  	  After	  conjugation	  
with	  AF488,	   characteristic	   peaks	   for	   the	   conjugated	  dyes	  molecules	   appear	   in	   the	  
range	   of	   δ	   6.8-­‐8.4	   ppm.	   	   The	   1H	  NMR	   spectrum	   of	   G7-­‐AF488-­‐Ac	   (Figure	   2.S1c)	   is	  
consistent	   with	   the	   previously	   published	   spectra	   using	   G5	   PAMAM.(31)	   	   UV/Vis	  
spectra	  reveal	  that	  maximum	  absorbance	  of	  AF488	  shifted	  from	  495	  to	  497	  nm	  after	  
conjugation	  with	   the	  dendrimer.	   	  Calculated	  molar	  extinction	  coefficients	  decrease	  
with	   the	   increase	   of	  molecular	  weights	   of	   the	   conjugates	   providing	   a	   rough	   guide	  
when	   the	   surface	  modification	   from	   primary	   amine	   end	   groups	   to	   acetamide	   and	  
carboxylate	  end	  groups	  is	  successfully	  performed	  (see	  Table	  2.1).	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Figure	  2.S1.	  1H	  NMR	  spectra	  of	  a)	  starting	  G7	  PAMAM	  dendrimers	  (G7-­‐NH2),	  b)	  G7-­‐
AF488	  conjugates	  with	  amine	  end	  groups	  (G7-­‐AF488-­‐NH2),	  c)	  G7-­‐AF488	  conjugates	  
with	   acetamide	   end	   groups	   (G7-­‐AF488-­‐Ac),	   and	   d)	   G7-­‐AF488	   conjugates	   with	  
carboxylate	  end	  groups	  (G7-­‐AF488-­‐COOH).	  Inset	  spectra	  are	  enlarged	  characteristic	  
peaks	  of	  AlexaFluor®488.	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HPLC	   chromatograms	   of	   the	   prepared	   G7	   PAMAM	   dendrimer	   conjugates	   are	  
provided	   in	  Figure	  2.S2.	   	  All	   the	   conjugates	   exhibit	   a	   single	  peak	  and	   it	   is	   notable	  
that	  no	  peak	   is	  present	   for	   free	  AF488	  in	  the	  chromatograms.	   	  The	  peak	  widths	  at	  
half-­‐height	  of	  all	  the	  dendrimers	  are	  ranged	  from	  0.49	  to	  0.62	  min	  indicate	  that	  the	  
dendrimer	   conjugates	   are	   relatively	   monodisperse	   compared	   to	   other	   types	   of	  
condensation	   polymers	   with	   molecular	   weights	   of	   >	   100,000	   g/mol.	   	   This	   is	  
consistent	  with	  GPC	  results	  presented	  in	  Table	  2.1.(32)	  In	  order	  to	  provide	  an	  even	  
more	   stringent	   assessment	   of	   polymer	   homogeneity,	   the	   same	   materials	   were	  
characterized	  using	  CE.(9,	  33,	  36-­‐38)	  The	  G7-­‐NH2	  dendrimer	  exhibits	  multiple	  peaks	  
which	  persists,	  with	  a	  change	   in	   relative	  magnitude,	  after	  conjugation	  with	  AF488	  
(Figure	  2.S3b).	  	  After	  surface	  modification	  with	  acetamide	  and	  carboxylate	  groups	  is	  
performed,	   the	   dendrimer	   conjugates	   produce	   sharper	   peaks	   although	   a	  multiple	  
peak	  structure	  is	  still	  apparent	  for	  G7-­‐AF488-­‐Ac.	  	  	  
	  
Figure	  2.S2.	  HPLC	  chromatograms	  of	  the	  dendrimer	  based	  conjugates.	  All	  the	  curves	  
are	  normalized	  based	  on	  the	  peak	  intensity	  of	  G7-­‐NH2.	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Figure	  2.S3.	  a)	  CE	  electropherograms	  and	  b)	  their	  normalized	  electropherograms	  of	  
the	   dendrimer	   based	   conjugates;	   G7-­‐NH2,	   G7-­‐AF488-­‐NH2,	   G7-­‐AF488-­‐Ac,	   and	   G7-­‐
AF488-­‐COOH	  measured	  at	  210	  nm	  (based	  on	  PAMAM	  dendrimers).	  Note	   that	  2,3-­‐
diaminopyridine	   (2,	   3-­‐DAP)	   is	   used	   as	   an	   internal	   standard	   (IS)	   for	   G7-­‐NH2,	   G7-­‐
AF488-­‐NH2,	  and	  G7-­‐AF488-­‐Ac.	  Thus	  only	  three	  curves	  are	  normalized	  in	  b)	  based	  on	  
the	   IS	   peak	   appearance.	   For	   G7-­‐AF488-­‐COOH,	   4-­‐Methoxybenzyl	   alcohol	   (MBA)	   is	  
used	  as	  a	  neutral	  marker.	  Also	  note	  that	  the	  data	  of	  G7-­‐AF488-­‐COOH	  is	  shown	  only	  
up	   to	  a	  20	  min	   time	  point	  because	  no	  additional	  peak	  was	  observed	   thereafter.	   c)	  
Electropherogram	  of	  G7-­‐AF488-­‐NH2,	  G7-­‐AF488-­‐Ac,	  and	  G7-­‐AF488-­‐COOH	  measured	  
at	  490	  nm	  (based	  on	  attached	  AF488).	  Peak	  heights	  are	  normalized	  based	  on	  the	  G7-­‐
AF488-­‐NH2	  
2.4.2 Cytotoxicity	  of	  Dendrimer	  Conjugates	  as	  Measured	  by	  XTT	  Assays	  
The	  cytotoxicity	  of	  the	  G7	  PAMAM	  conjugates	  on	  KB,	  Rat2,	  and	  C6	  cells	  in	  vitro	  was	  
explored	  using	  XTT	  assay	  (Figure	  2.3).	  	  The	  KB	  cell	  line,	  a	  variant	  of	  the	  human	  HeLa	  
line,	   and	   the	   Rat2	   cell	   line,	   a	   dermal	   fibroblast	   from	   Fisher	   Rat,	   were	   selected	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because	   they	   are	   adherent	   and	   robust	   cell	   lines	   enabling	   us	   to	   employ	   various	  
biological	   techniques.	   	  The	  C6	  cell	   line	  was	  selected	  because	   it	  contains	  caveolin-­‐1	  
but	  lacks	  GM1	  in	  the	  plasma	  membrane.	  
	  
Figure	   2.3.	   Percentage	   viability	   as	  measured	   by	   XTT	   assay	  when	   cells	   are	   treated	  
with	  various	  G5	  and	  G7	  PAMAM	  dendrimers:	  a)	  KB	  cells,	  b)	  RAT-­‐2	  cells,	  c)	  C6	  cells,	  
and	  d)	  C6	  cells.	  	  FA	  =	  folic	  acid.	  	  6T	  =	  6-­‐Tamra.	  
Amine	   terminated	   G7	   PAMAM	   dendrimers	   show	   a	   degree	   of	   cytotoxicity	   (~20%	  
toxicity)	   starting	   at	   a	   concentration	   of	   ~400	   nM	   whereas	   G5	   PAMAMs	   are	   not	  
cytotoxic	  at	  a	  concentration	  as	  high	  as	  1	  µM	  in	  both	  KB	  and	  Rat2	  cells.	  	  These	  results	  
are	   consistent	   with	   our	   previous	   report	   which	   concluded	   the	   cytotoxicity	   of	   the	  
PAMAM	  dendrimers	  is	  highly	  dependent	  on	  size	  of	  the	  macromolecules.(9)	  	  Surface	  
modification	  of	  the	  starting	  dendrimers	  significantly	  reduces	  their	  cytotoxicity.	   	  As	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shown	   in	   Figure	   2.3a	   and	   2.3b,	   G7-­‐AF488-­‐Ac,	   G7-­‐AF488-­‐COOH,	   G5-­‐6T-­‐FA	   (cancer	  
cell	   targeting	   dendritic	   nanodevices),	   and	   G5-­‐6T-­‐Ac	   do	   not	   show	   any	   significant	  
toxic	  effect	  on	  the	  both	  cell	  lines	  at	  the	  concentration	  range	  used	  in	  the	  experiment.	  	  
The	  effect	  of	  the	  presence	  of	  GM1	  in	  the	  cell	  plasma	  membrane	  on	  cytotoxicity	  was	  
explored	  using	  the	  C6	  cell	  line	  (Figure	  2.3,	  panel	  C	  and	  D).	  	  The	  C6	  cells	  exhibited	  a	  
greater	   sensitivity	   to	   G5-­‐NH2	   and	   G7-­‐NH2	   exposure	   but	   no	   differential	   effect	   was	  
observed	  as	  a	  function	  of	  the	  presence	  of	  GM1	  in	  the	  membrane.	  
2.4.3 The	  Induction	  of	  Membrane	  Permeability	  as	  Measured	  by	  LDH	  assays	  
The	  effect	  of	  GM1	  on	  the	  release	  of	  lactate	  dehydrogenase	  (LDH)	  was	  explored	  using	  
C6	  cells	   (Figure	  2.4).	   	  LDH	  release	  was	   independent	  of	   the	  presence	  of	  GM1	   in	   the	  
cell	  plasma	  membrane	  for	  exposure	  to	  G5-­‐NH2	  and	  G7-­‐NH2.	  	  By	  way	  of	  contrast,	  the	  
acetylated	  forms	  of	  the	  dendrimer,	  G5-­‐Ac	  and	  G7-­‐Ac,	  did	  not	  exhibit	  a	  concentration	  
dependent	  release	  of	  LDH.	  
 
Figure	  2.4.	  Percentage	  LDH	  release	  of	  C6	  cells	  when	  treated	  with	  a)	  G5	  and	  b)	  G7	  
	  PAMAM	  dendrimers.	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2.4.4 CLSM	  Observation:	  Surface	  Group	  Dependence	  on	  Dendrimer	  
Internalization	  
Figure	  2.5	  shows	  confocal	  images	  of	  Rat2	  cells	  after	  exposure	  to	  G7-­‐AF488-­‐NH2,	  G7-­‐
AF488-­‐Ac,	   and	   G7-­‐AF488-­‐COOH	   at	   37	   ºC,	   5%	   CO2	   for	   1	   hr.	   	   The	   cell	   nuclei	   were	  
stained	  with	  DAPI	  and	  appear	  as	  blue	   fluorescence	   in	  the	   images.	   	  Figure	  2.5d,	  5e,	  
and	  5f	   are	   digitally	   zoomed-­‐in	   images	   of	   Figure	  2.5a,	   5b,	   and	  5c,	   respectively.	   	   As	  
shown	   in	   Figure	   2.5a	   and	   5d,	   and	   confirmed	   by	   z-­‐stack	   images,	   G7-­‐AF488-­‐NH2	  
readily	  internalizes	  into	  the	  cells	  resulting	  in	  a	  punctate	  distribution	  of	  strong	  green	  
fluorescence.	   	  On	   the	  other	  hand,	   surface	  modified	  dendrimers	   (G7-­‐AF488-­‐Ac	   and	  
G7-­‐AF488-­‐COOH)	   do	   not	   interact	  with	   cell	  membrane	   or	   internalize	   into	   the	   cells	  
(Figure	   2.5b,	   c,	   e,	   and	   f).	   	   This	   is	   consistent	   with	   the	   XTT	   and	   LDH	   assay	   results	  
shown	  in	  Figures	  2.3	  and	  2.4	  as	  well	  as	  previously	  published	  AFM	  results	  indicating	  
that	  G7-­‐NH2	  is	  the	  most	  active	  with	  supported	  lipid	  bilayers.(24,	  25)	  	  These	  results	  
stand	  in	  stark	  contrast	  to	  CHARM/MD	  studies	  that	  suggest	  that	  all	  three	  dendrimers	  
should	   interact	   strongly	   with	   a	   lipid	   bilayer.(39,	   40)	   	   To	   clearly	   show	   cell	  
morphology,	   differential	   interference	   contrast	   (DIC)	   images	   of	   the	   cells	   incubated	  
with	   G7-­‐AF488-­‐Ac	   and	   G7-­‐AF488-­‐COOH	   were	   overlapped	   with	   confocal	  
fluorescence	  images	  in	  those	  images.	  	  Similar	  results	  were	  obtained	  using	  KB	  cells	  as	  
well	  (data	  not	  shown).	  
	   30	  
	  
Figure	   2.5.	   Confocal	   images	   of	   Rat2	   cells	   after	   exposure	   to	   (a)	  G7-­‐AF488-­‐NH2,	   (b)	  
G7-­‐AF488-­‐Ac,	   and	   (c)	   G7-­‐AF488-­‐COOH	   at	   37	   °C	   for	   1	   h.	   The	   concentration	   of	   the	  
dendrimer	  conjugates	  was	  at	  200	  nM.	  Images	  e,	  f,	  and	  g	  are	  digitally	  enlarged	  images	  
of	   a,	   b,	   and	   c,	   respectively.	   Images	   b,	   c,	   e,	   and	   f	   are	   overlays	   of	   confocal	   and	   DIC	  
images.	   Cell	   nuclei	   were	   stained	   by	   DAPI	   resulting	   in	   blue	   fluorescence	   in	   the	  
images.	  
	  
2.4.5 CLSM	  Observation:	  Effect	  of	  Low	  Temperature	  on	  G7-­‐NH2	  
Internalization	  	  
Figure	  2.6	  illustrates	  confocal	  images	  of	  Rat2	  cells	  after	  incubation	  with	  G7-­‐AF488-­‐
NH2	  and	  G5-­‐FITC-­‐NH2	  at	  both	  37	  ºC	  and	  4	  ºC.	   	  As	  shown	   in	  Figure	  2.6e	  and	   f,	  G5-­‐
FITC-­‐NH2	   penetrates	   into	   the	   cells	   at	   37	   ºC	   whereas	   they	   do	   not	   internalize	   but	  
associate	   with	   cell	   plasma	  membranes	   at	   4	   ºC,	   which	   is	   in	   good	   agreement	   with	  
previously	  published	  images.(9)	  Although	  G7-­‐AF488-­‐NH2	  internalization	  is	  reduced	  
at	   the	   lowered	   temperature	   by	   ~60%	   as	   measured	   by	   FACS,	   the	   dendrimers	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internalize	  into	  the	  cells	  not	  only	  at	  37	  ºC	  but	  also	  at	  4	  ºC	  as	  shown	  in	  Figure	  2.6a	  
and	  6b.	   	   It	  can	  be	  more	  clearly	  observed	  in	  the	  zoomed-­‐in	  image	  (Figure	  2.6d).	   	  Z-­‐
stack	  images	  of	  Figure	  2.6d	  also	  confirm	  internalization	  of	  the	  dendrimers	  (data	  not	  
shown).	   	   The	   intracellular	   distribution	   pattern	   of	   fluorescence	   in	   Figure	   2.6d	   is	  
slightly	   different	   from	   that	   of	   Figure	   2.6b.	   	   Less	   punctate	   distribution	   of	   the	  
dendrimers	  in	  the	  cytosol	  is	  observed	  in	  Figure	  2.6d	  (the	  low	  temperature	  case)	  as	  
compared	  intracellular	  distribution	  of	  the	  dendrimers	  in	  Figure	  2.6b.	  
	  
Figure	  2.6.	  Confocal	  images	  of	  Rat2	  cells	  after	  incubation	  with	  G7-­‐AF488-­‐NH2	  at	  (a)	  
37	   °C	   and	   (c)	   4	   °C,	   both	   for	   1	   h.	   Images	   b	   and	   d	   are	   enlarged	   images	   of	   a	   and	   c,	  
respectively.	  Concentration	  of	  the	  dendrimer	  conjugates	  was	  200	  nM.	  Note	  that	  G7-­‐
AF488-­‐NH2	  penetrates	  into	  the	  cells	  even	  at	  the	  low	  temperature.	  Controls	  using	  G5-­‐
FITC-­‐NH2	  at	  (e)	  37	  °C	  and	  (f)	  4	  °C.	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2.4.6 CLSM	  Observation:	  Intracellular	  Co-­‐localization	  of	  G7-­‐NH2	  with	  
Endocytic	  Markers	  
The	  generally	  reported	  endocytic	  pathways	  for	  large	  molecules	  such	  as	  biomedical	  
polymers	  and	  cell-­‐penetrating	  peptides	  (CPPs)	  include	  clathrin-­‐dependent	  and	  lipid	  
raft-­‐mediated	  endocytosis.(2,	  41)	  	  We	  employed	  commonly	  used	  endocytic	  markers,	  
transferrin	   for	   clathrin	   dependent	   pathways	   and	   CTB	   for	   lipid	   raft-­‐mediated	  
endocytosis	   to	   explore	   the	   mechanism	   of	   dendrimer	   uptake.(41,	   42)	   	   Direct	  
observation	  of	  intracellular	  localization	  of	  the	  markers	  using	  CLSM	  was	  enabled	  by	  
employing	  markers	   labeled	  by	  different	  AlexaFluors.	   	   As	   shown	   in	   Figure	  2.7,	  G7-­‐
AF488-­‐NH2	   (green	   fluorescence)	   is	   co-­‐localized	   with	   CTB-­‐AF647	   (purple	  
fluorescence)	  whereas	  intracellular	  localization	  of	  TF-­‐AF546	  is	  different	  from	  those	  
of	  dendrimers	  and	  CTB	   in	  both	  KB	  and	  Rat2	  cells.	   	  The	  quantified	  pixel	  counts	   for	  
overlapped	  pixels	   using	  Metamorph	   software	   indicate	   the	   co-­‐localization	  between	  
G7-­‐AF488-­‐NH2	  and	  CTB-­‐AF647	  is	  88%	  and	  68%	  for	  KB	  and	  Rat2	  cells,	  respectively.	  	  
In	   contrast,	   co-­‐localization	   as	   indicated	   by	   quantification	   of	   overlapped	   pixels	   for	  
G7-­‐AF488-­‐NH2	  and	  TF-­‐AF546	  was	  10	  and	  17	  %	  for	  KB	  and	  Rat2	  cells,	  respectively.	  
Co-­‐localization	  with	  CTB	  is	  commonly	  taken	  as	  evidence	  for	  GM1	  interactions	  and	  a	  
raft	  mediated	  endocytosis	  mechanism.(41)	  	  In	  order	  to	  directly	  test	  this	  hypothesis,	  
internalization	  of	  CTB	  and	  G7-­‐NH2	  was	  tested	  using	  C6	  cells.	   	   In	   their	  native	  state,	  
these	  cells	  contain	  little	  GM1	  in	  the	  plasma	  membrane.	  	  However,	  GM1	  can	  be	  added	  
to	   the	   membrane	   via	   incubation.	   	   Consistent	   with	   previous	   reports	   in	   the	  
literature,(43)	  CTB	  only	  internalized	  into	  C6	  cells	  that	  had	  been	  pre-­‐incubated	  with	  
GM1.	   	   However,	   G7-­‐NH2	   internalized	   independent	   of	   the	   presence	   of	   GM1	   in	   the	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plasma	  membrane	   (Figure	   2.8).	   	   Recall	   that	   the	   results	   of	   both	   the	   XTT	   and	   LDH	  
assays	  were	   independent	  of	   the	  presence	  of	  GM1	   in	   the	  C6	   cell	  plasma	  membrane	  
(Figures	  2.3	  and	  2.4).	  	  	  The	  interaction	  of	  G7-­‐NH2	  dendrimer	  and	  CTB	  was	  explored	  
using	   native	   poly(acrylamide)	   gel	   electrophoresis	   employing	   Coommassie	   blue	  
staining.	   	   The	   band	   associated	   with	   CTB	  was	   no	   longer	   present	   upon	  mixing	   the	  
dendrimer	  with	  the	  CTB	  at	  ratios	  from	  1:5	  to	  5:1.	  
	  
Figure	  2.7.	  Confocal	  images	  of	  KB	  cells	  incubated	  for	  1	  h	  with	  (a)	  200	  nM	  G7-­‐AF488-­‐
NH2,	   (b)	   50	   μg/mL	   transferrin-­‐AlexaFluor	   546	   (TF-­‐AF546),	   and	   (c)	   10	   μg/mL	  
cholera	  toxin	  subunit	  B-­‐Alexa	  Fluor	  647	  (CTB-­‐AF647)	  conjugates,	  and	  (d)	  a	  merged	  
image	   of	   those.	   Green,	   red,	   and	   purple	   fluorescence,	   respectively,	   represent	   G7-­‐
AF488-­‐NH2,	  TF-­‐AF546,	  and	  CTB-­‐AF647.	   Images	  e,	   f,	  g,	  and	  h	  are	  a	  data	  set	  of	  Rat2	  
cells	   at	   the	   same	   condition	   with	   KB	   cells.	   Note	   that	   dendrimers	   are	   colocalized	  
intracellularly	  with	  CTB	  in	  both	  cell	  lines.	  Bar:	  10	  μm.	  
	  
	   34	  
	  
Figure	  2.8.	   Confocal	   images	   of	   (a)	   C6	   cells	   having	  GM1-­‐pyrene	   (blue)	   treated	  with	  
Cholera	   toxin	   subunit	   B	   (CTB)-­‐AF647(red),	   (b)	   C6	   cells	  without	   GM1	   treated	  with	  
CTB,	   (c)	   C6	   cells	   having	   GM1-­‐pyrene	   (blue)	   treated	   with	   G7-­‐NH2-­‐AF488	   (green)	  
PAMAM	   dendrimer,	   and	   (d)	   C6	   cells	  without	   GM1	   treated	  with	   G7	   dendrimer.	   All	  
incubations	  were	   for	  1	  h.	  CTB	   is	   internalized	  only	  when	  GM1	   is	  present	   in	   the	  cell	  
membrane.	  G7-­‐NH2	  dendrimer	  is	  internalized	  independent	  of	  the	  presence	  of	  GM1	  in	  
the	  cell	  membrane.	  
	  
2.4.7 CLSM	  Observation:	  Diffusion	  of	  Neutral	  Dendrimers	  into	  cell?	  
Neutral	  dendrimers	   (G7-­‐Ac	  and	  G5-­‐Ac)	  do	  not	   interact	  with	   the	  cell	  membrane	  or	  
internalize	   into	   the	  cell	   as	   indicated	  by	  LDH	  and	  XTT	  assays	   (Figures	  2.3	  and	  2.4)	  
and	  CLSM	  experiments	  (Figure	  2.5).	   	  However,	  if	  holes	  of	  5-­‐25	  nm	  were	  created	  in	  
the	   membrane,	   G5-­‐Ac	   might	   be	   expected	   to	   enter	   the	   cell	   via	   passive	   diffusion	  
processes.	   	   Our	   previous	   studies	   have	   shown	   that	   LDH	   (135-­‐140	   kDa,	   ~	   4.3	   nm	  
diameter),	  propidium	  iodide,	  and	  fluorescein	  all	  diffusion	  across	  the	  membrane.(6)	  	  
However,	  as	  illustrated	  in	  Figure	  2.9,	  100	  nM	  G7-­‐NH2	  is	  sufficient	  to	  give	  substantial	  
internalization	   of	   dendrimer	   but	   1	   μM	   G5-­‐6T-­‐Ac	   still	   gives	   no	   detectable	  
	   35	  
internalization.	   	   Previous	   studies	   indicate	   that	   	   G7-­‐NH2	   should	   be	   about	   8	   nm	   in	  
diameter	  and	  the	  G5-­‐6T-­‐Ac	  should	  be	  about	  ~	  4-­‐7	  nm	  in	  diameter.(24,	  44)	  
2.5 Discussion	  
2.5.1 Dendrimer/Membrane	  Interactions	  and	  Dendrimer	  Internalization	  
Amine-­‐terminated	   (positively	   charged)	   G7	   PAMAM	   dendrimers	   (G7-­‐NH2)	   exhibit	  
cytotoxicity	  (Figure	  2.3),	  cause	  LDH	   leakage	  (Figure	  2.4),	  and	   internalize	   into	  cells	  
(Figures	  2.5-­‐2.8)	  at	  <200	  nM	  concentrations	  whereas	  charge	  neutral	  and	  negatively	  
charged	   G7	   PAMAM	   dendrimers	   do	   not.	   	   This	   is	   interesting	   because	   negatively	  
charged	   PAMAM	   dendrimers	   (G7-­‐AF488-­‐COOH),	   suggested	   as	   a	   potential	   drug	  
delivery	   vectors,(45)	   do	   not	   bind	   or	   internalize	   into	   cells	   at	   these	   concentrations	  
(Figure	   2.5c	   and	   f).	   	   We	   previously	   reported	   that	   G7-­‐NH2	   PAMAM	   dendrimers	  
caused	  more	  LDH	  leakage	  out	  of	  cells	  at	  37	  ºC	  than	  G5-­‐NH2	  indicating	  that	  G7-­‐NH2	  is	  
more	  effective	  in	  membrane	  permeabilization	  or	  dendroporation.	  	  Furthermore,	  G7-­‐
NH2	  induces	  LDH	  leakage	  at	  4	  ºC	  whereas	  G5-­‐NH2	  does	  not.(9)	  Confocal	  images	  also	  
illustrate	  that	  G7-­‐NH2	  internalizes	  into	  the	  cells	  at	  4	  ºC	  but	  G5-­‐NH2	  does	  not	  (Figure	  
2.9).	  	  One	  might	  argue	  that	  the	  enhanced	  LDH	  leakage	  is	  caused	  by	  cell	  death	  since	  
G7-­‐NH2	   appears	   to	   be	   more	   cytotoxic	   than	   G5-­‐NH2	   (Figure	   2.4).	   	   In	   our	  
concentration	  range	  (200	  nM),	  however,	  G7-­‐NH2	  exhibits	  minimal	  cytotoxic	  effects	  
which	  are	  ~100%	  viability	  for	  KB	  and	  >	  80%	  viability	  for	  Rat2.	   	  Consequently,	  the	  
observed	   LDH	   assay	   and	   confocal	   data	   are	   taken	   as	   evidence	   for	   membrane	  
permeabilization	  as	  opposed	  to	  cell	  death.	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Figure	  2.9.	  Confocal	  images	  of	  KB	  cells	  coincubated	  for	  1	  h	  with	  (a)	  100	  nM,	  (b)	  200	  
nM,	   and	   (c)	   400	   nM	   G7-­‐AF488-­‐NH2	   and	   1	   μM	  G5-­‐6T-­‐Ac.	   Image	   d	   shows	   KB	   cells	  
incubated	  with	  1	  μM	  G5-­‐6T-­‐Ac	  only.	  Note	  that	  red	  fluorescence	  should	  be	  detected	  if	  
G7-­‐AF488	  NH2	  induces	  diffusion	  of	  G5-­‐6T-­‐Ac	  into	  the	  cells.	  However,	  no	  noticeable	  
signal	   from	  G5-­‐6T-­‐Ac	   is	  observed.	  First	   row,	  green	   fluorescence	   channel	  detecting	  
G7-­‐AF488-­‐NH2;	  second	  row,	  red	  fluorescence	  channel	  detecting	  G5-­‐6T-­‐Ac;	  and	  third	  
row,	  DIC	  images	  of	  each	  sample.	  Bar:	  50	  μm.	  
	  
Low	   temperature	   has	   been	   used	   in	   a	   number	   of	   studies	   to	   investigate	   energy	   (or	  
metabolic	  activities)	  dependency	  of	  proposed	  internalization	  mechanisms.	   	  Studies	  
have	   been	   published	   for	   synthetic	   polymers	   and	   for	   CPPs.(41,	   42,	   46)	   The	  
observation	  of	  G7-­‐AF488-­‐NH2	  internalization	  at	  4	  ºC	  can	  be	  explained	  by	  a	  number	  
of	   possible	   mechanisms.	   	   One	   would	   be	   energy	   independent	   translocation	  
mechanism	  as	  previously	  proposed	  for	  CPP	  internalization.(47)	  However,	  lowering	  
temperature	   prevents	   G5-­‐NH2	   internalization	   and	   partially	   inhibits	   G7-­‐NH2	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internalization,	   indicating	   that	   dendrimer	   internalization	   is	   an	   energy	   dependent	  
process.	  	  We	  will	  now	  consider	  two	  possible	  contributors	  to	  the	  energy-­‐dependence	  
of	  the	  nanoscale	  hole	  formation	  mechanism.	  	  First,	  the	  glass	  transition	  temperature	  
(Tg)	   of	   the	   dendrimers	   may	   be	   responsible	   for	   the	   observed	   temperature	  
dependence.	   	   Since	   the	   incubation	   temperature	   (4	   ºC)	   is	   lower	   than	  Tg	  of	  both	  G5	  
and	   G7	   PAMAM	   dendrimers	   (14-­‐16	   ºC),(48)	   chain	   flexibility	   of	   the	   dendrimer	  
molecules	  should	  be	  significantly	  decreased.	   	  The	  decrease	  in	  dendrimer	  flexibility	  
could	  impact	  the	  interaction	  with	  the	  plasma	  membrane	  creating	  a	  large	  barrier	  to	  
micelle	   formation.	   	  Second,	  a	  phase	  change	   in	   the	  cell	  plasma	  membrane	   from	  the	  
fluid	  phase	  (Lα)	  to	  low	  temperature	  gel	  phase	  (L*β)(49)	  would	  also	  inhibit	  nanoscale	  
hole	   formation.	   	   It	   has	   recently	   been	  demonstrated	  using	   supported	   lipid	  bilayers	  
that	   G7-­‐NH2	   dendrimers	   only	   cause	   nanoscale	   hole	   formation	   in	   fluid	   phase	  
membranes.(23)	   This	   is	   consistent	   with	   other	   reports	   indicating	   the	   membrane	  
fluidity	  is	  related	  to	  transport	  properties	  in	  epithelial	  cells.(50)	  	  
There	  are	  several	  energy	  dependent	  pathways	  proposed	  	  for	  	  polycationic	  polymers	  
including	  endocytosis	  via	  clathrin-­‐coated	  pits(51,	  52)	  and	  endocytosis	  via	  lipid	  rafts	  
or	  caveolae.(53,	  54)	   	   	  For	  this	  study	  we	  employed	  transferrin	  which	  is	  a	  commonly	  
used	  marker	  for	  clathrin-­‐mediated	  endocytosis	  and	  CTB	  which	  is	  a	  commonly	  used	  
marker	  for	  clathrin-­‐independent	   lipid	  raft	  (or	  caveolae)	  mediated	  endocytosis.(41)	  	  
G7-­‐AF488-­‐NH2	   did	   not	   show	   substantial	   colocalization	  with	   transferrin	   (10%	   and	  
17%	   overlapping	   for	   KB	   and	   Rat2,	   respectively),	   indicating	   that	   G7-­‐AF488-­‐NH2	  
internalization	  is	  not	  related	  to	  the	  clathrin-­‐dependent	  pathway.	  	  Instead	  significant	  
colocalization	   of	   G7-­‐AF488-­‐NH2	   with	   CTB-­‐AF647	   was	   observed	   (88%	   and	   68%	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overlapping	   for	  KB	   and	  Rat2,	   respectively).	   	   Co-­‐localization	  with	  CTB	   implies	   that	  
G7-­‐AF488-­‐NH2	  localizes	  in	  the	  cell	  with	  ganglioside	  GM1.	   	  However,	  G7-­‐AF488-­‐NH2	  
internalized	   into	   C6	   cells	   independent	   of	   the	   presence	   of	   the	   GM1	   and	  G7-­‐AF488-­‐
NH2	   did	   not	   co-­‐localize	   with	   GM1-­‐pyrene.	   	   This	   indicates	   that	   the	   co-­‐localization	  
observed	  by	  us	  and	  others(16)	   is	  probably	  related	  to	  a	  dendrimer-­‐CTB	  interaction	  
and	  is	  not	  related	  to	  GM1	  interactions	  or	  a	  raft	  mediated	  endocytosis	  pathway.	  	  The	  
LDH	   assays	   for	   C6	   cells	   show	   no	   effect	   upon	   the	   presence	   or	   absence	   of	   GM1	  
indicating	   the	   GM1	   is	   also	   not	   important	   for	   the	   mechanism	   of	   membrane	  
permeabilization	  and	  nanoscale	  hole	  formation.	  
A	  substantial	   literature	  exists	  supporting	  polycationic	  endocytosis	  as	  a	  mechanism	  
for	   the	   uptake	   of	   polycationic	   polymers	   into	   cells.(16,	  41,	  55-­‐58)	   	   However,	  many	  
inconclusive	  and	  contradictory	  experiments	  can	  be	   found	   in	   the	   literature	  and	   the	  
details	  of	  the	  internalization	  mechanisms	  have	  remained	  elusive.	  	  In	  this	  paper,	  we	  
provide	  direct	   evidence	   indicating	   a	  GM1-­‐dendrimer	   interaction	   is	   not	   involved	   in	  
G7-­‐AF488-­‐NH2	   internalization.	   	   The	   best	   evidence	   supporting	   raft-­‐mediated	  
endocytosis	   for	   dendrimers,	   co-­‐localization	   with	   CTB,	   is	   shown	   to	   instead	   result	  
from	  a	  CTB-­‐dendrimer	  interaction.	  	  Our	  results	  including	  nanoscale	  hole	  formation	  
in	  supported	  lipid	  bilayers,(23-­‐25)	  enzyme	  leakage	  and	  small	  molecule	  diffusion	  in	  
and	   out	   of	   cells,(6,	   9)	   and	   G7-­‐AF488-­‐NH2	   internalization	   at	   4	   ºC,	   do	   provide	   an	  
alternative	   mechanism	   by	   which	   polycationic	   polymers,	   and	   nanoparticles	   more	  
broadly,(26)	  may	   enter	   cells;	   the	   formation	   of	   nanoscale	   holes	   in	   the	   cell	   plasma	  
membranes.(8)	  The	  data	  presented	  here,	  and	  published	  elsewhere	  by	  ourselves	  and	  
others,	  does	  not	   indicate	  that	  the	  nanoscale	  hole	  mechanism	  should	  be	  considered	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as	   a	   replacement	   for	   endocytosis	   mechanisms.	   	   Rather,	   it	   suggests	   a	   competitive	  
process	   in	  which	   both	  mechanisms	   are	   operative.	   	   The	  nanoscale	   hole	   hypothesis	  
does	   provide	   a	   straightforward	   explanation	   for	   data	   that	   is	   inconsistent	   with	   the	  
endocytosis	  mechanism,	  both	  in	  this	  paper	  and	  in	  polycationic	  polymer	  endocytosis	  
literature	  more	  generally.	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Chapter	  3	  
Polyplex-­‐Induced	  Cytosolic	  Nuclease	  Activation	  leads	  to	  
Differential	  Transgene	  Expression	  
	  
3.1 Abstract	  
In	  this	  chapter,	  cytosolic	  nucleases	  have	  been	  proposed	  to	  play	  an	  important	  role	  in	  
limiting	  the	  effectiveness	  of	  polyplex-­‐based	  gene	  delivery	  agents.	  The	  hypothesis	  is	  
that	  polyplex	   interaction	  with	  plasma	  membrane	   induces	   the	   cellular	   response	  by	  
activating	   cellular	   nucleases.	   In	   order	   to	   explore	   the	   effect	   of	   cell	   membrane	  
disruption	   on	   nuclease	   activation,	   nuclease	   activity	   upon	   polyplex	   uptake	   and	  
localization,	   and	   nuclease	   activity	   upon	   gene	   expression,	   we	   employed	   an	  
oligonucleotide	  molecular	   beacon	   (MB).	   	   The	  MB	  was	   incorporated	   as	   an	   integral	  
part	  of	  the	  polymer/DNA	  polyplex	  and	  two-­‐color	  flow	  cytometry	  experiments	  were	  
performed	   to	   explore	   the	   relationship	   of	  MB	   cleavage	  with	   Propidium	   iodide	   (PI)	  
uptake,	  protein	  expression,	  and	  polyplex	  uptake.	  	  In	  addition,	  confocal	  fluorescence	  
microcopy	  was	   performed	   to	   examine	   both	   polyplex	   and	   cleaved	  MB	   localization.	  	  
The	   impact	   of	   cell	   membrane	   disruption	   was	   also	   probed	   using	   whole-­‐cell	   patch	  
clamp	  measurement	  of	  the	  plasma	  membrane’s	  electrical	  conductance.	  	  Differential	  
activation	  of	  cytosolic	  nuclease	  was	  observed	  with	  substantial	  activity	  for	  B-­‐PEI	  and	  
G5	   PAMAM	   dendrimer	   (G5),	   less	   cleavage	   for	   jetPEITM,	   little	   activity	   for	   L-­‐PEI.	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jetPEITM	  and	  L-­‐PEI	  exhibited	  significantly	  greater	   transgene	  expression,	   consistent	  
with	   the	   lower	   amounts	   of	   MB	   oligonucleotide	   cleavage	   observed.	   	   	   Cytosolic	  
nuclease	  activity,	  although	  dependent	  on	  the	  choice	  of	  polymer	  employed,	  was	  not	  
related	   to	   the	   degree	   of	   cell	   plasma	   membrane	   disruption	   that	   occurred	   as	  
measured	  by	  PI	  uptake	  or	  whole-­‐cell	  patch	  clamp.	  	  
	  
3.2 Introduction	  
The	   development	   of	   safe	   and	   efficient	   nucleic	   acid	   delivery	   systems	   for	   use	   in	  
mammalian	   cells	   remains	   a	   significant	   scientific,	   technological,	   and	   clinical	  
challenge.	   	   Applications	   of	   plasmid	   DNA	   (pDNA),	   antisense	   DNA	   (asDNA),	   and	  
silencing	  RNA	  (siRNA)	  oligonucleotide	  therapeutics	  are	  severely	  limited	  due	  to	  the	  
absence	  of	  safe	  and	  efficient	  vector	  systems.	  	  Despite	  the	  outstanding	  promise	  of	  this	  
technology,	   there	  are	  no	  FDA-­‐approved	  vector	  systems	   for	  nucleic	  acid	  delivery	   in	  
humans.	  Of	  the	  many	  existing	  nucleic	  acid	  delivery	  systems,	  nonviral-­‐based	  systems	  
enjoy	   certain	   advantages	   because	   of	   their	   small	   size,	   lack	   of	   traditional	  
immunogenic	   epitopes,	   and	   avoidance	   of	   other	   viral-­‐based	   side-­‐effects;	   however,	  
they	  are	  not	  as	  efficient	  with	  respect	  to	  gene	  expression	  as	  viral	  based	  systems.[1-­‐
3]	   	  	  Nonviral	  vectors	  are	  efficient	  at	  delivering	  the	  transgene	  into	  the	  cells	  and	  can	  
also	  protect	  the	  nucleic	  acid	  from	  degradation;	  however	  most	  of	  the	  genetic	  material	  
is	   delivered	   into	   regions	   of	   the	   cytosol,	   including	   endosomes	   and	   lysosomes,	   in	   a	  
non-­‐functional	  manner.[4]	  
Efforts	   to	   increase	   the	   efficiency	   of	   gene	   delivery	   vectors	   have	   focused	   on	   uptake	  
mechanism,	   endosomal	   escape,	   and	  penetration	   of	   the	   nucleus.[5]	   	   Both	   viral	   and	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nonviral	  vectors	  are	   thought	   to	  enter	  via	  energy	  dependent	  endocytosis	  pathways	  
that	   can	   lead	   to	   vector/DNA	   localization	   inside	   endosomes.[2,	   6]	   Before	   the	  
endosomes	   become	   lysosomes,	   the	   two	   vector	   systems	   are	   thought	   to	   diverge	  
mechanistically.	  Viral	  systems	  have	  a	  dedicated	  mechanism	  to	  transfer	  nucleic	  acid	  
into	  the	  nucleus,	  but	  polyplexes	  are	  not	  known	  to	  have	  such	  a	  mechanism.[5,	  6]	  This	  
is	  thought	  to	  contribute	  to	  the	  inefficiency	  of	  polymeric	  vector	  systems	  in	  providing	  
transgene	   expression.	   	   In	   general,	   interpretation	   of	   mechanistic	   studies	   using	  
efficiency	   of	   protein	   expression	   as	   an	   endpoint	   is	   difficult	   because	   it	   is	   quite	  
challenging,	  or	   impossible,	   to	  separate	   the	   transfection	  steps	  (i.e.,	   crossing	   the	  cell	  
plasma	  membrane,	  cytosolic	  localization,	  transport	  to	  nucleus)	  and	  expression	  steps	  
(i.e.,	  presentation	  of	   functional	  material	   in	  the	  nucleus,	  optimization	  of	  promoters)	  
and	  to	  know	  the	  impact	  of	  any	  particular	  change	  in	  vector	  design	  on	  each	  of	  these	  
hurdles	  to	  effective	  expression.	  
In	  addition	  to	  the	  challenges	  discussed	  above,	  there	  is	  a	  common	  presumption	  that	  
the	   cellular	   environment	   present	   over	   the	   course	   of	   a	   transfection	   experiment	  
(typically	   12-­‐48	   h)	   is	   the	   same	   for	   all	   polymer	   vector	   systems	   tested.	   	   In	   other	  
words,	   it	   is	   assumed	   that	   either	   1)	   the	   cell	   does	   not	   actively	   respond	   to	   the	  
introduction	  of	  the	  polymer/DNA	  polyplex	  or	  2)	  if	  the	  cell	  does	  respond	  it	  does	  so	  in	  
fashion	  independent	  of	  the	  polymer	  employed.	  	  This	  critical,	  but	  generally	  unstated	  
assumption,	   may	   lead	   to	   incorrect	   mechanistic	   conclusions	   regarding	   vector	  
optimization	   if	   the	   cells	   respond	   in	   a	   differential	   fashion	   to	   the	   polymers	   and	   the	  
resulting	   transfection	   and	   expression	   processes	   are	   proceeding	   in	   dynamically	  
differing	   cellular	   environments.	   	   In	   this	   study	  we	   ask	   the	   question,	   does	   polyplex	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introduction	  trigger	  a	  cellular	  response	  that	  leads	  to	  a	  heightened	  ability	  to	  degrade	  
foreign	   pDNA?	   	   The	   centrality	   of	   this	   question	   to	   developing	   successful	   gene	  
therapies	  is	  supported	  by	  the	  difficulty	  of	  identifying	  consistent	  trends	  as	  a	  function	  
of	  physical	  properties	  of	   the	  nonviral	  vectors.[3,	  7-­‐9]	  Work	  to	  date	  has	   focused	  on	  
the	   key	   problem	   of	   how	   to	   transport	   the	   desired	   pDNA,	   asDNA,	   or	   siRNA	   across	  
cellular	   barriers,	   but	   not	   the	   possibility	   of	   dynamic	   cellular	   responses	   to	   these	  
barriers	  being	  breached.	  	  In	  particular,	  if	  the	  introduction	  of	  certain	  polyplex	  forms	  
leads	   to	   the	   heightened	   production	   and/or	   activation	   of	   cytosolic	   nucleases,	   this	  
would	   represent	   a	   major	   new	   factor	   for	   consideration	   in	   the	   design	   of	   nonviral	  
vectors.	  
The	  literature	  contains	  strong	  support	  for	  the	  idea	  that	  cytosolic	  nucleases[10]	  play	  
an	  important	  role	  in	  the	  half-­‐life	  of	  DNA	  in	  the	  cytosol.[11-­‐17]	   	  In	  a	  seminal	  study,	  
Lukacs	  et	  al.	  provided	  evidence	  that	  pDNA	  is	  degraded	  by	  nucleases	  constitutively	  
present	   in	   the	   cytosol.[11]	   Pollard	   et	   al.	   examined	   complementary	   DNA	   (cDNA)	  
degradation	   in	   the	   cytosol	   and	  noted	   that	   it	  was	  Ca+2	   dependent	   and	   inhibited	  by	  
nuclease	   inhibitors	  aurin	   tricarboxylic	  acid	  and	  Zn+2	  or	  by	   the	  complexation	  of	   the	  
cDNA	  with	  poly(ethyleneimine)	  (PEI).[16]	  	  A	  recent	  study	  by	  Ruponen	  et	  al.	  studied	  
the	   cytosolic	   half-­‐life	   for	   pDNA	   delivered	   by	   a	   variety	   of	   vectors	   to	   CV1	   cells	   and	  
confirmed	   that	   unprotected	   pDNA	   degraded	   quickly,	   but	   that	   when	   protected	   by	  
cationic	   lipids	   or	   polymers	   the	   half-­‐lives	   could	   be	   increased	   up	   to	   a	   factor	   of	  
~20.[12]	   	  They	  also	  noted	   that	   the	  pDNA	  release	  and	  elimination	   rates	   correlated	  
poorly	   with	   transgene	   expression.	   These	   studies	   suggest	   the	   possibility	   that	  
cytosolic	  nucleases	  contribute	   to	   the	  degradation	  of	   transported	  DNA,	  which	   leads	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to	  decrease	  in	  overall	  transgene	  expression,	  before	  nuclear	  uptake	  comes	  into	  play.	  
Indeed	   it	   has	   been	   shown	   that	   even	   nicking	   the	   plasmid	   can	   lead	   to	   significant	  
decrease	   in	   transgene	   expression.[18]	   	   	   Prazeres	   et	   al.	   have	   explored	   the	   effect	   of	  
cytosolic	   nucleases	   by	   varying	   the	   structure	   of	   the	   DNA	   sequence.[19,	   20]	   They	  
identified	  regions	  that	  could	  be	  modified	  to	  generate	  improved	  nuclease	  resistance.	  	  	  
In	   the	   work	   described	   above,	   efforts	   were	   focused	   on	   understanding	   the	  
degradation	  of	  pDNA	  by	  cytosolic	  nucleases	  and	  how	  the	  pDNA	  could	  be	  modified	  to	  
improve	   stability.	   	   In	   this	   report,	  we	   focus	   on	   the	   role	   of	   the	   polymer	   vector.	   	   In	  
particular,	  we	  test	  the	  hypotheses	  that	  polycationic	  polymers	  differentially	  activate	  
cytosolic	  nucleases	   and	   that	   this	   can	   lead	   to	  decreased	   transgene	  expression.	   	  We	  
employ	   a	   single	   stranded	   DNA	   oligonucleotide	   molecular	   beacon	   (MB)[21]	  
containing	   a	   fluorescein	   derivative	   6-­‐FAM	   on	   the	   5’	   end	   and	   an	   Iowa	   Black	   (IB)	  
quencher	   at	   the	   3’	   end	   	   (6-­‐FAM-­‐CCTCGTCCATACCCAAGAAGGAAGCGAGG-­‐IB)	   as	   a	  
sensitive	   indicator	   of	   cytosolic	   nuclease	   activity.	   	   The	   intact	   single	   strand	   forms	   a	  
hairpin	   structure	   leading	   to	   quenched	   fluorescence.	   	   The	   readily	   cleaved	   single	  
strand	   sequence	   of	   the	  MB	   is	   a	   good	  model	   for	   the	   single	   stranded	   “hot	   spots”	   in	  
pDNA	   identified	   by	   Prazeres	   et	   al.	   as	   being	   particularly	   susceptible	   to	   nuclease	  
attack.[19,	   20]	   Upon	   exposure	   to	   nucleases,	   the	   oligonucleotide	   is	   cleaved	   and	   a	  
fluorescent	  signal	  is	  obtained.	  	  The	  MB	  was	  employed	  for	  two-­‐color	  flow	  cytometry	  
studies	   comparing	   1)	   MB	   fluorescence	   to	   PI	   uptake,	   2)	   MB	   fluorescence	   to	   red	  
fluorescent	   protein	   (RFP)	   expression	   (when	   mixed	   at	   a	   10:1	   N:P	   (nitrogen	   to	  
phosphate	  molar	  ratio)	  ratio	  with	  pDNA	  encoding	  for	  RFP)	  and	  3)	  MB	  fluorescence	  
to	   DNA	   uptake.	   	   These	   polyplex	   materials	   were	   also	   employed	   for	   confocal	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microscopy	  to	  simultaneously	  study	  nuclease	  activity	  and	  polyplex	  localization	  and	  
for	   solution-­‐based	   experiments	   to	   examine	   the	   relative	   degree	   of	   nuclease	  
protection	  afforded	  by	  the	  three	  polymer	  vectors.	  
Nuclease	  activation	  as	  measured	  by	  the	  DNA-­‐based	  MB	  was	  compared	  to	  cell	  plasma	  
membrane	   permeability	   as	   measured	   by	   PI	   uptake	   and	   total	   protein	   expression	  
levels	   of	   RFP.	   	   Cell	   membrane	   permeability	   was	   also	   measured	   using	   whole-­‐cell	  
patch	   clamp.	   	   We	   examined	   nuclease	   activation	   in	   the	   context	   of	   cell	   membrane	  
permeability	  because	  our	  previous	  studies	  demonstrated	  that	  low	  concentrations	  of	  
polycationic	   polymer	   vectors	   induced	   nanoscale	   pores	   in	   the	   cell	  membrane	  with	  
varying	  degrees	  of	  activity	  and	  pore	   lifetimes.[22-­‐25]	   	  A	  number	  of	   the	  previously	  
published	   studies	   on	   nuclease	   degradation	   discussed	   above	   employed	  
permeabilization	  agents	  (for	  example,	  digitonin).	  This	  served	  to	  further	  interest	  us	  
in	  cell	  plasma	  membrane	  disruption	  as	  a	  possible	  trigger	  for	  nuclease	  activity.	  	  Since	  
protein	   expression	   is	   the	   end	   goal	   of	   pDNA	   delivery,	   we	   also	   examined	   the	  
relationship	  between	  protein	  expression	  levels	  and	  nuclease	  activity.	  
The	   choice	   of	   cationic	   polymer	   as	   vector	   for	   the	   transfection	   and	   expression	   of	  
pDNA	  can	  have	  a	  profound	  impact	  on	  the	  amount	  of	  protein	  expression	  observed	  for	  
the	  cell	  population.	  	  Polymer	  vectors	  are	  generally	  designed	  to	  optimize	  and	  balance	  
the	   following	  properties:	   	   uptake,	   protection	  of	   the	  plasmid	  DNA,	   transport	   of	   the	  
DNA	   to	   the	  nucleus,	   and	   release	  of	   the	  DNA	   to	   the	   transcription	  machinery	  of	   the	  
cell.[26,	  27]	   In	   this	   study,	  we	  compare	   the	   impact	  of	   selection	  of	  polymer	  vectors,	  
branched-­‐PEI	   (B-­‐PEI),	   generation	   5	   poly(amidoamine)	   (G5	   PAMAM)	   dendrimer,	  
jetPEITM,	   and	   linear	   PEI	   (L-­‐PEI),	   on	   the	   activation	   of	   nucleases	   that	   can	   cleave	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transported	   pDNA.	   The	   experiments	   were	   carried	   out	   inside	   the	   cell	   as	   part	   of	   a	  
normal	   polyplex	   transfection/expression	   treatment	   and	   as	   model	   solution-­‐based	  
experiments.	  	  For	  this	  study,	  we	  selected	  jetPEITM,	  a	  commercial	  form	  of	  linear	  PEI,	  
because	  it	  is	  one	  of	  the	  most	  effective	  commercially	  available	  polymeric	  vectors.	  	  We	  
chose	  G5	  PAMAM	  because	  it	   is	  a	  polymer	  of	  roughly	  similar	  molecular	  weight,	  has	  
an	  excellent	  polydispersity	  index	  (PDI)	  (1.01),	  and	  is	  well	  characterized	  in	  terms	  of	  
numbers	   of	   cationic	   primary	   amines.	   	   L-­‐PEI	   and	   B-­‐PEI	   were	   selected	   as	   non-­‐
proprietary	  PEI	  comparisons.	   	  Polyplexes	  were	  made	  using	  a	  10:1	  N:P	  ratio	  as	  this	  
was	   reasonable	   compromise	   for	   forming	   functional,	   low	   toxicity	   materials	   for	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Figure	   3.S1.	   	   HeLa	   Cell	   Viability	   after	   3-­‐hour	   transfection	   incubation:	   	   Polyplex	  
preparation:	   40,000	   cells/	   well	   were	   plated	   and	   incubated	   overnight	   in	   96-­‐wells	  
plate.	  Wells	  were	  rinsed	  with	  PBS	  containing	  Ca2+	  and	  Mg2+.	  10	  μL	  Polyplexes	  at	  N:P	  
ratio	  5:1,	  10:1	  and	  20:1	  containing	  0.08	  μg	  of	  Molecular	  Beacon	  were	  then	  added	  to	  
90	  μL	  SFM.	  	  3	  hours	  post-­‐transfection	  media	  was	  removed	  and	  added	  to	  a	  replicate	  
96	  wells	  plate.	  The	  media	  was	  then	  used	  for	  the	  LDH	  assay	  and	  the	  cells	  were	  used	  
for	  the	  XTT	  assay.	  	  XTT	  assay:	  Cells	  were	  rinsed	  with	  PBS	  containing	  Ca2+	  and	  Mg2+.	  
50	  μL	  of	  PBS	  containing	  divalent	  ions	  was	  then	  added	  to	  cells	  and	  followed	  by	  	  50	  μL	  
XTT	  working	  solution.	  The	  plate	  was	  then	   incubated	  at	  37	  °C	   for	  4	  hours	  before	   it	  
was	  measured.	   	  LDH	  assay:	  50	  μL	  of	  supernatant	  was	   incubated	  with	  50	  μL	  of	   the	  
LDH	  working	   solution.	  The	  plate	  was	   then	   incubated	   at	   37	   °C	   for	  20	  minutes	   and	  
then	  measured.	  	  
	  
For	   the	   polymer	   vectors	   employed	   in	   this	   study,	   B-­‐PEI,	   L-­‐PEI,	   jetPEITM,	   and	   G5	  
PAMAM,	   the	   following	   conclusions	   were	   reached:	   1)	   all	   four	   polymer/DNA	  
polyplexes	   cause	   substantial	   cell	   plasma	   membrane	   disruption,	   2)	   B-­‐PEI	   and	   G5	  
PAMAM	  polyplexes	   treated	   cells	   show	  substantial	  nuclease	   activity	  whereas	  L-­‐PEI	  
and	  jetPEITM	  treated	  cells	  exhibit	  significantly	  less,	  3)	  expressing	  cells	  for	  both	  L-­‐PEI	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expressing	   cells	   for	   B-­‐PEI	   and	   G5	   PAMAM	   polyplexes,	   4)	   the	   different	   levels	   of	  
expression	   observed	   are	   not	   simply	   explained	   by	   differential	   polymer	   protective	  
effects,	   and	   5)	   the	   data	   indicates	   that	   the	   dramatic	   difference	   in	   expression	  
efficiency	   is	   related	   to	   a	   significant	   difference	   in	   the	   extent	   to	  which	   the	   polymer	  
vectors	   induce	   an	   active	   nuclease	   response	   in	   the	   cells.	   In	   addition,	   the	   DNA	  
cleavage	   pattern	   of	   nuclease	   present	   in	   the	   cellular	   cytoplasm	   is	   similar	   to	   that	  
obtained	  for	  S1	  nuclease	  as	  observed	  in	  our	  agarose	  gel	  electrophoresis	  experiment.	  
3.3 Materials	  and	  Methods	  
3.3.1 Materials	  
jetPEITM	  was	  procured	   from	  VWR	   International.	   	   In-­‐house	  GPC	   characterization	  of	  
jetPEITM	  yielded	  Mn	  of	  25000	  Da	  and	  polydispersity	  index	  (PDI)	  of	  1.42.	  B-­‐PEI	  was	  
obtained	   from	  Sigma	  Aldrich	  Corporation	  with	  Mn	  of	  10,000	  and	  PDI	  of	  2.5.	   L-­‐PEI	  
was	   obtained	   from	   Polysciences,	   Inc.	   with	   Mn	   of	   23,750	   and	   PDI	   of	   1.04.	   Stock	  
solutions	  for	  G5	  PAMAM	  and	  B-­‐PEI	  were	  made	  in	  water	  at	  room	  temperature.	  L-­‐PEI	  
stock	  solution	  was	  also	  made	  in	  water	  but	  was	  heated	  to	  66°C	  to	  dissolve.	  	  	  Minimal	  
essential	   media	   (MEM)	   with	   glutamine	   and	   Earle	   salts	   (serum-­‐free	  media	   (SFM);	  
#11095)	  was	  obtained	   from	   life	   technologies.	   	  For	   suspending	  cells	  prior	   to	  patch	  
clamp,	   SFM	   for	   suspension	   culture	   (SFMII;#11868)	   from	   life	   technologies	   was	  
employed.	  	  Complete	  media	  was	  made	  by	  adding	  50	  mL	  of	  fetal	  bovine	  serum	  (FBS)	  
and	  5	  mL	  100x	  of	  penicillin-­‐streptomycin	  to	  500	  mL	  SFM.	  	  Detachin	  was	  purchased	  
from	   Gelantis	   Inc.	   PBS	   (1X)	   with	   and	   without	   Ca2+	   and	   Mg2+	   was	   obtained	   from	  
Thermo	  Scientific.	  Luciferase	  plasmid	  DNA,	  S1	  nuclease,	  and	  LDH	  assays	  kits	  were	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obtained	  from	  Promega	  Corporation.	  	  XTT	  assay	  kits	  were	  obtained	  from	  Hoffmann-­‐
La	   Roche	   Ltd.	   	   Salmon	   sperm	   DNA	   was	   obtained	   from	   Ambion.	   	   Blank	   plasmid	  
(plasmid	  that	  doesn’t	  express	  any	  protein)	  was	  obtained	  from	  Aldevron,	  L.L.C.	  Label	  
IT	   CX-­‐Rhodamine	  Nucleic	   Acid	   Labeling	   Kit	  was	   obtained	   from	  Mirus	   Bio.	   	   2-­‐well	  
coverglass	  chambers	  were	  obtained	  from	  Thermo	  Fisher	  Scientific,	  Inc.	  BD	  FalconTM	  
24	  well	   culture	  plates	  were	  used	   for	   flow	  cytometry	  experiments.	  PI	  and	  protease	  
inhibitor	   cocktail	   were	   obtained	   from	   Sigma-­‐Aldrich	   and	   Prolong	   GoldTM	   antifade	  
reagent	   was	   procured	   from	   Invitrogen.	   	   NP-­‐40	   lysis	   buffer	   was	   procured	   from	  
Boston	   BioProducts	   Inc.	   	   pDsRed1-­‐N1	   (RFP)	   was	   purchased	   from	   Clontech	  
Laboratories,	   Ltd.	   The	   MB	   employed	   was	   custom	   ordered	   from	   Integrated	   DNA	  
Technologies.	   The	   sequence	   is	   CCTCGTCCATACCCAAGAAGGAAGCGAGG	   where	   5’	  
end	  modified	  with	  6-­‐FAMTM	  (Fluorescein)	  and	  3’	  end	  with	  Iowa	  Black	  FQ.	  An	  EPICS	  
XL-­‐MCL	   Beckman	   Coulter	   flow	   cytometer	   was	   employed.	   For	   each	   sample,	   two	  
replicates	   of	   10,000	   cells	   each	  were	   used;	   ∆	  MF	   and	   standard	   error	   are	   reported.	  	  	  
For	  confocal	  microscopy,	  a	  Zeiss	  510	  Meta	  confocal	  microscope	  was	  used	  with	  63X	  
objective.	   	  351	  nm,	  488	  nm	  and	  543	  nm	   lasers	  were	  used	   to	  excite	  DAPI,	  MB	  and	  
rhodamine	   respectively.	   	   For	   both	   flow	   cytometry	   and	   confocal	  microscopy	   using	  
two	   dyes,	   independent	   excitation	   and	   emission	   detection	   was	   employed	   with	  
microsecond	   delays	   to	   avoid	   potential	   fluorescence	   resonance	   energy	   transfer	  
(FRET)	  artifacts.	  	  
3.3.2 Porosity	  vs.	  MB	  Fluorescence	  
Polyplex	   preparation:	   Each	   polymer	  was	   diluted	   in	   sterile	  water	   to	   obtain	   an	  N:P	  
ratio	  of	  10:1.	  Dilutions	  of	  blank	  plasmid	  (0.5	  μg)	  and	  MB	  (0.5	  μg)	  were	  prepared	  and	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mixed	  to	  obtain	  a	  final	  N:P	  ratio	  of	  10:1	  in	  the	  polyplex.	  The	  polymer	  dilutions	  (25	  
μL)	  were	  added	   to	  equal	   volumes	  of	  DNA	  mixture	   (25	  μL)	  and	   incubated	  at	   room	  
temperature	   for	   25	  min	   before	   transfection.	   	   Transfection:	   HeLa	   cells	   at	   200,000	  
cells/well	  in	  1	  mL	  of	  complete	  media	  were	  incubated	  overnight	  in	  24-­‐well	  plates	  for	  
flow	  cytometry.	  The	   cells	  were	   transfected	  with	   jetPEITM,	  G5	  PAMAM,	  B-­‐PEI,	   or	  L-­‐
PEI	  polyplexes	  and	  incubated	  at	  37o	  C	  in	  440	  μL	  of	  SFM.	  After	  10	  minutes,	  10	  μL	  of	  5	  
μg/μL	   PI	   was	   added	   to	   each	   well.	   After	   3	   h	   of	   polyplex	   incubation,	   transfecting	  
media	  was	  removed,	  500	  μL	  of	   fresh	  complete	  media	  was	  added	  to	  each	  well,	  and	  
cells	  were	   incubated	  at	  37	   oC.	   	  Flow	  Cytometry:	  After	  9	  h	   (12	  h	  post	   transfection)	  
cells	  were	  rinsed	  with	  PBS	  without	  Ca2+	  and	  Mg2+,	  trypsinized,	  and	  suspended	  in	  1.8	  
mL	   of	   PBS	   with	   Ca2+	   and	   Mg2+	   and	   centrifuged	   at	   2000	   rpm	   for	   5	   min.	   	   The	  
supernatant	  was	  removed	  and	  the	  pellet	  was	  re-­‐suspended	  in	  400	  μL	  of	  PBS	  without	  
Ca2+	   and	   Mg2+	   ions	   and	   kept	   on	   ice.	   	   In	   a	   separate	   study,	   we	   examined	   the	   pH	  
stability	  of	  the	  MB	  and	  determined	  that	  it	  was	  stable	  at	  neutral	  to	  acidic	  pH	  values	  
present	  in	  the	  cell	  (supplementary	  Figure	  3.S2).	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Figure	  3.S2.	  	  Molecular	  Beacon	  stability	  analysis.:	  	  The	  experiment	  was	  carried	  out	  in	  
a	  96-­‐well	  plate.	  Each	  well	  contained	  0.08	  µg	  of	  molecular	  beacon	  diluted	  in10	  μL	  
water	  solution.	  Molecular	  beacon	  solution	  was	  then	  added	  to	  wells	  containing	  90	  μL	  
of	  water	  or	  PBS	  at	  pH	  2,	  5	  and	  7.4	  without	  S1	  nuclease	  or	  in	  S1	  nuclease	  buffer	  with	  
S1	  nuclease.	  The	  plate	  was	  read	  at	  excitation	  of	  485/20	  nm	  and	  emission	  of	  528/20	  
nm.	  Based	  on	  this	  study	  it	  can	  be	  concluded	  that	  molecular	  beacon	  is	  stable	  at	  acidic	  
and	  neutral	  pH.	  	  
	  
3.3.3 Whole-­‐Cell	  Patch	  Clamp	  using	  Ionflux	  16TM[28]	  	  	  
Traditional	   whole-­‐cell	   patch	   clamp	   is	   very	   labor	   intensive.	   The	   high	   throughput	  
IonFlux16TM	   (IF-­‐16)	   patch	   clamp	   instrument	   simultaneously	   traps	   320	   cells	   in	   16	  
ensembles	   of	   20.	   	   The	   electrical	   characteristics	   of	   each	   ensemble	   of	   20	   cells	   are	  
measured	  using	  a	  dedicated	  amplifier.	  	  The	  changes	  in	  cell	  membrane	  permeability	  
are	   measured	   for	   the	   ensemble	   of	   cells	   as	   a	   group	   in	   eight	   independently	  
controllable	   microfluidic	   environments	   that	   allow	   simultaneous	   measurement	   of	  
control	  cells	  and	  the	  different	  polyplex	  formulations.	   	  Detailed	  operation	  protocols	  
























Time	  in	  Minutes	  
Molecular	  Beacon	  stability	  test	  
MB	  in	  Water	  pH	  2	  
MB	  in	  Water	  pH	  5.5	  
MB	  in	  PBS	  pH	  2	  
MB	  in	  PBS	  pH	  5	  
MB	  in	  PBS	  pH	  7.4	  
MB	  with	  S1	  Nuclease	  in	  S1	  
nuclease	  buffer	  






Phase Main Channel Traps Traps and Compounds Compounds 
Preprime 1 psi (0-92 s) 
0.3 psi (92-120 s) 
5 psi (0-90 s) 
1.5 psi (90-115 s) 
6 psi (115-120s)  
Prime 1 psi (0-30 s) 
0.4 psi (30-55 s) 
6 Hg (50-55 s) 5 psi (0-20 s) 
2 psi (20-50 s) 
Not used 
Trap Pulse: 0 psi for 4.2s 
0.25 psi for 0.8 s 
15 such pulses 
6 Hg (0-85 s) Not used Not used 
Break 0.2 psi (0-20 s) 6 Hg (0-5 s) 
10 Hg (5-15 s) 
6 Hg (15-20 s) 
Not used Not used 
Data  
Acquisition 
0.16 psi (Duration of 
experiment) 
6 Hg (Duration of 
experiment) 





Figure	  3.S3.	  A	  shows	  the	  order	  and	  relative	  durations	  of	  the	  4	  phases	  in	  the	  
experiment.	  B	  summarizes	  the	  pressure	  settings	  at	  the	  different	  phases.	  C	  is	  a	  
graphic	  representation	  of	  the	  pressure	  settings.	  	  
	  
HeLa	  cells	  were	  cultured	  in	  175	  cm2	  flasks	  in	  complete	  media	  at	  37	  °C	  and	  5%	  CO2.	  
The	  cells	  were	  cultured	  to	  ~90%	  confluency	  (~20-­‐25	  million	  cells).	  The	  cells	  were	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5	  mL	  Detachin	  at	  37	  °C	  for	  5	  minutes.	  5	  mL	  of	  complete	  media	  was	  added	  and	  the	  
cells	  were	   triturated.	   The	   suspension	  was	   centrifuged	   at	   1000	   rpm	   for	   2	  minutes	  
(220	   x	   g)	   and	   the	   supernatant	  was	   discarded.	   The	   cells	  were	   suspended	   in	   SFMII	  
supplemented	  with	   25	  mM	  HEPES	   and	   penicillin-streptomycin,	   placed	   in	   a	   25	   cm2	  
suspension	  flask	  and	  shaken	  at	  75	  rpm	  for	  5	  minutes.	  Employing	  SFMII	  as	  opposed	  
to	   the	   regular	  SFM	  resulted	   in	  a	   roughly	   three-­‐fold	   increase	   in	   cell	   count	  and	  was	  
critical	  for	  achieving	  improved	  seal	  resistance	  in	  each	  trapping	  zone.	  The	  cells	  were	  
triturated	  and	  counted	  using	  a	  cytometer.	  The	  suspension	  was	  centrifuged	  at	  1000	  
rpm	  for	  2	  minutes.	  The	  cells	  were	  suspended	   in	  ECS	   to	  a	  concentration	  of	  8	   to	  12	  
million	   cells/mL	   and	   loaded	   in	   the	   IonFlux-­‐16TM	   96	   well	   microfluidic	   plate.	  	  
Polyplexes	   at	   N:P	   ratio	   of	   10:1	   were	   prepared	   in	   the	   same	   manner	   and	  
concentrations	  as	  prepared	  for	  the	  	  flow	  cytometry	  studies	  describe	  above.	  	  50	  µL	  of	  
Polyplexes	  were	  added	  to	  450	  µL	  of	  SFM.	  	  
The	  current	  vs	  time	  trace	  files	  were	  exported	  and	  processed	  using	  Microsoft	  Excel	  
and	  MATLAB.	  	  In	  all	  cases,	  initial	  current	  magnitudes	  less	  than	  -­‐15	  nA	  were	  required	  
to	   indicate	   patching	   of	   sufficient	   quality	   for	   each	   ensemble	   of	   20	   cells.	   	   Data	   for	  
ensembles	  with	   starting	   currents	   above	   -­‐15	  nA	  were	  not	   included	   in	   the	   analysis.	  	  
The	   time	   averages	   of	   current	   from	   4s	   prior	   to	   exposure	   (60	   -­‐	   64	   s	   from	   the	  
beginning)	  was	   compared	  with	   the	   time	   averaged	   current	   600-­‐604	   s	   (665	   -­‐669	   s	  
from	  the	  beginning)	  following	  exposure	  to	  polymers/polyplexes	  suspended	  in	  SFM.	  
One	  way	   analysis	   of	   variance	   (ANOVA)	   followed	   by	   Tukey’s	  multicomparison	   test	  
was	  performed	  to	  determine	  the	  statistical	  significance	  of	  the	  difference	  in	  current	  
changes	  across	  different	  treatments.	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3.3.4 RFP	  Expression	  vs.	  MB	  Fluorescence	  
Polyplex	   preparation:	   Each	   polymer	  was	   diluted	   in	   sterile	  water	   to	   obtain	   an	  N:P	  
ratio	  of	  10:1.	  Dilutions	  of	  RFP	  plasmid	  (0.5	  μg)	  and	  MB	  (0.5	  μg)	  were	  prepared	  and	  
mixed	  to	  obtain	  a	  final	  N:P	  ratio	  of	  10:1	  in	  the	  polyplex.	  The	  polymer	  dilutions	  (25	  
μL)	  were	  added	   to	  equal	   volumes	  of	  DNA	  mixture	   (25	  μL)	  and	   incubated	  at	   room	  
temperature	   for	   25	   min	   before	   transfection.	   Transfection:	   Hela	   cells	   at	   200,000	  
cells/well	  in	  1	  mL	  of	  complete	  media	  were	  incubated	  overnight	  in	  24-­‐well	  plates	  for	  
flow	  cytometry.	  The	   cells	  were	   transfected	  with	   jetPEITM,	  G5	  PAMAM,	  B-­‐PEI,	   or	  L-­‐
PEI	   polyplexes	   and	   incubated	   at	   37o	   C	   in	   450	   μL	   of	   SFM.	   After	   3	   h,	   transfection	  
media	  was	  removed	  and	  500	  μL	  of	  fresh	  complete	  media	  was	  added	  to	  each	  of	  them	  
and	   incubated	  at	  37oC.	   	   	   Flow	  Cytometry:	  After	  33	  h	   (36	  h	  post-­‐transfection)	   cells	  
were	  rinsed	  with	  PBS	  without	  Ca2+	  and	  Mg2+,	  trypsinized,	  and	  suspended	  in	  1.8	  mL	  
of	  PBS	  with	  Ca2+	  and	  Mg2+	  and	  centrifuged	  at	  2000	  rpm	  for	  5	  min.	  	  The	  supernatant	  
was	   removed	  and	   the	  pellet	  was	   re-­‐suspended	   in	  400	  μL	  of	  PBS	  without	  Ca2+	  and	  
Mg2+	   and	  kept	   on	   ice	   and	  analyzed	  using	   an	  EPICS	  XL-­‐MCL	  Beckman	  Coulter	   flow	  
cytometer.	  
3.3.5 DNA	  Uptake	  vs.	  MB	  Fluorescence	  
Polyplex	   preparation:	   Each	   polymer	  was	   diluted	   in	   sterile	  water	   to	   obtain	   an	  N:P	  
ratio	  of	  10:1.	  Dilutions	  of	  Rhodamine	  labeled	  blank	  plasmid	  (0.5	  μg)	  and	  MB	  (0.5	  μg)	  
were	   prepared	   and	  mixed	   to	   obtain	   a	   final	   N:P	   ratio	   of	   10:1	   in	   the	   polyplex.	   The	  
polymer	  dilutions	  (25	  μL)	  were	  added	  to	  equal	  volumes	  of	  DNA	  mixture	  (25	  μL)	  and	  
incubated	  at	  room	  temperature	  for	  25	  min	  before	  transfection.	   	  Transfection:	  Hela	  
cells	  at	  200,000	  cells/well	   in	  1	  mL	  of	  complete	  media	  were	  incubated	  overnight	  in	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24-­‐well	   plates	   for	   flow	   cytometry.	   The	   cells	   were	   transfected	   with	   jetPEITM,	   G5	  
PAMAM,	  B-­‐PEI,	  or	  L-­‐PEI	  polyplexes	  and	  incubated	  at	  37o	  C	  in	  450	  μL	  of	  SFM.	  After	  3	  
h,	  transfecting	  media	  was	  removed	  and	  500	  μL	  of	  fresh	  complete	  media	  was	  added	  
to	   each	   of	   them	   and	   incubated	   at	   37oC.	   	   Flow	   Cytometry:	   After	   9	   h	   (12	   h	   post	  
transfection)	   cells	   were	   rinsed	   with	   PBS	   without	   Ca2+	   and	   Mg2+,	   trypsinized,	   and	  
suspended	  in	  1.8	  mL	  of	  PBS	  with	  Ca2+	  and	  Mg2+	  and	  centrifuged	  at	  2000	  rpm	  for	  5	  
min.	  	  The	  supernatant	  was	  removed	  and	  the	  cell	  pellet	  was	  resuspended	  in	  400	  μL	  
of	  PBS	  without	  Ca2+	  and	  Mg2+	  and	  analyzed	  by	  flow	  cytometry.	  For	  each	  sample	  two	  
replicates	  were	  used	  and	   fluorescence	   from	  10,000	  cells	  was	  measured	   form	  each	  
replicate.	  	  
3.3.6 DNA	  Protection	  Assay	  
The	   experiment	   was	   carried	   out	   in	   96-­‐well	   plates.	   0.08	   µg	   of	   MB	   was	   added	   to	  
specific	  wells	  with	  and	  without	  jetPEITM,	  G5	  PAMAM,	  B-­‐PEI,	  or	  L-­‐PEI	  polymers.	  For	  
polyplex	   containing	   samples	   an	   N:P	   ratio	   of	   10:1	   was	   maintained.	   5	   units	   of	   S1	  
nuclease	  were	  used	  and	  experiment	  was	  done	   in	  100	  μL	  of	  1X	  S1	  nuclease	  buffer.	  
The	  plate	  was	  read	  at	  excitation	  of	  485/20	  nm	  and	  emission	  of	  528/20	  nm,	  the	  plate	  
reader	  was	  kept	  at	  37	  °C	  for	  the	  experiment.	  
3.3.7 Cellular	  Localization	  of	  MB	  Fluorescence	  
Polyplex	  preparation:	  B-­‐PEI,	  G5	  PAMAM,	  jetPEITM	  and	  L-­‐PEI	  polymer	  were	  diluted	  in	  
sterile	  water	  to	  obtain	  an	  N:P	  ratio	  of	  10:1.	  Dilutions	  of	  Rhodamine	  labeled	  plasmid	  
(0.5	  ug)	  and	  MB	  (0.5	  ug)	  was	  prepared	  and	  mixed	  to	  obtain	  a	  final	  N:P	  ratio	  of	  10:1	  
in	  the	  polyplex.	  The	  polymer	  dilution	  (25	  uL)	  was	  then	  added	  to	  equal	  volumes	  of	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DNA	   mixture	   (25	   uL)	   and	   incubated	   at	   room	   temperature	   for	   25	   min	   before	  
transfection.	   	   Transfection:	   Hela	   cells	   at	   100,000	   cells/well	   in	   1	   mL	   of	   complete	  
media	   were	   incubated	   overnight	   in	   2-­‐well	   coverglass	   chambers	   for	   confocal	  
microscopy.	   The	   cells	  were	   transfected	  with	   jetPEITM,	   G5	  PAMAM,	  B-­‐PEI,	   or	   L-­‐PEI	  
polyplexes	   respectively	   and	   incubated	   at	   37o	   C	   in	   950	   uL	   of	   SFM.	   After	   3	   h,	  
transfecting	  media	  was	   removed	  and	  1	  mL	  of	   fresh	  complete	  media	  was	  added	   to	  
each	  of	   them	  and	   incubated	  at	  37oC.	   	  After	  9	  h	   (12	  h	  post-­‐transfection)	  cells	  were	  
rinsed	  with	   PBS	  with	   Ca2+	   and	  Mg2+.	   	   2%	  paraformaldehyde	  was	   then	   used	   to	   fix	  
cells	  for	  15	  minutes	  at	  room	  temperature.	  Cells	  were	  then	  given	  another	  rinse	  with	  
PBS	   with	   Ca2+	   and	   Mg2+	   and	   were	   treated	   with	   Prolong	   goldTM	   to	   reduce	  
photobleaching	   and	   with	   DAPI	   (4',6-­‐diamidino-­‐2-­‐phenylindole)	   to	   stain	   the	   cell	  
nucleus.	   
3.3.8 DNA	  Gel	  Electrophoresis	  
A	   6-­‐well	   plate	   was	   plated	   with	   HeLa	   cells	   (ATCC	   CCL-­‐2)	   at	   a	   count	   of	   500,000	  
cells/well	   and	   incubated	   overnight	   at	   37	   oC.	   The	   cells	   were	   transfected	   with	  
polyplexes	  formed	  at	  an	  N:P	  ratio	  of	  10:1	  between	  G5	  PAMAM	  and	  2	  µg	  of	  salmon	  
sperm	  DNA	   in	   SFM.	   	   The	   cells	  were	   trypsinized	   and	   the	   cytosol	  was	   extracted	   by	  
treating	  with	  NP:40	  lysis	  buffer	  (with	  protease	  inhibitors)	  and	  incubating	  on	  ice	  for	  
30	  minutes.	   	   Using	   this	   protocol,	   complete	   cell	   lysis	   occurs	   in	   less	   than	   1	  minute	  
(data	   not	   shown).	   	   The	   protein	   concentration	   of	   the	   extract	   was	   then	   measured.	  
Luciferase	  plasmid	  DNA	  was	  mixed	  with	  the	  extract	  for	  30	  minutes	  at	  37	  oC	  and	  run	  
on	  0.9	  %	   agarose	   gel.	   Lane	  2	   contains	   0.2	   µg	   of	   cytosolic	   protein	   (from	   cells	   only	  
control)	  and	  0.2	  µg	  plasmid	  DNA.	  Lane	  3	  contains	  0.2	  µg	  of	  cytosolic	  protein	  from	  G5	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PAMAM	  polyplex	   treated	   cells	   and	  0.2	  µg	  plasmid	  DNA.	  Lanes	  4	  and	  5	   contain	  0.2	  
units	  of	  S1	  nuclease	  and	  0.2	  µg	  of	  plasmid	  DNA,	  with	  S1	  nuclease	  reaction	  buffer	  and	  
water	  as	  solvent,	  respectively.	  	  
3.4 Results	  and	  Discussion	  
Polyplexes	   formed	   using	   all	   four	   polymer	   vectors	   at	   an	   N:P	   ratio	   of	   10:1	   were	  
exposed	   to	   HeLa	   cells	   in	   SFM	   containing	   PI.	   	   In	   all	   cases,	   cell	   plasma	  membrane	  
permeability	  was	  measured	  using	  PI	   diffusion	   into	   the	   cell	   (Figure	   3.1,	   y-­‐axis	   and	  
Table	   3.1).	   	   The	   G5	   PAMAM	   polyplexes	   and	   jetPEITM	   gave	   the	   largest	   mean	  
fluorescence	   shifts	   (ΔMF	  =	   145	   (±5)	   and	   131	   (±13)	   respectively)	  whereas	   B-­‐PEI	  
and	   L-­‐PEI	   showed	   the	   least	   permeability	   with	  ΔMF	   of	   71	   (±29)	   and	   37	   (±3),	  
respectively	  (ΔMF	  is	  calculated	  by	  subtracting	  the	  Log	  mean	  fluorescence	  value	  of	  
the	   control	   cells	   from	   sample	   cells).	   Treatment	   with	   the	   four	   polyplexes	   yielded	  
significantly	   different	   results	   in	   terms	   of	   the	   total	   amount	   of	   MB	   fluorescence	  
obtained	   with	   B-­‐PEI	   and	   G5	   PAMAM	   polyplexes,	  ΔMF	   of	   21	   (±3)	   and	   15	   (±2)	  
respectively,	  and	  no	  shift	  in	  ΔMF	  measured	  after	  treatment	  with	  jetPEITM	  and	  L-­‐PEI	  
polyplexes	  (Figure	  3.1,	  x-­‐axis	  and	  Table	  3.1).	  	  When	  compared	  at	  a	  cell-­‐by-­‐cell	  level,	  
the	  behavior	  of	  the	  four	  polyplexes	  also	  differed.	  	  For	  G5	  PAMAM	  and	  B-­‐PEI	  most	  of	  
the	  cells	  exhibiting	  porosity	  also	  showed	  MB	  fluorescence.	  	  jetPEITM	  and	  L-­‐PEI	  were	  
remarkable	   for	   showing	   1-­‐2	   log	   shifts	   in	   PI	   intensity	   for	   93%	   and	   46%	   of	   cells,	  
respectively,	  without	  much	  evidence	  of	  nuclease	  activation.	  	  To	  ensure	  that	  cleavage	  
of	  MB,	  which	  gives	   rise	   to	   fluorescence,	   is	  due	   to	  nuclease	  activity	  and	  not	   simply	  
due	  to	  changes	  in	  pH	  associated	  with	  endosome/lysosome	  localization,	  the	  stability	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of	  MB	  was	  tested	  under	  a	  range	  of	  pH	  (supplementary	  material	  Figure	  3.S2),	  which	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  B-­‐PEI	  polyplex	  treated	  cells	  	  	  	  	  	  	  	  G5	  PAMAM	  polyplex	  treated	  cells	  	  	  	  	  	  	  	  	  
	  
	  
	  	  	  	  	  jetPEITM	  polyplex	  treated	  cells	  	  	  	  L-­‐PEI	  polyplex	  treated	  cells	  
	  
	   	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   	  Cells	  only	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  3.1.	  Two-­‐color	  flow	  cytometry	  of	  PI	  uptake	  (y-­‐axis)	  vs	  MB	  fluorescence	  (x-­‐
axis)	  in	  HeLa	  cells	  after	  3	  h	  polyplex	  exposure	  followed	  by	  9	  h	  incubation.	  	  PI	  uptake	  
is	  used	  to	  indicate	  cell	  plasma	  membrane	  permeability	  and	  MB	  fluorescence	  is	  used	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Table	  3.1.	  ∆	  MF	  and	  standard	  error	  for	  PI	  uptake	  and	  MB	  fluorescence	  for	  samples	  in	  
Figure	  3.1.	  
Polyplex	   PI	  uptake	   MB	  fluorescence	  
∆	  MF	  
(average)	  
Standard	  error	   ∆	  MF	  
(average)	  
Standard	  error	  
jetPEITM	   131.4	   13.3	   0.5	   0.4	  
B-­‐PEI	   70.8	   29.3	   21.4	   3.4	  
G5	  PAMAM	   144.6	   5.2	   15.3	   1.9	  
L-­‐PEI	   37.0	   3.4	   1.0	   0.4	  
	  
In	  order	  to	  further	  explore	  the	  impact	  of	  polyplexes	  on	  cell	  membrane	  permeability,	  
we	   then	   employed	   whole-­‐cell	   patch	   clamp.[28]	   	   This	   allowed	   us	   to	   evaluate	   the	  
impact	   of	   these	   oligonucleotide	   delivery	   materials	   on	   the	   diffusion	   of	   small	  
inorganic	   ions	   through	   the	   cell	   plasma	   membrane,	   as	   opposed	   to	   small	   organic	  
molecules,	  as	  represented	  by	  PI	  (MW	  =	  668).	  	  For	  these	  experiments,	  we	  monitored	  
the	  change	   in	  permeability	  over	  the	   initial	   ten	  minutes	  of	  polyplex	  exposure.	   	  As	  a	  
positive	  control,	  we	  first	  measured	  the	  porosity	  of	  the	  cell	  membrane	  caused	  by	  the	  
polymer	  vectors	  alone	  (Figure	  3.2)	  and	  obtained	  data	  consistent	  with	  our	  previous	  
whole-­‐cell	   patch	   clamp	   studies	   performed	   using	   a	   traditional	   glass	   electrode	  
probing	   a	   single	   cell.[25]	   	   All	   the	   polymers	   induced	  membrane	   permeability	  with	  
jetPEITM	  and	  L-­‐PEI	  inducing	  the	  most	  permeability.	  We	  then	  examined	  the	  impact	  of	  
the	  polyplexes	  on	  cell	  membrane	  permeability.	   	  As	  illustrated	  in	  Figure	  3.2,	   jetPEI-­‐
based	   polyplexes	   in	   SFM	   generate	   the	   largest	   trans-­‐membrane	   ion	   currents,	  
whereas	   B-­‐PEI,	   G5	   PAMAM,	   and	   L-­‐PEI	   polyplexes	   do	   not	   generate	   currents	   that	  
differ	   significantly	   from	   the	   control	   cells.	   The	  polyplexes	   generate	   a	   solution	  with	  
less	  charge	  density	  than	  the	  polymer	  vectors	  alone,	  since	  the	  net	  positive	  charge	  is	  
reduced	   by	   the	   addition	   of	   DNA.	   This	   is	   consistent	   with	   the	   reduced	   ability	   of	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polyplexes	   to	   induce	  membrane	   permeability	  when	   compared	   to	   polymers	   alone.	  
The	  change	  in	  current	  due	  to	  jetPEITM	  polyplexes	  is	  significantly	  different	  from	  the	  
controls	   as	   determined	   by	   one-­‐way	   ANOVA	   (P	   =	   <	   0.001)	   followed	   by	   Tukey’s	  
multiple	   comparison	   test	   (α	   =	   95%).	   	   The	   positive	   change	   in	   currents	   for	   cells	  
treated	   with	   B-­‐PEI	   and	   L-­‐PEI	   polyplexes	   are	   not	   statistically	   different	   from	   the	  
control.	   It	   represents	   a	   small	   improvement	   in	   the	   seal	   of	   the	   cells	   at	   the	   trapping	  
site.	  This	  gradual	  improvement	  in	  the	  seal	  resistance	  is	  observed	  for	  all	  the	  different	  
treatments.	   This	   phenomenon	   is	  masked	  when	  permeability	   induced	  by	  polymers	  
and	   polyplexes	   is	   high	   enough.	   These	   whole-­‐cell	   patch	   clamp	   experiments	   were	  
performed	  in	  SFM	  to	  most	  closely	  match	  the	  PI-­‐based	  measure	  of	  plasma	  membrane	  
permeability	  as	  well	  as	  the	  expression	  and	  uptake	  experiments.	  	  We	  also	  examined	  
the	   impact	   of	   the	   polyplexes	   on	   cell	   membrane	   using	   the	   more	   traditional	   patch	  
clamp	  medium	  of	  an	  extracellular	  solution	  (ECS)	  consisting	  of	  138	  mM	  NaCl,	  4	  mM	  
KCl,	  1.8	  mM	  CaCl2,	  1	  mM	  MgCl2,	  10	  mM	  HEPES,	  and	  5.6	  mM	  glucose	  adjusted	  to	  pH	  
7.45	  using	  NaOH	   (supplementary	  material	   Figure	  3.S4).	   	   In	   this	   case,	   a	   significant	  
amount	  of	  cell	  plasma	  membrane	  permeability	  is	  observed	  for	  all	  polyplexes.	  	  	  	  The	  
SFM	  primarily	  differs	   from	  ECS	   in	  containing	  up	  to	  2	  mM	  concentrations	  of	  amino	  
acids,	  with	  the	  negatively	  charged	  L-­‐glutamine	  being	  particularly	  notable,	  and	  0.002	  
to	  0.01	  mM	  concentration	  of	  vitamins.	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Figure	  3.2.	  Cell	  plasma	  membrane	  currents	  induced	  by	  exposure	  of	  HeLa	  cells	  to	  
SFM	  solutions	  of	  jetPEI,	  B-­‐PEI,	  G5	  PAMAM,	  and	  L-­‐PEI	  polymers	  and	  polymer/DNA	  
polyplexes.	  	  	  Only	  the	  jetPEI	  polymer	  and	  polyplex	  exhibits	  evidence	  for	  membrane	  
porosity	  that	  is	  significantly	  different	  from	  SFM	  only	  controls.	  
	  
Figure	  3.S4.	  	  Cell	  membrane	  permeability	  induced	  by	  polyplex	  exposure	  in	  ECS.	  
	  
	  
The	  relationship	  between	  MB	  fluorescence	  and	  protein	  expression	  was	  compared	  by	  
forming	   polyplexes	   at	   an	   N:P	   ratio	   of	   10:1	   that	   contained	   the	  MB	   DNA	   and	   RFP-­‐
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encoding	  pDNA	   in	   a	  1:1	  w/w	  ratio	   (Figure	  3.3	   and	  Table	  3.2).	   	  Again,	  G5	  PAMAM	  
polyplexes	  yielded	  the	  greatest	  ΔMF	  for	  MB	  of	  49	  (±1)	  whereas	  B-­‐PEI,	  jetPEITM,	  and	  
L-­‐PEI	  exhibited	  shifts	  of	  27	  (±3),	  28	  (±3),	  and	  6	  (±1),	  respectively	  	  	  	  
B-­‐PEI	  polyplex	  treated	  cells	  	  	  	  	  G5	  PAMAM	  polyplex	  treated	  cells	  	  	  	  	  	  	  	  	  
	    
jetPEITM	  polyplex	  treated	  cells	  	  	  	  	  	  L-­‐PEI	  polyplex	  treated	  cells	  
	  
 	  	   	  
	  	  	  	  	  	  	  	  	  	  	  	  Cells	  only	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  3.3.	  Two-­‐color	  flow	  cytometry	  of	  RFP	  expression	  (y-­‐axis)	  vs	  MB	  fluorescence	  
(x-­‐axis)	  in	  HeLa	  cells	  after	  3	  h	  polyplex	  exposure	  followed	  by	  33	  h	  incubation.	  	  RFP	  
expression	  is	  used	  as	  the	  marker	  of	  transfected	  pDNA	  expression	  and	  MB	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Table	  3.2.	  ∆	  MF	  and	  standard	  error	  for	  MB	  fluorescence	  for	  samples	  in	  Figure	  3.3.	  








jetPEI	   17.2	   0.8	   28.1	   3.0	  
B-­‐PEI	   5.1	   0.1	   26.7	   2.8	  
G5	  PAMAM	   0.9	   0.1	   49.4	   1.0	  
L-­‐PEI	   21.2	   0.1	   5.8	   1.0	  
	  
	  
The	   change	   in	   cellular	   fluorescence	   related	   to	   RFP	   expression	   was	   qualitatively	  
different	  than	  that	  observed	  for	  MB	  fluorescence	  or	  PI	  uptake.	  	  For	  both	  MB	  and	  PI	  
fluorescence,	   the	   entire	   cell	   population	   shifted	   in	   response	   by	   up	   to	   one	   order	   in	  
magnitude.	  	  By	  way	  of	  contrast,	  the	  RFP	  expression	  varied	  by	  up	  to	  three	  orders	  of	  
magnitude	   in	   fluorescence	   intensity	   and	   was	   caused	   by	   individual	   cells	   showing	  
significantly	   larger	   signal	   while	   the	  majority	   of	   the	   population	   exhibited	   no	   shift.	  	  
The	   G5	   PAMAM	   polyplexes	   induced	   RFP	   fluorescence	   in	   less	   than	   1%	   of	   the	   cell	  
population	  and	  B-­‐PEI	  polyplexes	  showed	  expression	  in	  5.1%	  of	  the	  population.	  	  RFP	  
expression	  was	  observed	  in	  17.2%	  of	  cells	  for	  jetPEITM	  with	  most	  of	  this	  expression	  
occurring	  in	  cells	  exhibiting	  a	  small	  ΔMF	  for	  MB	  fluorescence.	  	  The	  greatest	  amount	  
of	  expression	  was	  observed	  for	  L-­‐PEI,	  21.2%	  of	  the	  population,	  with	  essentially	  no	  
ΔMF	   for	  MB	   fluorescence	  observed.	  To	   summarize	   the	   results	   from	  Figures	  3.1	  –	  
3.3,	  all	  of	  the	  polyplexes	  cause	  substantial	  membrane	  permeability	  as	  measured	  by	  
PI	   uptake;	   however	   for	   jetPEITM	   and	   L-­‐PEI,	   this	   permeability	   did	   not	   cause	   an	  
increase	   in	   MB	   fluorescence.	   	   Only	   jetPEITM	   polyplexes	   showed	   enhanced	   ion	  
permeability	   according	   to	   whole-­‐cell	   patch	   clamp	   studies.	   	   Generally,	   the	   L-­‐PEI	  
polyplex-­‐exposed	   cells	   that	   express	   RFP	   do	   not	   show	   MB	   fluorescence	   and	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increasing	   amounts	   of	   MB	   fluorescence	   for	   jetPEITM,	   B-­‐PEI,	   and	   G5	   PAMAM	  
correspond	  to	  decreased	  amounts	  of	  protein	  expression.	  
This	  data	  raises	  a	  number	  of	  interesting	  questions	  and	  the	  need	  for	  related	  control	  
experiments:	  	  1)	  Is	  the	  large	  difference	  in	  MB	  fluorescence	  related	  to	  a	  difference	  in	  
nuclease	  activity,	  or	  is	  it	  actually	  controlled	  by	  a	  substantial	  difference	  in	  uptake	  of	  
polyplexes	   as	   a	   function	   of	   polymer	   vector?	   	   2)	   Is	   the	   large	   difference	   in	   MB	  
fluorescence	   observed	   accounted	   for	   by	   L-­‐PEI	   and	   jetPEITM	   providing	   better	  
protection	   of	   the	   MB	   DNA?	   	   3)	   Is	   the	   MB	   fluorescence	   associated	   with	   “intact”	  
polyplexes	   or	   with	   only	   with	   degraded	   DNA	   that	   is	   no	   longer	   associated	   with	  
polyplexes?	   	   4)	   Finally,	   if	   nucleases	   are	   involved,	   what	   are	   possible	   identities	   of	  
these	  nucleases?	  
In	  order	  to	  test	  any	  impact	  of	  differential	  DNA	  uptake	  on	  our	  results	  we	  generated	  
10:1	  N:P	   ratio	   polyplexes	   containing	   a	   1:1	  w/w	   ratio	   of	  MB	  DNA	  and	   rhodamine-­‐
labeled	  DNA	  (Figure	  3.4	  and	  Table	  3.3).	   	  The	  cells	  were	  exposed	  to	   the	  polyplexes	  
for	   3	   h,	   rinsed,	   and	   incubated	   for	   an	   additional	   9	   h.	   	   Similar	   to	   the	   PI	   and	   MB	  
fluorescence	   data,	   the	   fluorescence	   due	   to	   DNA	   uptake	   also	   results	   in	   an	   overall	  
population	  shift	  with	  a	  ΔMF	  of	  1092	  (±63),	  1277	  (±59),	  622	  (±9),	  and	  1268	  (±65)	  
for	  B-­‐PEI,	  G5	  PAMAM,	   jetPEITM	  and	  L-­‐PEI,	  respectively.	   	  All	   four	  vectors	  are	  highly	  
effective	   at	   transfection	   and	   the	   differences	   in	   MB	   fluorescence	   vs	   plasma	  
membrane	   porosity	   and	  MB	   fluorescence	   vs	  RFP	   expression	   are	   not	   a	   function	   of	  
differential	  polyplex	  uptake.	  	  The	  G5	  PAMAM	  polyplex	  treated	  cells	  again	  exhibited	  
the	   greatest	   amount	   of	  MB	   fluorescence,	   consistent	  with	   porosity	   and	   expression	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studies,	  with	   the	   overall	   trend	   remaining	   for	  MB	  ΔMF	  of	   G5	   PAMAM	  >	  B-­‐PEI	   	  ~	  
jetPEITM	  >	  L-­‐PEI.	  	  	  
	  	  	  	  B-­‐PEI	  polyplex	  treated	  cells	  	  	  	  G5	  PAMAM	  polyplex	  treated	  cells	  	  	  	  	  	  	  	  	  
	  
	  	  	  	  	  	  jetPEITM	  polyplex	  treated	  cells	  	  	  	  L-­‐PEI	  polyplex	  treated	  cells	  
	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  Cells	  only	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Figure	  3.4.	  Two-­‐color	  flow	  cytometry	  of	  DNA	  uptake	  (y-­‐axis)	  vs	  MB	  fluorescence	  (x-­‐
axis)	  in	  HeLa	  cells	  after	  3	  h	  polyplex	  exposure	  followed	  by	  9	  h	  incubation.	  	  DNA	  
uptake	  is	  measured	  using	  a	  rhodamine	  labeled	  DNA	  plasmid	  and	  MB	  fluorescence	  is	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Table	  3.3.	  ∆	  MF	  and	  standard	  error	  for	  DNA	  uptake	  for	  samples	  in	  Figure	  3.4.	  
Polyplex	   DNA	  uptake	   MB	  fluorescence	  
∆	  MF	  
(average)	  
Standard	  error	   ∆	  MF	  
(average)	  
Standard	  error	  
jetPEI	   621.6	   9.3	   43.7	   6.5	  
B-­‐PEI	   1091.6	   63.0	   57.5	   6.2	  
G5	  PAMAM	   1276.6	   58.8	   144.5	   7.8	  
L-­‐PEI	   1268.1	   65.1	   21.8	   2.5	  
	  
Having	  ruled	  out	  differential	  uptake	  as	  a	  mechanism,	   the	  significant	  differences	   in	  
MB	  fluorescence	  observed	  in	  Figures	  3.1	  and	  3.3	  could	  be	  the	  result	  of	  differential	  
nuclease	  activity	  in	  the	  cells	  or	  the	  result	  of	  differential	  DNA	  protection	  offered	  by	  
the	   polymers.	   	   Indeed,	   the	   hypothesis	   of	   providing	   improved	  DNA	   protection	   has	  
often	   been	   a	   goal	   of	   synthetic	   polymer	   vector	   design	   to	   improve	   transfection	   and	  
expression	   activity.[11,	   16,	   29]	   To	   test	   if	   the	   polymers	   protected	   the	   DNA	   to	  
different	   extents,	   we	   exposed	   10:1	   N:P	   polyplexes	   to	   cytosolic	   extract	   containing	  
nuclease	  and	  to	  S1	  nuclease	  (vida	  infra	  for	  the	  selection	  of	  nuclease).	   	  Our	  controls	  
(Figures	   3.5	   and	   3.S7c)	   indicate	   that	   the	   MB	   is	   stable	   to	   the	   process	   of	   polyplex	  
formation	  and	  the	  overall	  conditions	  of	  the	  nuclease	  experiment.	   	  Cytosolic	  and	  S1	  
nuclease	   cleavage	   of	   the	   MB	   with	   no	   polymer	   protection,	   Figures	   3.5	   and	   3.S5a,	  
indicate	  the	  total	  amount	  of	  fluorescence	  signal	  that	  is	  possible	  for	  each	  experiment.	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Figure	  3.5.	  Fluorescence	  of	  MB	  after	  complexing	  as	  a	  10:1	  N:P	  polyplex	  with	  B-­‐PEI,	  
G5	  PAMAM,	  jetPEITM	  or	  L-­‐PEI	  followed	  by	  cytosolic	  nuclease	  treatment	  (5	  μg	  of	  
cytosolic	  extract).	  	  Fluoresence	  of	  MB	  treated	  with	  cytosolic	  nuclease	  and	  MB	  only	  in	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Figure	  3.S5:	  	  Fluorescence	  of	  MB	  a)	  after	  treatment	  with	  S1	  nuclease	  b)	  after	  
complexing	  as	  a	  10:1	  N:P	  polyplex	  with	  L-­‐PEI,	  B-­‐PEI,	  G5	  PAMAM,	  or	  jetPEITM	  
followed	  by	  S1	  nuclease	  treatment	  	  c)	  controls	  of	  	  MB	  and	  polyplex	  with	  no	  S1	  
nuclease	  added.	  
	  
For	  the	  experiment	  where	  the	  beacon	  polyplex	  was	  exposed	  to	  S1	  nuclease,	  all	  four	  
polymers	   provide	   similar	   protection	   to	   the	   DNA,	  with	   jetPEITM	   being	   slightly	   less	  
protective	   for	   the	   first	   20	   minutes	   of	   the	   assay	   (Figure	   3.S5b),	   The	   inhibition	   of	  
fluorescence	   observed	   between	   20	   and	   40	   minutes	   for	   the	   L-­‐PEI	   and	   jetPEITM	  
experiments	   is	   consistent	   with	   a	   reduction	   in	   fluorescence	   observed	  when	  MB	   is	  
first	  cleaved	  with	  S1	  and	  then	  polymer	  added	  (data	  not	  shown).	  	  This	  type	  of	  kinetic	  
behavior	   is	   consistent	   with	   our	   recent	   observations	   that	   polyplexes	   are	   dynamic	  
species	  with	  the	  pDNA	  and	  polymer	  components	  in	  rapid	  equilibrium	  that	  includes	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For	   the	   experiment	   where	   the	   beacon	   polyplex	   was	   exposed	   to	   cytoplasm	  
containing	  cytosolic	  nuclease,	  we	  observed	  a	  significant	  difference	   in	  protection	  of	  
the	  MB	  as	  a	  function	  of	  polymer	  employed.	   	   In	  particular,	   jetPEITM	  and	  G5	  PAMAM	  
provide	  essentially	  complete	  protection	  as	  indicated	  by	  no	  increase	  in	  fluorescence	  
above	   the	   control;	   however,	   both	   L-­‐PEI	   and	   B-­‐PEI	   show	   a	   substantial	   increase	   in	  
fluorescence	   consistent	   with	   roughly	   25-­‐50%	   of	   the	   beacon	   being	   cleaved.	   	   	   One	  
limiting	  case	  for	  explaining	  this	  data	  is	  that	  nucleases	  are	  present	  inside	  the	  cell	  to	  
which	   the	   polyplexes	   offer	   differential	   protection	   as	   a	   function	   of	   polymer	  
employed.	  	  Another	  limiting	  case	  is	  that	  other	  components	  are	  present	  (ie	  proteins	  
and/or	  lipids)	  that	  interact	  with	  the	  polyplexes	  as	  a	  function	  of	  polymer	  employed	  
to	  give	  differing	  amounts	  of	  MB	  release.	  	  Some	  combination	  of	  these	  limiting	  cases	  is	  
also	   possible.	   	   The	   second	   hypothesis	   of	   differential	   release	   is	   intriguing	   with	  
respect	  to	  our	  previous	  observation	  of	  polyplex	  equilibrium.[30]	  
To	   summarize	   our	   tests	   of	   nuclease	   activity,	   the	   results	   illustrated	   in	   Figure	   3.S5	  
indicate	   that	   the	   four	   polymers	   provide	   a	   similar	   level	   of	   S1	   nuclease	   protection;	  
however,	  exposure	  to	  cytoplasm	  containing	  nucleases	  shows	  a	  significant	  difference	  
in	   the	   level	   of	  MB	  protection	   (Figure	  3.5).	   	   In	   particular,	   G5	  PAMAM	  and	   jetPEITM	  
exhibit	  no	  MB	  degradation	  whereas	  B-­‐PEI	  and	  L-­‐PEI	  exhibit	  substantial	  fluorescence	  
resulting	  from	  MB	  cleavage.	  	  Interestingly,	  the	  fluorescence	  intensity	  trend	  observed	  
for	   this	   solution	   based,	   cell-­‐free	   test	   of	   cytosolic	   nucleases	   is	   L-­‐PEI>	   B-­‐PEI	   >>	   G5	  
PAMAM	  ~	  	  jetPEITM,	  which	  is	  significantly	  different	  from	  the	  ΔMF	  observed	  for	  the	  
in-­‐cell	  experiments	  of	  G5	  PAMAM	  >	  B-­‐PEI	  	  ~	  jetPEITM	  >	  L-­‐PEI.	  	  The	  difference	  in	  both	  
the	  S1	  nuclease	  (Figure	  3.S7)	  and	  the	  cytosolic	  nuclease	  (Figure	  3.5)	  trends	  with	  the	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consistent	  trends	  in	  MB	  activity	  seen	  in	  Figures	  3.1,	  3.3,	  and	  3.4	  suggest	  that	  neither	  
of	   these	   nuclease	   controls	   is	   able	   to	   fully	   capture	   the	   in-­‐cell	   activity.	   	   Neither	  
experiment	   supports	   the	   simple	   hypothesis	   that	   the	  MB	   fluorescence	   observed	   in	  
the	   flow	   cytometry	   studies	   is	   due	   to	   differential	   DNA	   protection	   facilitated	   by	  
polymers.	   	   	  We	  note	  that	  one	  the	  polymers	  providing	  the	  best	  protection	  in	  Figure	  
3.5	  (G5	  PAMAM)	  provides	  the	  least	   in	  the	  flow	  cytometry	  studies	  (Figures	  3.1,	  3.3,	  
3.4)	  and	  the	  polymer	  providing	  the	  worst	  protection	  in	  Figure	  3.5	  (L-­‐PEI)	  routinely	  
provides	  the	  best	  protection	  in	  the	  flow	  cytometry	  studies.	  
The	   view	  of	   the	   polyplex	   as	   a	   dynamic	   and	   rapid	   equilibrium	  between	  pDNA	   and	  
polymer[30]	   raises	   the	   question	   of	   cellular	   distribution	   of	   the	   fluorescence	   as	  
measured	   by	   flow	   cytometry	   in	   Figures	   3.1,	   3.3,	   and	   3.4.	   	   Specifically,	   does	   the	  
fluorescence	  arise	  from	  polyplexes	  distributed	  in	  a	  the	  punctate	  fashion	  commonly	  
observed	   for	   polymer	   vectors[31,	   32]	   or	   from	   a	   more	   diffuse	   signal	   from	   short,	  
dispersed	   oligonucleotide	   fragments?	   	   Confocal	   fluorescence	   microscopy	   of	   HeLa	  
cells	  exposed	  to	  polyplexes	  consisting	  of	  MB	  and	  B-­‐PEI,	  G5	  PAMAM,	  jetPEITM,	  or	  L-­‐
PEI	  in	  a	  10:1	  N:P	  ratio	  for	  3	  h	  followed	  by	  another	  9	  h	  incubation	  indicates	  a	  typical	  
punctate	   transfection	   pattern	   for	   the	   internalized	  materials	   (Figure	   3.6).	   	   The	  MB	  
fluorescence	   appears	   to	   remain	   associated	   with	   the	   polymer	   and	   polyplexes,	  
consistent	  with	  the	  decrease	  in	  fluorescence	  exhibited	  in	  Figure	  3.5.	   	  For	  the	  B-­‐PEI	  
and	  G5	  PAMAM	  polyplexes	  most	  of	   the	   fluorescence	  observed	   is	   green,	   consistent	  
with	   the	   presence	   of	   cleaved	  MB.	   	   For	   the	   jetPEITM	   and	   L-­‐PEI	   polyplexes,	  most	   of	  
fluorescence	   observed	   is	   red,	   consistent	   with	   the	   presence	   of	   intact	   MB.	   	   These	  
differences	   in	   MB	   cleavage	   are	   consistent	   with	   those	   observed	   by	   the	   flow	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cytometry	   experiments	   (Figures	   3.1,	   3.3,	   and	   3.4)	   for	   L-­‐PEI	   and	   G5	   PAMAM	   and	  
suggest	   an	   interesting	   difference	   for	   the	   similar	  ΔMF	   shifts	   seen	   for	   B-­‐PEI	   and	  
jetPEITM.	  	  	  
	  
B-­‐PEI	  polyplex	  treated	  cells	   	   	   G5	  PAMAM	  polyplex	  treated	  cells	  
	   	  	   	  
jetPEITM	  polyplex	  treated	  cells	   	   	   L-­‐PEI	  polyplex	  treated	  cells	  
	   	  	   	  
Figure	   3.6.	   Confocal	   fluorescence	  microscopy	   of	   HeLa	   cells	   exposed	   to	   polyplexes	  
consisting	   of	   MB	   (to	   measure	   nuclease	   activity),	   Rhodamine-­‐labeled	   plasmid	   (to	  
measure	  DNA	  uptake)	  and	  polymer	  in	  a	  10:1	  N:P	  ratio	  for	  3	  h	  followed	  by	  another	  9	  
h	  incubation.	  	  Nuclease	  cleaved	  MB	  is	  shown	  in	  green,	  DNA	  uptake	  shown	  in	  red	  and	  
DAPI-­‐stained	  cell	  nuclei	  are	  shown	  in	  blue.	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The	  identity	  and	  origin	  of	  the	  nuclease(s)	  responsible	  for	  the	  degradation	  of	  the	  MB	  
polyplexes	  is	  of	  great	  interest.	  	  The	  seminal	  studies	  by	  Lukacs	  et	  al.	  suggest	  that	  the	  
nucleases	  are	  not	  part	  of	  the	  apoptotic	  cascade	  (i.e.,	  not	  DNAse	  I,	  DNAse	  II,	  caspase-­‐
3,	   etc.)	   and	   support	   the	   notion	   that	   they	   are	   constitutively	   present	   in	   the	  
cytosol.[11]	  Pollard	  et	  al.	  also	  noted	  degradation	  in	  the	  cytosol	  and	  reported	  a	  Ca2+	  
dependency.[16]	   Ribeiro	   et	   al.	   have	   shown	   how	   supercoiled	   plasmid	   DNA	   can	   be	  
degraded	  by	  S1	  nuclease	  to	  yield	  open-­‐circle	  and	  linear	  topology	  of	  the	  plasmid.[20]	  
By	   using	   gel	   electrophoresis	   it	   was	   also	   shown	   that	   this	   degradation	   pattern	   is	  
consistent	  with	  cytosolic	  nucleases	  found	  in	  CHO	  cells.	  
In	   order	   to	   explore	   the	   origin	   of	   the	   nuclease	   in	   the	   HeLa	   cells	   employed	   in	   this	  
study,	  we	  exposed	  HeLa	  cells	   to	  polyplexes	  generated	  from	  G5	  PAMAM	  dendrimer	  
and	  salmon	  sperm	  DNA.	  	  G5	  PAMAM	  dendrimer	  was	  chosen	  for	  this	  experiment	  as	  
we	   have	   seen	   it	   causes	   maximum	   MB	   fluorescence	   in	   the	   cell	   studies	   discussed	  
above.	  	  Salmon	  sperm	  DNA	  was	  employed	  for	  these	  polyplexes	  so	  that	  we	  would	  not	  
introduce	  pDNA	  into	  the	  cytoplasm	  at	  this	  step.	  	  After	  3	  h,	  the	  cytoplasm	  from	  these	  
treated	   cells	  was	   extracted	   and	   then	   incubated	  with	   the	   luciferase	  plasmid	   for	   45	  
minutes	   at	   37	   °C.	   	   	   The	  mixture	  was	   then	   run	  on	   a	  0.9	  %	  agarose	   gel.	   	   Luciferase	  
plasmid	  was	  also	   treated	  with	  S1	  nuclease	   in	  S1	  nuclease	  buffer	  and	   in	  molecular	  
grade	  water.	  	  As	  illustrated	  in	  Figure	  3.7,	  the	  degradation	  pattern	  for	  the	  cytoplasm-­‐
treated	  plasmid	  is	   identical	  within	  the	  resolution	  of	  the	  gel	  to	  that	  obtained	  for	  S1	  
nuclease.	  	  We	  have	  also	  shown	  that	  simply	  treating	  the	  luciferase	  plasmid	  with	  the	  
isolated	  cytoplasm	  yields	  the	  same	  result.	  	  Given	  the	  wholesale	  disruption	  of	  the	  cell	  
in	  the	  process	  used	  to	  isolate	  the	  cytoplasm,	  we	  are	  unable	  to	  separate	  out	  the	  effect	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of	  the	  polyplex	  treatment	  and	  the	  cytosol	  isolation	  protocol.	   	  The	  experiments	  also	  
indicate	   that	   the	   nuclease	   must	   be	   constitutively	   present	   in	   the	   cytosol,	   as	  
previously	   proposed	   by	   Lukacs,[11]	   as	   the	   cytoplasm	   isolation	   protocol	   lyses	   the	  
cells	  in	  under	  1	  minute.	  	  	  	  
	  
Figure	   3.7.	   Agarose	   gel	   electrophoresis	   showing	   DNA	   cleavage	   pattern	   of	   HeLa	  
cytoplasm	  treated	  pDNA	  and	  S1	  nuclease	  treated	  pDNA.	  
	  
Both	   PI	   uptake	   and	   whole-­‐cell	   patch	   clamp	   measure	   membrane	   permeability	  
induced	   by	   polyplexes.	   Whole-­‐cell	   patch	   clamp	   measures	   the	   movement	   of	   ions	  
across	  the	  membrane	  and	  thus	  is	  sensitive	  to	  smaller	  membrane	  perturbations	  than	  
PI.	   	   Under	   the	   conditions	   employed	   in	   this	   study,	   all	   four	   polyplexes	   caused	  
substantial	   cell	   plasma	   permeability	   as	   indicated	   by	   PI	   uptake	   (Figure	   3.1).	  
Surprisingly,	   only	   JetPEITM	   polyplexes	   exhibited	   substantial	   cell	   permeability	   as	  
measured	   by	   whole-­‐cell	   patch	   clamp	   (Figure	   3.2);	   however,	   both	   techniques	  
pDNA	  in	  water 
Cells	  only	  
cytosol	  +	  pDNA	  
in	  water 
G5-­‐NH2	  polyplex	  treated	  
cytosol	  +	  pDNA	  in	  water 
S1	  nuclease	  +	  
pDNA	  in	  buffer 
S1	  nuclease	  +	  pDNA	  in	  
water 
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indicate	   that	   jetPEITM	   polyplexes	   induce	   the	  most	   permeability.	   	   	   There	   are	   three	  
major	   differences	   between	   whole-­‐cell	   patch	   clamp	   experiment	   and	   PI	   uptake	  
measured	   by	   flow	   cytometry.	   First,	   the	  whole-­‐cell	   patch	   experiment	   is	   performed	  
under	   flow	   conditions	   whereas	   the	   PI	   uptake	   experiment	   is	   in	   quiescent	   wells.	  	  	  
Second,	   the	   time	   frame	   for	   the	   whole-­‐cell	   patch	   experiment	   was	   10	   minutes	  
whereas	   the	   flow	   cytometry	  was	  performed	  after	  9	  h	   exposure.	   It	   is	   possible	   that	  
polyplexes	   made	   using	   G5	   PAMAM,	   B-­‐PEI	   and	   L-­‐PEI	   induce	   permeability	   at	   time	  
points	   greater	   than	   10	  minutes.	   Third,	   the	   patch	   clamp	   experiment	  measures	   ion	  
conductance	   across	   the	   cell	   membrane	   whereas	   the	   flow	   cytometry	   experiment	  
examines	   PI	   crossing	   the	   membrane.	   	   Regardless,	   neither	   assay	   demonstrates	   a	  
relationship	  between	  polyplex-­‐induced	  cell	  membrane	  permeability	  (JetPEITM	  ~	  G5	  
PAMAM>	  B-­‐PEI	  >	  L-­‐PEI	  for	  PI;	   JetPEITM	  >>	  G5	  PAMAM	  ~	  B-­‐PEI	  ~	  L-­‐PEI	  for	  whole-­‐
cell	  patch	  clamp)	  with	  DNA	  uptake	  (Figure	  3.4)	  or	  expression	  efficiency	  (Figure	  3.3).	  	  	  
Overall,	  materials	   exhibiting	   the	   least	   amount	   of	   in-­‐cell	  MB	   fluorescence	   (L-­‐PEI	   <	  
jetPEITM	  ~	   B-­‐PEI	   <	   G5	   PAMAM)	   showed	   the	   greatest	   amount	   of	   RFP	   expression.	  	  
Interestingly,	  B-­‐PEI	  and	  jetPEITM	  show	  the	  same	  amount	  of	  MB	  fluorescence	  at	  36	  h,	  
and	  thus	  apparently	  similar	   levels	  of	  nuclease	  activation,	  yet	   jetPEITM	  gives	  overall	  
4x	   greater	  RFP	  expression.	   Since	   jetPEITM	   is	   a	  proprietary	   form	  of	   linear	  PEI	  with	  
undisclosed	  components,	  we	  cannot	  comment	   further	  on	   this	  difference;	  however,	  
L-­‐PEI	  containing	  no	  additives	  shows	  very	   little	  MB	  fluorescence	  and	  also	  gives	  the	  
highest	  expression	  efficiency.	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3.5 Conclusions	  
The	  low	  transgene	  expression	  facilitated	  by	  polymer	  gene	  delivery	  systems	  presents	  
a	  substantial	  challenge	  for	  their	  use	  in	  genetic	  engineering.	  	  In	  this	  study	  we	  tested	  
the	   hypothesis	   that	   cells	   respond	   to	   polymer-­‐based	   vector	   systems	   by	   activating	  
cytosolic	  nucleases	   that	   in	   turn	  decrease	   transgene	  expression.	   	  The	  results	  of	  our	  
study	  indicate	  that	  cellular	  nuclease	  activity	  is	  activated	  differentially	  as	  a	  function	  
of	   the	   polymer	   employed	   for	   polyplex	   formation.	   	   Enhanced	   levels	   of	   nuclease	  
activation	  are	  related	  to	  lower	  levels	  of	  transgene	  expression.	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Chapter	  4	  
Quantification	  of	  Cytosolic	  Plasmid	  DNA	  Degradation	  Using	  High-­‐





Although	   cytosolic	   DNA	   degradation	   plays	   an	   important	   role	   in	   decreasing	  
transgene	   expression,	   their	   plasmid	   degradation	   pattern	   remains	   largely	  
unexplored.	   	   Herein,	   we	   use	   Illumina	   dye	   sequencing	   to	   provide	   degradation	   site	  
information	  for	  S1	  and	  cytosolic	  nucleases.	  	  S1	  nuclease	  provides	  a	  positive	  control	  
for	  comparison	  between	  the	  agarose	  gel	  method	  and	  the	  sequencing	  approaches.	  	  In	  
addition	   to	   identifying	   the	   plasmid	   bacterial	   origin	   of	   replication	   (OriC)	   as	   the	  
highest	   probability	   cut	   region,	   consistent	  with	   agarose	   gel	   results,	   the	   sequencing	  
approaches	  yielded	   information	  about	  previously	  unknown	  cut	   sites.	   	  The	  poly(A)	  
region	  between	  the	  β–lactamase	  gene	  and	  the	  CMV	  promoter	  was	  identified	  as	  most	  
likely	   cut	   site	   for	   plasmid	   treated	   with	   cytosol	   from	   polyplex-­‐treated	   cells.	   	   The	  
second	  most	  likely	  site,	  at	  the	  5’	  end	  of	  the	  β–lactamase	  gene,	  was	  identified	  by	  gel	  
electrophoresis	   and	   by	   sequencing.	   	   Additional	   sites	   were	   detected	   in	   the	   OriC	  
region,	   the	   SV40/poly(A)	   region,	   the	   luciferase	   gene,	   and	   the	   CMV	   promoter.	  	  
Sequence	   analysis	   of	   plasmid	   treated	   with	   cytosolic	   nucleases	   from	   control	   cells	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showed	   the	  greatest	   cut	  activity	   in	   the	  OriC	   region,	   the	  β–lactamase	  gene,	   and	   the	  
poly(A)	   region	   following	   the	   luciferase	   gene.	   	   Additional	   regions	   of	   cut	   activity	  
include	   the	   SV40	   promoter	   and	   the	   β–lactamase	   poly(A)	   termination	   sequence.	  	  
Both	   cytosolic	   nucleases	   and	   the	   S1	   nuclease	   showed	   substantial	   activity	   at	  OriC.	  	  
This	  analysis	   reveals	   regions	  of	   the	   luciferase	  plasmid	  DNA	  (pDNA)	  sequence	   that	  
are	  important	  for	  effective	  transgene	  expression	  and	  sensitive	  to	  degradation.	  	  This	  
provides	  new	  targets	  for	  improving	  plasmid	  and/or	  polymer	  design	  to	  optimize	  the	  
likelihood	  of	  protein	  expression.	  
4.2 Introduction	  
	  
Delivery	  of	  oligonucleotides,	   including	  antisense	  DNA	   	   (asDNA)	  and	  silencing	  RNA	  
(siRNA),	  and	  plasmid	  DNA	  (pDNA)	   is	  a	  promising	  strategy	   in	   the	   field	  of	  medicine	  
with	   possible	   applications	   including	   diagnosis,	   vaccines	   and	   disease	  
management.[1]	  The	  big	  range	  of	  applications	  and	  potential	  impact	  on	  common,	  life	  
threatening	   diseases	   like	   diabetes	   mellitus	   and	   metastatic	   neoplasm,[1]	   led	   to	   a	  
predicted	  pharmaceutical	  industry	  of	  $16.8	  billion/year	  by	  2020-­‐2025;[2]	  however,	  
almost	   15	   years	   after	   this	   prediction	   gene	   therapy	   is	   only	   a	   small	   fraction	   of	   this	  
multi-­‐billion	   dollar	   market	   projection.	   This	   lack	   of	   market	   availability	   and	  
penetration	   arises	   primarily	   because	   of	   safety	   and	   efficiency	   issues	   for	   current	  
nucleic	  acid	  delivery	  systems.[3,	  4]	  	  In	  addition	  to	  gene	  therapy,	  many	  other	  nucleic	  
acid	  manipulation	   techniques	   like	   asDNA	  and	   siRNA	   can	   greatly	   benefit	   from	   safe	  
and	   efficient	   delivery	   systems.[1,	   3]	   	   Development	   of	   non-­‐viral	   delivery	   systems	  
such	  as	  polycationic	  polymers	  present	  a	  unique	  and	  unprecedented	  opportunity	  to	  
genetic	   engineers.[5,	   6]	   Polymers	   allow	   a	   significant	   amount	   of	   customization,	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provide	   a	   high	   surface	   moiety	   to	   volume	   ratio,	   and	   are	   relatively	   safe	   when	  
compared	   to	   viral	   systems;[7]	   [8]	   however,	   they	   still	   have	   the	  major	  drawback	  of	  
low	   transgene	   expression.	   	   Incomplete	   understanding	   of	   cellular	   uptake	  
mechanisms[9,	  10],	   inefficient	  endosomal	  escape,[11-­‐13]	  and	  poorly	  designed	  and	  	  
understood	   nuclear	   uptake[13,	   14]	   are	   thought	   to	   be	   the	   major	   reasons	   limiting	  
optimization.	  [3,	  13]	  
Recent	  work	  by	  Lechardaur	  et	  al.[15]	  and	  Pollard	  et	  al.[16]	  indicated	  the	  activity	  of	  
cyotosolic	   nucleases	   plays	   a	   significant	   role	   in	   limiting	   expression	   efficiency.	   Our	  
recent	  work	  has	  shown	  that	  differential	  transgene	  expression	  facilitated	  by	  jetPEITM,	  
linear	   PEI,	   and	   generation	   5	   poly(amidoamine)	   (G5	   PAMAM)	   dendrimer	   can	   be	  
explained	  by	  activation	  of	  cytosolic	  nucleases	  that	  degrade	  the	  plasmid	  into	  a	  non-­‐
functional	  form.[17]	  	  Characterizing	  the	  activity	  pattern	  of	  these	  cytosolic	  nucleases	  
is	  a	  key	  step	  needed	  to	  develop	  better	  synthetic	  strategies	  for	  polymers	  capable	  of	  
delivering,	   protecting,	   and	   releasing	   the	   plasmid.	   	   	   Substantial	   efforts	   have	   been	  
expended	   to	   make	   the	   plasmid	   less	   susceptible	   to	   nuclease	   degradation	   via	  
backbone,	   codon,	   and	   poly(A)	   modifications	   and	   by	   removing	   viral	   DNA	  
components.[18,	  19]	  	  
	  In	   this	   study,	   high-­‐throughput	   sequencing	   is	   used	   to	   identify	   and	   quantify	   labile	  
sites	   on	   a	   pGL4.51	   luciferase	   expressing	   plasmid	   that	   are	   susceptible	   to	   cytosolic	  
nucleases.	  	  S1	  nuclease	  was	  used	  both	  to	  validate	  the	  experimental	  protocols	  and	  to	  
develop	  a	  comparison	  to	  the	  published	  cleavage	  pattern	  determined	  using	  agarose	  
gel	   electrophoresis.[18,	   19]	   High-­‐throughput	   sequencing	   not	   only	   identifies	   more	  
labile	   sites	   than	   previously	   observed	   using	   agarose	   gel	   electrophoresis,	   it	   also	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provides	   information	   about	   the	   relative	   degree	   of	   degradation	   per	   site	   and	  
significantly	  greater	  resolution	  of	  the	  site	  location	  in	  the	  plasmid	  sequence.	  	  Many	  of	  
the	  cleavage	  sensitive	  sequences	  lay	  in	  homopurine	  and	  homopyrimidine	  regions	  of	  
the	  synthetic/viral	  poly(A)	  regions	  and	  the	  plasmid’s	  bacterial	  origin	  of	  replication	  
(OriC);	  however,	   labile	  sites	  were	  also	   identified	   in	   the	  reporter	  and	   the	  antibiotic	  
resistance	   genes	   required	   for	   stable	   expression.[20]	   	   Many	   of	   the	   labile	   sites	  
identified	   in	   the	  plasmid	   correspond	   to	   regions	   that	   are	   indispensible	   for	  plasmid	  
functionality.	  
Human	  epithelial	  carcinoma	  cells	  (HeLa	  cells)	  were	  used	  based	  on	  previous	  studies	  
exploring	   the	   role	   of	   cytosolic	   nucleases.[15,	   18]	   	   S1	   nuclease	   was	   used	   as	   the	  
control	  nuclease	   in	  this	  study	  because	   it	  has	  already	  been	  shown	  that	  customizing	  
plasmid	  sequences	  on	  the	  basis	  of	  S1	  nuclease	  activity	  can	  improve	  plasmid	  stability	  
in	  vitro	  studies.[18,	  19]	  The	  luciferase	  expression	  plasmid	  was	  selected	  because	  it	  is	  
widely	  used	  in	  gene	  expression	  studies	   in	  mammalian	  cells	  and	  understanding	  the	  
susceptibility	  to	  cytosolic	  nucleases	  should	  be	  useful	  for	  a	  broad	  range	  of	  research	  
groups.	  The	  plasmid	  also	  contains	  the	  commonly	  employed	  selective	  Neomycin	  gene	  
to	  select	  for	  permanently	  transgene	  expressing	  mammalian	  cells.	  
4.3 Materials	  and	  Methods	  
	  
HeLa	   cells	   (Catalogue	   #CCL-­‐2)	   were	   obtained	   from	   American	   Type	   Culture	  
Collection	   (ATCC).	   	   S1	   nuclease	   and	   10x	   S1	   nuclease	   buffer,	   salmon	   sperm	   DNA	  
(ssDNA),	   and	   luciferase	   plasmid	   (pGL4.51)	   were	   purchased	   from	   Promega	  
Corporation.	  	  A	  circular	  map	  of	  the	  plasmid	  is	  provided	  in	  the	  supplemental	  material	  
(Figure	  4.S1).	   	  NP-­‐40	   lysis	  buffer	  was	  procured	   from	  Boston	  BioProducts	   Inc.	   and	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protease	  inhibitor	  cocktail	  was	  obtained	  from	  Sigma-­‐Aldrich.	  The	  BCA	  protein	  assay	  
kit	   was	   purchased	   from	   Thermo	   Fisher	   Scientific,	   Inc.	   The	   Gel	   extraction	   kit	   was	  
purchased	  from	  Qiagen	  (Catalogue	  #28706).	  	  10xBlueJuiceTM	  gel	  loading	  buffer	  was	  
obtained	   from	   Life	   Technologies	   Corporations	   (Catalogue	   #	   0816-­‐015).	   	   Three	  
restriction	   endonucleases	   SacI	   (Catalogue	   #R3156S),	   DraIII	   (Catalogue	   #R3510S)	  
and	  StuI	  (Catalogue	  #R0187S)	  were	  obtained	  from	  New	  England	  BioLabs®,	  Inc.	  	  The	  
Serum	   free	   media	   (SFM)	   employed	   in	   this	   study	   was	   Minimal	   Essential	   Media	  
(MEM)	   with	   glutamine	   and	   Earle	   salts	   obtained	   from	   life	   technologies.	   Complete	  
media	  was	  made	  by	  adding	  50	  mL	  of	   fetal	  bovine	   serum	   (FBS)	   and	  5	  mL	  of	  100X	  
penicillin-­‐streptomycin	  to	  500	  mL	  of	  MEM.	  An	  Illumina	  HiSeq	  2000	  (Illumina,	  Inc.) 
was	   employed	   for	   all	   sequencing	   experiments.	   Initial	   sequence	   alignment	   was	  
completed	  with	  the	  help	  of	  Bowtie.	  Integrated	  Genomic	  Viewer	  was	  used	  to	  view	  the	  
aligned	   sequence.	   MATLABTM	   was	   employed	   to	   generate	   heat-­‐maps	   of	   nuclease	  
activity.	   PAMAM	   dendrimer	   was	   purchased	   from	   Dendritech,	   Inc.	   	   In-­‐house	  
characterization	   revealed	   Mw	   as	   28910	   and	   polydispersity	   index	   (PDI)	   as	   1.01.	  	  
Titration	  showed	  116	  amines	  per	  dendrimer.	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Figure	  4.S1:	  Circular	  plasmid	  map	  pGL4.51	  employed	  in	  the	  presented	  study.	  
Courtesy:	  Promega	  Corporation.	  	  
	  
Transfection	  and	  cytosol	   extraction:	  500,000	  HeLa	  cells/well	  were	   cultured	   in	  a	  6	  
well	   plate	  with	   1.5	  mL	   of	   complete	  media	   at	   37	   °C	   overnight.	   Subsequently,	   cells	  
were	   treated	   in	   duplicate	   with	   10:1	   nitrogen	   to	   phosphorus	   (N/P)	   ratio	   of	   G5	  
PAMAM	  polyplexes	  (2	  µg	  ssDNA,	  15.13	  µg	  G5	  PAMAM,	  100	  µL	  water)	  for	  3	  h	  in	  0.9	  
mL	  SFM.	   	  After	  3	  hours	  the	  transfection	  media	  was	  replaced	  with	  1.5	  mL	  complete	  
media	  and	   the	   cells	  were	   incubated	   for	   another	  1	  h.	  Cells	  were	   then	  washed	  with	  
PBS	  without	  Ca2+	  and	  Mg2+	  and	  incubated	  with	  200	  µL	  0.1%	  trypsin	  for	  5	  minutes	  at	  
37	  °C.	  	  	  1.8	  mL	  of	  cold	  PBS	  (4	  °C)	  with	  Ca2+	  and	  Mg2+	  ions	  was	  added	  to	  each	  well	  to	  
stop	  trypsin	  activity.	  Duplicates	  were	  pooled	  together	  and	  cells	  were	  centrifuged	  at	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1200	  rpm.	  To	  obtain	  cell	  lysates,	  the	  cell	  pellet	  was	  suspended	  in	  200	  µL	  of	  ice-­‐cold	  
cell	  lysis	  buffer	  and	  incubated	  for	  30	  minutes	  on	  ice.	  Afterwards,	  the	  samples	  were	  
centrifuged	  at	  3,000	  rpm	  for	  5	  minutes	  at	  4	  °C	  and	  the	  supernatants	  were	  collected.	  	  
A	  BCA	  assay	  was	  used	  to	  assess	  and	  normalize	  protein	  concentration	  in	  subsequent	  
experiments.	  20	  µg	  of	  pDNA	  was	  incubated	  with	  10	  µg	  of	  the	  cytosol	  lysate	  in	  100	  µL	  
of	  water	   for	  30	  minutes	  at	  37	  °C.	   	  The	  control	   lysates	   from	  non-­‐treated	  cells	  were	  
prepared	  identically	  except	  no	  polyplexes	  were	  added	  in	  the	  initial	  step.	  S1	  nuclease	  
cleavage	  sample	  were	  prepared	  by	  adding	  10	  units	  of	  S1	  nuclease	  to	  20	  µg	  of	  pDNA	  
in	  100	  µL	  of	  water	  and	  1X	  S1	  nuclease	  buffer	  for	  30	  minutes	  at	  37	  °C.	  	  	  The	  negative	  
control	  was	   prepared	   using	   20	   µg	   of	   pDNA	   re-­‐suspended	   in	   100	   µL	   of	  water	   and	  
employed	  using	  the	  same	  incubation	  conditions.	  	  
For	   Illumina	   dye	   sequencing,	   samples	   containing	   100	   µL	   of	   the	   plasmid	   reaction	  
mixture	  were	  treated	  with	  cell	  extracts	  (polyplex-­‐treated	  cells	  or	  untreated	  cells)	  or	  
S1	   nuclease	   and	   optimized	   using	   the	   Qiagen	   gel	   extraction	   kit	   (the	   100	   µL	   of	  
reaction	  mixture	  was	  used	  in	  place	  of	  excised	  gel)	  to	  change	  the	  buffering	  media	  to	  
10	  mM	  Tris-­‐Cl	  at	  pH	  8.5	   for	  downstream	  sequencing.	   	   	   In	  addition,	  a	  plasmid-­‐only	  
control	  was	  brought	  through	  the	  identical	  procedure.	  
For	  agarose	  gel	   electrophoresis,	  10	  µL	  of	   the	  plasmid	   reaction	  mixtures	  described	  
above	   were	   added	   to	   each	   well	   in	   1X	   BlueJuiceTM	   gel	   loading	   buffer.	   The	   gel	  
electrophoresis	  was	  performed	  on	  a	  0.9%	  agarose	  gel	  containing	  ethidium	  bromide	  
at	  60	  V	  for	  3	  hours.	  	  
For	   the	   restriction	   nuclease	   analysis	   presented	   in	   Figure	   4.2,	   agarose	   gel	  
electrophoresis	   was	   performed	   using	   10	   µL	   of	   the	   S1	   nuclease	   and	   luciferase	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plasmid	   reaction	  mixture	   in	   10	   parallel	   lanes	   (under	   the	   conditions	   used	   for	   this	  
mixture	   in	   Figure	   4.1,	   lane	   5).	   	   The	   linear	   topology	   6.4	   kB	   form	   of	   the	   luciferase	  
plasmid	   was	   then	   cut	   out	   from	   gel	   and	   purified	   using	   a	   gel	   extraction	   protocol	  
(explained	  below).	  0.2	  µg	  of	  the	   isolated	  6.4	  kB	  linear	  plasmid	  was	  incubated	  with	  
either	   2	   units	   of	   SacI,	   DraIII	   or	   StuI	   restriction	   endonucleases	   in	   the	   supplied	  
reaction	  buffer	  for	  60	  minutes	  at	  37	  °C.	  Control	  digests	  were	  performed	  with	  these	  
restriction	  endonucleases	  and	  using	  the	   luciferase	  plasmid	  under	  same	  conditions.	  
SacI,	   DraIII	   and	   StuI	   endonucleases	   were	   used	   because	   they	   each	   have	   a	   single	  
restriction	  site	   in	  the	  plasmid	  sequence,	  which	  provides	  enough	  resolution	  to	  map	  
the	  pDNA.	   	  The	  endonuclease	   treated	  samples	  were	  analysed	  on	  0.9%	  agarose	  gel	  
containing	  ethidium	  bromide	  at	  60	  V	  for	  3	  hours.	  
Gel	  extraction	  protocol	  (employing	  buffers	  QG,	  PE	  and	  EB	  supplied	  with	  the	  kit):	  The	  
region	   containing	   the	   linear	   form	   of	   pDNA	  was	   excised	   from	   the	   agarose	   gel	   and	  
weighed.	  The	  excised	  gel	  was	  then	  incubated	  with	  3	  volumes	  of	  buffer	  QG	  (1	  volume	  
of	   QG	   buffer	   is	   100	   µL	   for	   100	   µg	   of	   gel)	   at	   50	   °C	   for	   10	  minutes.	   Afterwards,	   1	  
volume	  of	  isopropanol	  was	  added	  to	  the	  mixture.	  This	  sample	  was	  then	  applied	  to	  a	  
QIAquick	  column	  and	  centrifuged	  at	  13,000	  rpm	  for	  1	  minute;	  the	  flow-­‐through	  was	  
discarded.	  To	  remove	  the	  trace	  amount	  of	  gel	  left	  on	  the	  column,	  0.5	  mL	  of	  buffer	  QG	  
was	   centrifuged	   through	   the	   column	   for	   1	   minute	   at	   13,000	   rpm	   and	   the	   flow-­‐
through	  was	  discarded.	   	  0.75	  mL	  of	  buffer	  PE	  was	  added	   to	   the	  QIAquick	   column.	  	  
The	   buffer	   was	   left	   on	   the	   column	   for	   5	   minutes	   after	   which	   the	   column	   was	  
centrifuged	   at	   13,000	   rpm	   for	   1	  minute	   and	   the	   flow-­‐through	  was	   discarded.	   The	  
QIAquick	   column	   was	   centrifuged	   again	   to	   discard	   any	   remaining	   PE	   buffer.	   	   To	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elute	   the	  DNA,	  30	  µL	  of	   buffer	  EB	   (for	   the	   Illumina	   sequencing)	   or	  water	   (for	   the	  
restriction	  endonuclease	  experiment)	  was	  added	  to	  the	  column	  and	  the	  column	  was	  
allowed	  to	  stand	  for	  2	  minutes	  before	  being	  centrifuged	  at	  13,000	  rpm	  for	  1	  minute.	  
The	   flow-­‐through	   was	   collected	   and	   the	   DNA	   concentration	   measured	   using	   a	  
spectrophotometer.	  	  
4.4 Results	  and	  Discussion	  
	  
4.4.1 Cleavage	  Sites	  as	  Determined	  by	  Agarose	  Gel	  Electrophoresis	  
The	   degradation	   pattern	   resulting	   from	   treatment	   of	   luciferase	   plasmid	   with	   S1	  
nuclease	   or	   the	   nucleases	   present	   in	   cytosol	   was	   first	   studied	   using	   agarose	   gel	  
electrophoresis.	   	   	   Figure	   4.1	   illustrates	   that	   upon	   treatment	   with	   either	   S1	   or	  
cytosolic	  nucleases	   the	  supercoiled	  pDNA	  degrades	   into	   two	  major	   forms,	  a	   linear	  
plasmid	  (6.4	  kB)	  and	  nicked	  plasmids	  (appearing	  as	  ~10	  kB	  fragments	  as	  compared	  
to	  the	  linear	  DNA	  size	  ladder).	  	  The	  gel	  also	  shows	  substantial	  streaking	  suggesting	  
the	  presence	  of	  other	  sites	  susceptible	  to	  nuclease	  cleavage.	  The	  major	  band	  of	  the	  
6.4	   kB	   linear	   plasmid	  was	   extracted	   from	   the	   gel	   and	   incubated	  with	   either	   Sac1,	  
DraIII,	   or	   StuI	   endonucleases	   (Figure	   4.2).	   These	   three	   restriction	   endonucleases,	  
which	  cut	  at	  the	  735,	  2006,	  and	  3212	  bp	  sites,	  respectively,	  provide	  the	  redundancy	  
necessary	   to	   define	   the	   primary	   S1	   cut	   site.	   The	   pattern	   obtained	   with	   all	   three	  
endonucleases	   indicated	  a	  S1	  cut	  site	   located	  at	   the	  5000	  ±	  500	  bp	  position	  of	   the	  
pDNA.	   	   This	   site	   is	   close	   to	   the	   homopurine/homopyrimidine	   rich	   plasmid	   OriC	  
region,	   consistent	   with	   previous	   work	   that	   showed	   homopurine	   regions	   are	  
susceptible	  to	  S1	  nuclease	  degradation.[19].	  In	  previous	  work	  two	  predominant	  cut	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regions,	  defined	  as	  hot	  spots,	  were	  found	  the	  in	  poly(A)	  sequence	  and	  in	  OriC.	  [19]	  
In	   this	  paper	  we	   show	   that	   gel	   electrophoresis	  method	  has	   low	   sensitivity	   for	   cut	  
site	   detection	   and	   that	   high-­‐throughput	   sequencing	   can	   be	   used	   to	   determine	   S1	  
nuclease	   and	   cytosolic	   nuclease	   labile	   regions	   in	   pDNA.	   The	   presence	   of	   discrete	  
bands	  of	  linear	  DNA	  in	  Figures	  4.1	  and	  4.2	  also	  indicate	  that	  endonuclease	  cleavage	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  Figure	  4.1.	  	  Agarose	  gel	  electrophoresis	  showing	  the	  DNA	  cleavage	  pattern	  of	  
HeLa	  cytosol	  and	  S1	  nuclease	  treated	  luciferase	  pDNA.	  Lanes	  1	  and	  8)	  10	  kB	  
DNA	  ladder.	  Lane	  2)	  pDNA	  in	  water.	  	  Lane	  3)	  pDNA	  treated	  with	  cells	  only	  
cytosol	  in	  water.	  	  Lane	  4)	  pDNA	  treated	  with	  cytosol	  in	  water	  from	  cells	  
exposed	  to	  G5	  polyplexes.	  Lane	  5)	  pDNA	  treated	  with	  S1	  nuclease	  in	  S1	  
nuclease	  buffer.	  	  Lane	  6)	  pDNA	  treated	  with	  S1	  nuclease	  in	  water.	  	  In	  lanes	  3-­‐6,	  
both	  the	  nicked	  and	  linear	  topology	  of	  the	  plasmid	  can	  be	  seen.	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Figure	  4.2.	  	  	  
	  
The	  analysis	  presented	  in	  Figures	  4.1	  and	  4.2	  provided	  a	  useful	  start	  to	  The	  analysis	  
The	   analysis	   presented	   in	   Figures	   4.1	   and	   4.2	   provided	   a	   useful	   start	   to	  
understanding	  nuclease	  activity	  against	  plasmids	   in	  cells;	  however,	   two	  aspects	  of	  
the	   experiment	   could	   benefit	   from	   substantial	   improvement.	   	   First,	   the	   inherent	  
resolution	   of	   the	   gel	   electrophoresis	   method	   (~500	   bp)	   prevents	   a	   detailed	  
sequence	  determination	  of	  where	  the	  pDNA	  was	  cut.	  	  This	  limits	  the	  extent	  to	  which	  
one	   can	   understand	   the	   S1	   and	   cytosolic	   nucleases	   activity	   and	   to	   make	  
pDNA 
	  LP	  DNA	  (LP) 
pDNA	  +	  SacI 
LP	  +	  SacI LP	  +	  DraIII 
pDNA	  +	  DraIII 
LP	  +	  StuI 
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Figure	  4.2.	  Endonuclease	  treatment	  of	  6.4	  kB	  linear	  plasmid	  (LP).	  	  Lanes	  1	  and	  10;	  
10	  kB	  DNA	  ladder.	  	  	  Lane	  2)	  	  pDNA	  in	  water.	  	  Lane	  3)	  	  LP	  in	  water.	  	  	  Lanes	  4,	  6,	  8)	  
pDNA	  treated	  with	  SacI,	  DraIII	  and	  StuI,	  respectively.	  	  	  Lanes	  5,	  7,	  9)	  	  LP	  treated	  
with	  SacI,	  DraIII	  and	  StuI,	  respectively.	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comparisons	   between	   them.	   	   Second,	   it	   seemed	   unlikely,	   particularly	   giving	   the	  
streaking	   in	  Figure	  4.1,	   that	  a	  single	  cleavage	  sequence	  existed	   for	  either	  cytosolic	  
nucleases	  or	  the	  S1	  nuclease,	  suggesting	  that	  the	  gels	  did	  not	  have	  the	  desired	  level	  
of	   sensitivity.	   	   In	   addition	   to	   these	   concerns,	   Sanger	   sequencing	   is	   limited	   by	   the	  
choice	  of	  primers.	   	  Given	   this	   set	  of	   concerns	  and	  challenges,	   the	  high-­‐throughput	  
Illumina	   dye	   sequencing	   method	   was	   employed	   to	   explore	   the	   range	   of	   cellular	  
nuclease	   cuts	   introduced	   on	   the	   pDNA.[21]	   	  We	   employed	   S1	   nuclease	   as	   both	   a	  
positive	   control,	   in	   comparison	   to	   the	   gel	   work,	   and	   to	   learn	   more	   about	   the	   S1	  
activity.	   	   There	   are	   number	   of	   advantages	   of	   using	   high-­‐throughput	   Illumina	   dye	  
sequencing	  for	  the	  cytosolic	  nuclease	  experiments.	  	  	  The	  development	  of	  the	  specific	  
sequencing	  primer	  sets	  as	  well	  as	  the	  need	  to	  perform	  multiple	  gels	  for	  the	  analysis	  
of	  restriction	  enzyme	  patterns	  for	  each	  cut	  site	  of	  interest	  is	  avoided	  (as	  illustrated	  
in	   Figure	   4.2).	   In	   addition,	   the	   high-­‐throughput	   sequencing	   also	   provides	   higher	  
resolution	  of	   the	   cut	   site	   location.	   	   Lastly,	  high-­‐throughput	   sequencing	  defines	   the	  
degree	  of	  cutting	  over	  a	  region	  (vida	  infra),	  as	  opposed	   to	   the	  notion	  of	  a	  singular	  
base	   pair	   location.	   	   This	   observation	   is	   important	   both	   for	   design	   of	  more	   robust	  
plasmids	  and	  for	  the	  design	  of	  polymers	  that	  might	  protect	  these	  regions.	  
4.4.2 Cleavage	  Sites	  as	  Determined	  by	  High-­‐Throughput	  Sequencing	  
High-­‐throughput	   Illumina	   dye	   sequencing	   was	   performed	   in	   three	   steps.[21]	   The	  
first	   step	  was	   library	   preparation	  where	   the	   treated	   and	   control	   luciferase	   pDNA	  
samples	  were	  randomly	  broken	  into	  smaller	  fragments	  with	  sonication,	  adenylated,	  
connected	   to	   adapter	   oligonucleotides,	   size-­‐selected,	   and	   purified.	   	   Next,	   the	  
materials	   underwent	   cluster	   generation	   where	   each	   library	   of	   fragments	   was	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clonally	  amplified.	  	  The	  final	  step	  was	  sequencing,	  which	  was	  accomplished	  for	  each	  
cluster	   using	   fluorescent	   deoxyribonucleotides	   (dNTPs).	   Each	   dNTP	   addition	   (50	  
bases)	  was	  recorded	  for	  every	  cluster	  on	  the	  lane.	  	  	  
Heat	  maps	  were	  used	  to	  visualize	  both	  the	  location	  and	  extent	  of	  nuclease	  cut	  on	  the	  
luciferase	  pDNA	  (Figures	  4.3-­‐4.5).	  	  Each	  panel	  provides	  data	  for	  the	  specified	  range	  
of	  pDNA	  cutting	  efficiency.	  	  Sample	  normalization	  for	  S1	  nuclease,	  untreated	  cytosol	  
and	   G5	   polyplex-­‐treated	   cytosol	   samples	   was	   accomplished	   using	   the	   untreated	  
pDNA	   control.	   First	   the	   readcount	   for	   each	   base	   was	   normalized	   by	   the	   average	  
readcount	   for	   that	   sample.	   For	   each	   base	   in	   nuclease-­‐treated	   samples,	   the	  
normalized	   base	   readcount	   was	   divided	   by	   the	   normalized	   readcount	   from	  
untreated	  pDNA	  control.	  This	  ratio	  was	  used	  for	  heat	  map	  generation.	  The	  greyscale	  
vertical	  lines	  indicate	  the	  percentage	  of	  plasmids	  cut	  at	  that	  location.	  	  White	  regions	  
indicate	   a	   cut	   frequency	   lower	   than	   or	   equal	   to	   the	   lowest	   value	   of	   the	   specified	  
range.	  	  A	  black	  line	  indicates	  a	  cut	  extent	  equal	  to	  the	  highest	  value	  of	  the	  range.	  	  For	  
each	  figure,	  panel	  A	  illustrates	  the	  full	  set	  of	  data.	  	  The	  range	  in	  panel	  B	  is	  defined	  to	  
focus	  on	  approximately	   the	   top	  15	  cut	   regions.	   	  The	   range	   in	  panel	  C	   is	   chosen	   to	  
focus	   on	   the	   top	   3-­‐5	   cut	   regions	   for	   easiest	   comparison	   to	   agarose	   gel	  
electrophoresis	  data.	  	  At	  the	  bottom	  of	  each	  figure,	  a	  luciferase	  gene	  functional	  map	  
is	  provided	  in	  registry	  with	  the	  heat	  map	  to	  facilitate	  comparison	  of	  cut	  sites	  to	  the	  
different	  regions	  of	  the	  pDNA	  plasmid.	  
The	  heat	  map	  in	  Figure	  4.3	  illustrates	  the	  activity	  of	  S1	  nuclease	  in	  water	  on	  pDNA.	  
Panel	  A	  indicates	  the	  locations	  were	  0	  to	  45%	  of	  the	  plasmids	  were	  cut.	  	  There	  are	  
few	   “white”	   regions	   corresponding	   to	   sequences	   where	   no	   cuts	   were	   detected,	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suggesting	   that	   the	   nuclease	   is	   promiscuous	   with	   respect	   to	   the	   types	   of	   base	  
sequences	  suitable	  for	  a	  cleavage	  location.	  	  Panel	  B	  illustrates	  only	  sites	  in	  which	  25-­‐
45%	  of	   the	   plasmids	  were	   cleaved	   and	  Panel	   C	   illustrates	   sites	   in	  which	   only	   28-­‐
45%	  of	  the	  plasmids	  were	  cleaved.	  	  	  Information	  regarding	  	  each	  cut	  site,	  including	  
%	   AT	   content,	   function	   of	   plasmid	   region,	   cut	   location	   and	  width	   and	   fraction	   of	  
plasmids	  cut	  is	  summarized	  in	  Table	  4.1	  for	  the	  top	  15	  regions	  (Figure	  4.3b).	  	  These	  
regions	   include	   four	   cuts	   (S1-­‐4)	   in	   the	   luciferase	   gene,	   a	   cut	   in	   the	   SV40	  
promoter/enhancer	  (S5),	  cuts	  in	  three	  locations	  on	  the	  Neomycin	  gene	  (S6-­‐8),	  cuts	  
at	   three	   sites	   on	   the	   origin	   of	   replication	   region	   (S9-­‐11),	   and	   three	   sites	   on	  
ampicillin	  gene	  (S13-­‐15).	  	  Cuts	  S9-­‐11	  at	  OriC	  are	  consistent	  with	  the	  primary	  region	  
previously	  determined	  by	  agarose	  gel	  electrophoresis[19]	  and	  illustrated	  in	  Figure	  
4.1.	   The	  homopurine/homopyrimidine	   rich	   sites	   like	  poly	   (A)	   and	  OriC	   have	  been	  
reported	  as	  susceptible	  to	  S1	  nucleases	  using	  gel	  electrophoresis;[19,	  22]	  however,	  
using	  high-­‐throughput	  sequencing	  we	  have	  found	  many	  additional	  labile	  regions	  not	  
previously	   identified.	   These	   findings	   challenge	   the	   long	   held	   hypothesis	   that	   S1	  
nuclease	  only	  attacks	  single	  stranded	  secondary	  structures	  of	  DNA.[18,	  19,	  22]	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Figure	  4.3.	  Heat	  maps	  showing	  frequency	  of	  cuts	  on	  the	  luciferase	  pDNA	  resulting	  
from	  the	  S1	  nuclease	  digest	  in	  water.	  	  White	  color	  indicates	  the	  percentage	  of	  
plasmids	  cut	  is	  between	  zero	  and	  the	  lower	  part	  of	  the	  cut	  range	  listed.	  	  Black	  color	  
indicates	  the	  percentage	  cut	  is	  the	  maximum	  value	  for	  that	  cut	  range.	  	  Greyscale	  	  
indicates	  cut	  percentages	  between	  these	  extrema.	  	  Panel	  A	  shows	  the	  full	  range	  of	  
labile	  sites,	  Panel	  B	  represents	  labile	  regions	  that	  have	  frequency	  of	  cuts	  between	  
25-­‐45%	  (showing	  ~15	  most	  cut	  regions).	  	  Panel	  C	  shows	  ~top	  5	  cut	  regions	  
between	  28-­‐45%.	  	  The	  luciferase	  functional	  map	  is	  provided	  in	  registry	  with	  the	  
heat	  map	  to	  facilitate	  comparison	  of	  cuts	  sites	  to	  the	  different	  regions	  of	  the	  
plasmid.	  
	  
Table	  4.1.	  Summary	  of	  the	  top	  15	  regions	  of	  the	  luciferase	  plasmid	  cut	  by	  S1	  
nuclease,	  as	  illustrated	  in	  Figure	  4.3B.	  	  	  
Region	   %	  AT	  
content	  
Function	   Cut	  Location	  and	  
width(bp)	  
Percent	  extent	  of	  cut	  
(average,	  maximum)	  
S1	   43	   Luciferase	  gene	   1142-­‐1187	  (46)	   29,	  33	  
S2	   50	   “	   2042-­‐2067	  (26)	   26,	  27	  
S3	   36	   “	   2195-­‐2217	  (22)	   27,	  29	  
S4	   25	   “	   2292-­‐2319	  (28)	   28,	  30	  
S5	   55	   SV40	  promoter	   2903-­‐2913	  (11)	   25,	  26	  
S6	   39	   Neomycin	  gene	   3261-­‐3296	  (36)	   27,	  29	  
S7	   32	   “	   3489-­‐3544	  (56)	   28,	  29	  
S8	   38	   “	   3967-­‐4018	  (52)	   27,	  29	  
S9	   53	   OriC	   4474-­‐4484	  (15)	   26,	  26	  
S10	   54	   “	   4812-­‐4910	  (99)	   31,	  41	  
S11	   78	   “	   4974-­‐4990	  (17)	   35,	  38	  
S12	   48	   Close	  to	  OriC	   5062-­‐5076	  (14)	   25,	  26	  
S13	   67	   Ampicillin	  gene	   5116-­‐5145	  (30)	   27,	  29	  
S14	   47	   “	   5283-­‐5325	  (43)	   26,	  28	  
S15	   53	   “	   5725-­‐5741	  (17)	   26,	  28	  
Luc2
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Similar	  to	  Figure	  4.3,	  the	  heat	  map	  in	  Figure	  4.4	  illustrates	  the	  activity	  of	  cytosolic	  
nucleases	  overlaid	  on	  the	  luciferase	  pDNA	  functional	  map.	  	  	  Panels	  A-­‐C	  provide	  data	  
for	  nuclease	  activity	  from	  cytosol	  obtained	  for	  cells	  treated	  with	  G5	  polyplexes.	  	  	  In	  a	  
previous	   study,	  we	  demonstrated	   that	   the	  nuclease	   activity	   is	  polyplex	  dependent	  
and	  is	  negatively	  related	  to	  the	  level	  of	  protein	  expression.[17]	  	  G5	  polyplexes	  were	  
selected	  because	  they	  induced	  the	  maximum	  level	  of	  nuclease	  activity	  and	  gave	  the	  
minimum	  level	  of	  expression.	  	  We	  also	  prepared	  lysates	  from	  cells	  that	  had	  not	  been	  
treated	  with	   polyplexes	   in	   order	   to	   establish	   the	   “background”	   level	   of	   nucleases.	  	  	  
The	   data	   presented	   in	   panels	   D-­‐F,	   although	   important	   and	   informative,	   must	   be	  
treated	  with	  caution	  in	  ascribing	  nuclease	  levels	  in	  a	  normal,	  functional	  cell.	  	  Caveats	  
may	  include	  the	  neoplastic	  origin	  of	  HeLa	  cancer	  cell	   line	  and	  that	  the	  cytosol	  was	  
obtained	   by	   cell	   lysis,	   a	   procedure	  which	  may	   itself	   trigger	   nuclease	   activity.	   [23]	  
[24]	  	  
	  
	   99	  
	  
Figure	  4.4.	  Heat	  maps	  showing	  frequency	  of	  cuts	  on	  the	  luciferase	  plasmid	  resulting	  
from	  cytosolic	  nuclease	  treatments.	  	  White	  color	  indicates	  the	  percentage	  of	  cut	  is	  
between	  zero	  and	  the	  lower	  part	  of	  the	  cut	  range	  listed.	  	  Black	  color	  indicates	  the	  
percentage	  of	  cut	  is	  the	  maximum	  value	  for	  that	  cut	  range.	  	  Greyscale	  indicates	  cut	  
percentages	  between	  these	  extrema.	  	  Panels	  A,	  B	  and	  C	  show	  labile	  cut	  regions	  for	  
G5	  polyplex-­‐treated	  cell	  cytosol	  treatment.	  Panel	  A	  shows	  the	  full	  range	  of	  labile	  
sites,	  Panel	  B	  represents	  labile	  regions	  that	  have	  a	  frequency	  of	  cuts	  between	  41-­‐
65%	  (showing	  ~15	  most	  cut	  regions).	  	  Panel	  C	  shows	  ~top	  5	  cut	  regions	  between	  
52-­‐65%.	  	  Panels	  D,	  E	  and	  F	  represent	  cells-­‐only	  cytosol	  treatment.	  Panel	  D	  shows	  
the	  full	  range	  of	  labile	  sites,	  Panel	  E	  represents	  labile	  regions	  that	  have	  a	  frequency	  
of	  cuts	  between	  50-­‐75%	  (showing	  ~15	  most	  cut	  regions)	  and	  Panel	  F	  shows	  ~top	  5	  
cut	  regions	  between	  59-­‐75%.	  
	  
Panels	  A	  and	  D	  show	  all	  the	  labile	  sites	  present	   in	  0-­‐65%	  and	  0-­‐75%	  extent	  of	  cut	  
range	   for	   the	   G5	   polyplex-­‐treated	   and	   untreated	   cells,	   respectively.	   	   Similar	   to	   S1	  
nuclease,	   the	  cytosolic	  nucleases	  are	  promiscuous	  and	  attack	  numerous	  regions	   in	  
addition	   to	   the	   most	   common	   cuts	   in	   the	   poly(A)	   and	   viral	   enhancer/promoter	  
regions	  of	  the	  pDNA.	   	  Panels	  B	  and	  E	  represent	  the	  15	  most	   labile	  regions	   lying	  in	  
the	   range	   of	   41-­‐65%	   and	   50-­‐75%	   for	   G5	   polyplex-­‐treated	   and	   untreated	   cell	  








CMV immediate early enhancer/promoter
Luc
6.4 kb
	   	   	   	   	   	   
Black:	  Early	  promoters/enhancers	   	   Blue:	  PolyA	  sequence 
Red:	  Genes	   	   	   	   	   Green:	  OriC 
  
  
	   100	  
extent	  of	  cut)	  represent	  the	  most	  labile	  regions	  and	  are	  most	  useful	  for	  comparison	  
to	  gel	  electrophoresis	  data.	  	  
Table	  4.2	  summarizes	  the	  top	  15	  most	  labile	  regions	  obtained	  with	  the	  cytosol	  from	  
untreated	  cells	  (data	  in	  Figure	  4.4e).	  Cytosolic	  nucleases	  in	  this	  cytosol	  produce	  four	  
cuts	   in	   the	   viral	   CMV	   enhancer/promoter	   region,	   one	   cut	   in	   the	   luciferase	   gene,	  
three	  cuts	  in	  the	  poly(A)	  regions,	  two	  cuts	  on	  OriC,	  and	  three	  cuts	  on	  the	  ampicillin	  
gene.	  
	  
Table	  4.2.	  Summary	  of	  the	  top	  15	  regions	  of	  the	  luciferase	  plasmid	  cut	  by	  cells	  only	  
cytosolic	  nucleases	  (as	  illustrated	  in	  Figure	  4.4E).	  	  	  
Region	   %	  AT	  
content	  
Function	   Cut	  Location	  and	  
width(bp)	  
Percent	  extent	  of	  cut	  
(average,	  maximum)	  
C1	   67	   CMV	  promoter	   62-­‐113	  (52)	   51,	  53	  
C2	   57	   “	   321-­‐327	  (7)	   51,	  53	  
C3	   50	   Luciferase	  gene	   2483-­‐2520	  	  (38)	   55,	  63	  
C4	   62	   SV40	  poly	  A	   2573-­‐2580	  	  (8)	   51,	  53	  
C5	   73	   “	   2633-­‐2683	  	  (51)	   53,	  57	  
C6	   62	   SV40	  promoter	   2831-­‐2859	  	  (29)	   52,	  54	  
C7	   44	   “	   3081-­‐3160	  (80)	   58,	  61	  
C8	   45	   OriC	   4774-­‐4804	  (31)	   58,	  61	  
C9	   50	   “	   4915-­‐5022	  (103)	   58,	  71	  
C10	   50	   Close	  to	  OriC	   5060-­‐5063	  (4)	   52,	  53	  
C11	   62	   “	   5075-­‐5126	  	  (52)	   51,	  56	  
C12	   86	   Ampicillin	  gene	   5148-­‐5196	  	  (49)	   57,	  62	  
C13	   58	   “	   5991-­‐6002	  	  (12)	   52,	  55	  
C14	   42	   “	   6025-­‐6066	  	  (42)	   54,	  57	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Table	  4.3.	  Summary	  of	  the	  top	  15	  regions	  of	  the	  luciferase	  plasmid	  cut	  by	  G5	  
polyplex-­‐treated	  cells	  cytosolic	  nucleases	  (as	  illustrated	  in	  Figure	  4.4B).	  	  	  
Region	   %	  AT	  content	   Function	   Cut	  Location	  and	  
width(bp)	  
Percent	  extent	  
of	  cut	  (average,	  
maximum)	  
G1	   57	   CMV	  promoter	   -­‐4	  –	  33	  (37)	   45,	  49	  
G2	   83	   “	   38-­‐55	  (18)	   42,	  44	  
G3	   37	   “	   141-­‐148	  (8)	   41,	  42	  
G4	   75	   “	   150-­‐181	  (32)	   41,	  45	  
G5	   56	   Luciferase	  gene	   1738-­‐1764	  (27)	   44,	  48	  
G6	   73	   SV40	  poly	  A	   2610-­‐2686	  (71)	   45,	  55	  
G7	   54	   SV40	  promoter	   2827-­‐2850	  (24)	   42,	  44	  
G8	   25	   “	   3002-­‐3005	  (4)	   42,	  44	  
G9	   47	   “	   3083-­‐3156	  (74)	   48,	  54	  
G10	   33	   Neomycin	  gene	   3947-­‐3949	  (3)	   41,	  41	  
G11	   33	   Close	  to	  OriC	   4359-­‐4361	  (3)	   41,	  41	  
G12	   48	  
OriC	  
4748-­‐4797	  (50)	   43,	  48	  
G13	   59	   “	   4882-­‐5182	  (300)	   47,	  59	  
G14	   51	   Ampicillin	  gene	   6051-­‐6109	  (51)	   44,	  49	  
G15	   72	   Synthetic	  poly(A)	   6208-­‐6275	  (60)	   52,	  61	  
	  
Similar	  to	  Table	  4.2,	  Table	  4.3	  shows	  top	  15	  labile	  sites	  for	  cytosol	  from	  G5	  polyplex	  
treated	   cells	   (data	   in	   Figure	   4.4b).	   	   Three	   cuts	   are	   observed	   in	   the	   viral	  
enhancer/promoter	  regions,	  one	  cut	  in	  the	  luciferase	  gene,	  two	  cuts	  in	  the	  poly(A)	  
sequence,	  two	  cuts	  near	  OriC,	  one	  cut	  in	  the	  ampicillin	  resistance	  gene,	  and	  one	  cut	  
in	  the	  neomycin	  gene.	  
Cytosol	  nuclease	  activity	  from	  untreated	  cells	  and	  G5	  polyplex	  treated	  cells	  display	  
significant	   similarities.	   The	   top	   15	   labile	   regions	   for	   cytosolic	   samples	   can	   be	  
divided	   into	   three	  major	   regions:	   the	   viral	   promoter/enhancer	   sequence,	   poly(A)	  
sequences,	  and	  OriC.	  	  There	  are	  also	  some	  cut	  regions	  in	  the	  luciferase	  reporter	  and	  
the	  selective	  neomycin	  resistance	  gene.	   	  Cuts	  in	  viral	  promoter/enhancers,	  poly(A)	  
sequences,	   and	   the	   transgene	  can	  severely	  abrogate	   transgene	  expression[18,	  25].	  
The	  multiple	  cuts	  in	  the	  selective	  neomycin	  and	  ampicillin	  resistance	  genes	  point	  to	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the	   additional	   challenge	   in	   efforts	   to	   establish	   the	   cell	   lines	  with	   a	   stable	   plasmid	  
expression.	   The	   bacterial	   origin	   of	   replication	   (OriC)	   is	   necessary	   for	   plasmid	  
replication	  in	  bacteria[26]	  though	  it	  has	  little	  functional	  role	  in	  eukaryotes.	  [27]	  The	  
discovery	   that	  OriC	   is	   one	   of	   the	   most	   degraded	   regions	   for	   S1	   (Table	   4.S1)	   and	  
cytosolic	   nucleases	   (Tables	   4.S2	   and	   4.S3)	   suggests	   that	   eukaryotic	   cells	   may	  
recognize	  OriC	  as	  a	  marker	  for	  foreign	  DNA.	  	  
Table	  4.S1:	  Top	  20	  most	  cut	  sites	  for	  S1	  nuclease	  in	  luciferase	  plasmid.	  S10_X	  
represents	  cut	  site	  belonging	  to	  S10	  region	  from	  Table	  4.1.	  
Site	   Location	   Function	   Percent	  extent	  
of	  cut	  
S10_1	   4883	   Origin	  of	  replication	   42	  
S10_2	   4884	   “	   41	  
S10_3	   4885	   “	   41	  
S10_4	   4886	   “	   41	  
S10_5	   4887	   “	   41	  
S10_6	   4888	   “	   41	  
S10_7	   4889	   “	   41	  
S10_8	   4890	   “	   41	  
S10_9	   4891	   “	   41	  
S10_10	   4877	   “	   40	  
S10_11	   4892	   “	   40	  
S10_12	   4893	   “	   40	  
S10_13	   4894	   “	   40	  
S10_14	   4895	   “	   40	  
S10_15	   4879	   “	   39	  
S10_16	   4880	   “	   39	  
S10_17	   4881	   “	   39	  
S10_18	   4896	   “	   39	  
S10_19	   4874	   “	   38	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Table	  4.S2:	  Top	  20	  most	  cut	  sites	  for	  untreated	  cells	  cytosolic	  nucleases	  in	  luciferase	  
plasmid.	  C9_X	  represents	  cut	  site	  belonging	  to	  C9	  region	  from	  Table	  4.2.	  
Site	   Location	   Function	   Percent	  extent	  of	  cut	  
C9_1	   4984	   Origin	  of	  Replication	   71	  
C9_2	   4985	   “	   70	  
C9_3	   4983	   “	   69	  
C9_4	   4982	   “	   68	  
C9_5	   4979	   “	   67	  
C9_6	   4980	   “	   67	  
C9_7	   4981	   “	   67	  
C9_8	   4978	   “	   66	  
C9_9	   4993	   “	   66	  
C9_10	   4994	   “	   66	  
C9_11	   4995	   “	   66	  
C9_12	   4976	   “	   65	  
C9_13	   4977	   “	   65	  
C9_14	   4986	   “	   65	  
C9_15	   4988	   “	   65	  
C9_16	   4989	   “	   65	  
C9_17	   4990	   “	   65	  
C9_18	   4991	   “	   65	  
C9_19	   4992	   “	   65	  
C9_20	   4975	   “	   64	  
	  
Table	  4.S3:	  Top	  20	  most	  cut	  sites	  for	  G5	  polyplex	  treated	  cells	  cytosolic	  nuclease.	  
G15_X	  and	  G13_X	  represents	  cut	  site	  belonging	  to	  G15	  and	  G13	  regions	  respectively	  
from	  Table	  4.3.	  
Site	   Location	   Function	   Percent	  extent	  of	  cut	  
G15_1	   6235	   Synthetic	  Poly	  (A)	   61	  
G15_2	   6236	   “	   61	  
G15_3	   6237	   “	   61	  
G15_4	   6234	   “	   60	  
G15_5	   6238	   “	   60	  
G15_6	   6239	   “	   60	  
G15_7	   6240	   “	   60	  
G15_8	   6241	   “	   60	  
G15_9	   6242	   “	   60	  
G15_10	   6243	   “	   60	  
G15_11	   6244	   “	   60	  
G15_12	   6245	   “	   59	  
G15_13	   6246	   “	   59	  
G15_14	   6247	   “	   59	  
G15_15	   6232	   “	   59	  
G15_16	   6233	   “	   59	  
G13_1	   5151	   Origin	  of	  Replication	   59	  
G13_2	   5152	   “	   59	  
G15_17	   6248	   Synthetic	  Poly	  (A)	   59	  
G15_18	   6249	   “	   59	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In	   summary,	   we	   have	   detected	   a	   greater	   number	   of	   labile	   regions	   suceptabile	   to	  
cleavage	  for	  cytosolic	  extracts	  than	  for	  S1	  indicating	  that	  cytosol	  contains	  additional	  
nucleases.	  	  This	  observation	  is	  consistent	  with	  the	  hypothesis	  that	  S1	  type	  nucleases	  
are	  part	  of	  a	  group	  of	  cytosolic	  nucleases	  targeting	  the	  pDNA	  at	  the	  predominately	  
homopurine/homopyrimidine	  sequences.[18]	  [19]	  
In	  other	  studies,	  treatment	  with	  G5	  PAMAM	  polyplexes	  lead	  to	  the	  highest	  cytosolic	  
nuclease	  activation	  leading	  to	  a	  decrease	  in	  transgene	  expression[17].	  In	  Figure	  4.5	  
we	  showed	  that	  G5	  PAMAM	  polyplex	  treated	  cytosol	  has	  activity	  similar	  to	  control	  
cytosol	  with	   several	   notable,	   and	  possibly	   significant	   differences,	   especially	   in	   the	  
luciferase	   transgene.	   	   The	   labile	   region	   in	   the	   luciferase	   gene	   is	   one	  of	   the	   top	  15	  
most	  labile	  regions	  for	  G5	  polyplex	  treated	  cytosol;	  however,	  it	  is	  not	  for	  untreated	  
cells	  cytosol.	  This	  may	  contribute	  to	  poor	  luciferase	  transgene	  expression	  facilitated	  
by	  G5	  PAMAM	  polyplexes.	   	  This	   is	   consistent	  with	   the	  hypothesis	   that	  G5	  PAMAM	  
polyplexes	  induce	  heightened	  activation	  of	  cytosolic	  nuclease,	  therefore	  decreasing	  
the	   transgene	   expression[17].	   In	   making	   this	   comparison,	   it	   is	   important	   to	   note	  
that	  cells	  were	  lysed	  for	  the	  sequencing	  experiments,	  which	  may	  lead	  to	  changes	  in	  
the	  activity	  of	  cytosolic	  nucleases.	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Figure	  4.5.	  Heat	  map	  comparison	  between	  cytosol	  nuclease	  samples	  and	  S1	  
nuclease.	  (A)	  	  G5	  polyplex-­‐treated	  cytosol	  cut	  regions	  with	  41-­‐65%	  cuts	  (B)	  cells-­‐
only	  cytosol	  cut	  regions	  with	  50-­‐75%	  cuts	  (C)	  S1	  nuclease	  cut	  regions	  with	  25-­‐45%	  
cuts.	  
4.4.3 Consensus	  Analysis	  	  
Apart	   from	  showing	  the	  position	  of	   labile	  sites,	  sequencing	  also	  provides	  a	  unique	  
opportunity	   to	   evaluate	  homology	  between	   the	   labile	   sites.	   To	   study	   and	  quantify	  
homology	   between	   the	   labile	   sequence	   for	   S1	   and	   cytosolic	   sample,	   a	   consensus	  
sequence	  was	  developed	  by	  performing	  a	  multiple	  sequence	  alignment	  of	  the	  most	  
labile	  region	  of	   the	  cytosolic	  samples	  and	  the	  S1	  nuclease	  sample	  (S10,	  C9,	  G13	   in	  
Tables	   4.1,	   4.2	   and	   4.3,	   respectively).	   The	   consensus	   sequence	  
AGCTCTTGATCCGGCAAACAAACCACC	  was	  then	  used	  to	  calculate	  similarity	  for	  other	  
labile	  sequence	  locations.	  Tables	  4.S4,	  4.S5,	  and	  4.S6	  show	  the	  analyses	  performed	  
for	   S1	   nuclease,	   control	   cytoplasm	   and	   the	   G5	   polyplex	   treated	   cells	   cytoplasm	  
samples,	   respectively.	   	   Low	   sequence	   homology	   between	   the	   consensus	   sequence	  
and	  labile	  region	  for	  S1	  nuclease	  and	  cytosolic	  samples	  supports	  the	  hypothesis	  that	  
nuclease	   are	   not	   primary	   DNA	   sequence	   specific,	   and	   can	   be	   considered	  





CMV immediate early enhancer/promoter
Luc
6.4 kb
	   	   	   	   	   	   
1:	  CMV	  immediate	  early	  promoters/enhancers	  	   5	  and	  8:	  Synthetic	  poly(A)	  sequence 
2:	  Luciferase	  gene	  	   	   	   	   6:	  OriC 
3:	  SV40	  poly(A)	  sequence	   	   	   	   7:	  Beta-­‐Lactamase	  coding	  region 
4:SV40	  early	  promoters/enhancers	   	   	   Purple	  crescent:	  agarose	  gel	  result	  for	  S1	  nuclease 
	   
	  I 	  2 	  3 	  4 	  5 	  6 	  7 	  8 
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Table	  4.S4:	  S1	  nuclease	  treatment:	  pairwise	  alignment	  using	  consensus	  sequence.	  
	  
Region	   Size	   Identity	  to	  consensus	  
S1	   46	   16/46	  
S2	   26	   13/26	  
S3	   22	   10/22	  
S4	   28	   10/28	  
S5	   11	   6/11	  
S6	   36	   12/36	  
S7	   56	   9/56	  
S8	   52	   20/52	  
S9	   15	   11/15	  
S10	   99	   18/99	  
S11	   17	   4/17	  
S12	   14	   3/14	  
S13	   30	   9/30	  
S14	   43	   16/46	  
S15	   17	   13/17	  
	  
Table	  4.S5:	  Cytoplasmic	  extract	  from	  HeLa	  cells	  only	  treatment:	  pairwise	  alignment	  
using	  consensus	  sequence.	  
	  
Region	   Size	   Identity	  to	  consensus	  
C1	   52	   17/52	  
C2	   7	   2/7	  
C3	   38	   11/38	  
C4	   8	   7/8	  
C5	   51	   16/51	  
C6	   29	   8/29	  
C7	   80	   11/80	  
C8	   31	   11/31	  
C9	   108	   27/108	  
C10	   4	   3/4	  
C11	   52	   14/52	  
C12	   49	   14/49	  
C13	   12	   9/12	  
C14	   42	   14/42	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Table	  4.S6:	  Cytoplasmic	  extract	  from	  G5	  polyplex.	  HeLa	  cells	  treatment:	  pairwise	  
alignment	  using	  consensus	  sequence.	  
	  
Region	   Size	   Identity	  to	  consensus	  
G1	   37	   15/37	  
G2	   18	   1/18	  
G3	   8	   6/8	  
G4	   32	   7/32	  
G5	   27	   15/27	  
G6	   71	   16/71	  
G7	   24	   12/24	  
G8	   4	   3/4	  
G9	   74	   12/74	  
G10	   3	   2/3	  
G11	   3	   2/3	  
G12	   50	   20/50	  
G13	   300	   27/300	  
G14	   51	   12/51	  
G15	   60	   8/60	  
	  
4.5 Conclusions	  
Agarose	   gel	   electrophoresis	   and	   Illumina	   dye	   sequencing	   confirm	   that	   cytosolic	  
nucleases	   cleave	   luciferase	   pDNA,	   rendering	   it	   as	   non-­‐functional	   template	   for	  
expression,	  and	  that	  S1	  nuclease	  cuts	  at	  high	  homopurine/homopyrimidine	  regions	  
of	   the	   plasmid[18,	   19].	   To	   the	   best	   of	   our	   knowledge,	   this	   is	   the	   first	   time	   high-­‐
throughput	   sequencing	   has	   been	   used	   to	   study	   degradation	   effects	   of	   S1	   and	  
cytosolic	  nucleases	  on	  pDNA.	   	   Interestingly,	   the	  most	  susceptible	  cut	  region	   for	  S1	  
nuclease	  overlaps	  the	  susceptible	  region	  for	  cytosolic	  nucleases,	  consistent	  with	  the	  
hypothesis	  that	  S1	  type	  nucleases	  are	  part	  of	  the	  cytosolic	  nuclease	  milieu.	  Lack	  of	  
significant	   homology	   between	   labile	   sequences	   and	   a	   consensus	   sequence	   (Table	  
4.S4,	   4.S5	   and	   4.S3)	   suggests	   that	   these	   nucleases	   are	   highly	   promiscuous.	   	   In	  
addition,	   our	   agarose	   gel	   results	   are	   consistent	   with	   the	   hypothesis	   that	   S1	   and	  
cytosolic	  nucleases	  are	  more	  likely	  to	  cleave	  supercoiled	  pDNA	  than	  the	  linear	  form	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of	  DNA.	   	   Our	   data	   further	   indicates	   that	   since	  many	   of	   susceptible	   sites	   lie	   in	   the	  
indispensible	   functional	   units	   of	   pDNA	   there	   is	   a	   limit	   to	   DNA	   sequence	  
optimization.	  To	  overcome	   this	   challenge,	   further	   research	   is	  needed	  on	  polymers	  
designed	   to	   protect	   these	   labile	   regions	   from	  degradation	   during	   the	   transport	   of	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Chapter	  5	  
Conclusions	  and	  Future	  Directions	  
	  
In	   this	   dissertation,	   I’ve	   examined	   cellular	   internalization	   mechanisms	   for	  
polycationic	   polymers	   used	   in	   nucleic	   acid	   delivery	   systems	   and	   also	   how	   cell	  
responds	  to	  the	  polymer/DNA	  polyplexes	  once	  they	  are	  inside	  cells.	  In	  chapter	  2	  it	  
was	  shown	  that	  contrary	  to	  literature	  reports,	  [1]	  GM1	  mediated	  endocytosis	  doesn’t	  
play	  an	   important	  role	   in	  G7	  PAMAM	  dendrimer	   internalization.	  The	   false	  positive	  
results	  that	  the	  other	  investigations	  reported,	  reproduced	  by	  our	  laboratory	  as	  well,	  
was	  due	  to	  a	  previously	  unappreciated	  interaction	  between	  G7	  PAMAM	  dendrimer	  
and	   the	   endocytosis	   marker	   CTB.	   	   Our	   study	   was	   successful	   because	   it	   was	  
performed	   with	   the	   help	   of	   a	   unique	   and	   indispensably	   functional	   marker	   called	  
GM1.	   C6	   cells	   were	   employed	   in	   this	   experiment	   because	   of	   their	   unique	  
characteristic	   of	   inherently	   lacking	   GM1	   but	   still	   possessing	   all	   downstream	  
requirements	  for	  successful	  GM1	  mediated	  endocytosis.	  [2]	  C6	  cells	  can	  be	  made	  to	  
undergo	   GM1	  mediated	   endocytosis	   by	   simple	   overnight	   incubation	  with	   GM1.	   [2]	  
This	   unique	   characteristic	   of	   C6	   cells	   resulted	   in	   the	   reported	   binary	   experiment	  
where	   C6	   cells	   without	   and	   with	   GM1	   did	   not	   show	   differential	   G7	   PAMAM	  
dendrimer	  uptake.	  This	  supports	   the	  hypothesis	   that	  GM1	  mediated	  endocytosis	   is	  
not	   the	   primary	   pathway	   for	   G7	   PAMAM	   dendrimer	   internalization.	   Subsequent	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repetition	  of	  this	  study	  with	  G7	  polyplexes	  by	  Qi	  et	  al.	  also	  resulted	  in	  the	  conclusion	  
that	   GM1	   mediated	   endocytosis	   is	   not	   the	   primary	   internalization	   pathway	   for	  
PAMAM	   dendrimer	   polyplexes.	   [3]	   In	   chapter	   2,	   only	   G7	   PAMAM	   dendrimer	  was	  
tested.	  One	  way	  to	  improve	  this	  study	  is	  to	  test	  polyplexes	  made	  by	  B-­‐PEI,	  L-­‐PEI	  and	  
jetPEITM.	  As	  all	  these	  polymers	  facilitate	  different	  level	  of	  gene	  expression	  testing	  if	  
they	   require	   GM1	   mediated	   endocytosis	   to	   transfect	   can	   provide	   important	  
information	  about	  role	  of	  GM1	  in	  successful	  gene	  expression.	  	  	  
	  
The	  overall	  goal	  of	  chapters	  3	  and	  4	  is	  to	  improve	  our	  understanding	  of	  intracellular	  
response	  to	  polyplexes	  that	  lead	  to	  decrease	  transgene	  expression.	  In	  these	  chapters	  
I	  examine	  the	  downstream	  processes	  that	  happen	  once	  polyplexes	  are	   inside	  cells.	  
Work	  by	  Pollard	  et	  al.	  [4]	  and	  Lechardeaur	  et	  al.	  [5]	  showed	  that	  foreign	  DNA	  inside	  
cells	   is	   rapidly	   degraded.	   This	   leads	   to	   the	   hypothesis	   that	   cells	   respond	   to	   the	  
polyplexes	   by	   activating	   cytosolic	   nucleases.	   These	   active	   nucleases	   then	   degrade	  
the	  transported	  nucleic	  acid	  and,	  in	  case	  of	  pDNA,	  lead	  to	  a	  decrease	  in	  downstream	  
gene	  expression.	  Another	  important	  observation	  from	  this	  study	  was	  that	  the	  level	  
of	  nuclease	  activation	   is	  directly	  dependent	  on	   the	   specific	  polymer	  used	   to	  make	  
polyplexes.	  	  
In	   this	   study	   a	   variety	   of	   polycationic	   polymers	   with	   different	   molecular	  
architecture	  were	  used.	  This	  is	  the	  first	  time	  molecular	  architecture	  of	  polymer	  has	  
been	   related	   to	   nuclease	   activation	   inside	   cells	   bearing	   direct	   impact	   on	   the	  
transgene	   expression.	   Having	   the	   missing	   link	   between	   polymer	   system	   and	  
expression	  is	  a	  great	  tool	  as	  this	  nuclease	  activation	  can	  be	  easily	  measured	  with	  the	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help	  of	  molecular	  beacon.	  Specific	  polymers	  can	  now	  be	  designed	  to	  mimic	  L-­‐PEI	  in	  
terms	   of	   nuclease	   activation	   to	   in	   turn	   facilitate	   good	   transgene	   expression.	  
Nuclease	   activation	  may	  not	   be	   a	   bad	   consequence	   for	   some	  nucleic	   acid	  delivery	  
systems	  like	  asDNA	  and	  siRNA	  delivery.	  asDNA	  and	  siRNA	  are	  oligonucleotides	  that	  
have	   been	   shown	   to	   have	   many	   important	   applications	   in	   therapeutics	   and	   are	  
functional	  in	  cytoplasm.	  [10-­‐13]	  
An	   optimum	   polymer	   system	   for	   asDNA	   and	   siRNA	   will	   be	   characteristically	  
different	   from	   polymer	   vectors	   for	   pDNA	   delivery.	   An	   optimum	   polymer	   for	  
oligonucleotide	   delivery	   should	   hypothetically	   allow	   DNA	   to	   be	   in	   a	   less-­‐bound	  
form,	   so	   that	   it’s	   available	   for	   the	  downstream	  processes	   in	   the	   cytosol.	   	   Studying	  
nuclease	   activation	   facilitated	   by	   polymers	   transporting	   oligonucleotide	   and	   how	  
that	   impacts	   the	   efficacy	   of	   these	   oligonucleotides	   will	   provide	   unprecedented	  
knowledge	  to	  help	  design	  better	  polymer	  systems	  asDNA	  and	  siRNA	  delivery.	  	  
Nuclease	   activity	   in	   these	   systems	   will	   represent	   greater	   cytosolic	   enzyme	  
interaction,	  which	  can	  be	  very	  important	  for	  success	  of	  these	  systems.	  asDNA	  and	  si	  
RNA	   may	   require	   downstream	   enzyme	   interaction	   in	   the	   cytosol	   for	   them	   to	   be	  
functional.	   Polymer	   systems	   can	   be	   designed	   that	   allow	   cytosolic	   enzyme	  
interaction	  but	  specifically	  inhibit	  nuclease	  activity	  if	  required.	  	  
Some	   specific	   experimental	   ways	   to	   improve	   our	   understanding	   of	   cytosolic	  
nucleases:	  one	  way	  to	  take	  this	  study	  forward	  is	  to	  examine	  if	  there	  is	  a	  direct	  one	  to	  
one	   relationship	   between	   cytosolic	   nuclease	   activation	   and	   gene	   expression.	   	   If	  
decreasing	   nuclease	   activity	   inside	   cells	   leads	   to	   increase	   in	   gene	   expression	   by	  
polyplexes,	  it	  will	  indicate	  that	  nuclease	  activation	  is	  a	  primary	  reason	  for	  low	  gene	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expression.	   One	   way	   to	   address	   above	   the	   hypothesis	   is	   by	   adding	   nuclease	  
inhibitors	   during	   polyplex	   treatment.	   The	   presence	   of	   nuclease	   inhibitors	   will	  
decrease	   nuclease	   activation	   measured	   by	   MB	   fluorescence	   thus	   increasing	   gene	  
expression.	  This	  experiment	  is	  different	  from	  other	  published	  studies[6-­‐9]	  because	  
here	   we	   will	   have	   a	   direct	   measurement	   of	   nuclease	   activity	   which	   none	   of	   the	  
previous	  studies	  had.	  
One	   important	   question	   that	   arises	   from	   chapter	   3	   is	   where	   the	   foreign	   DNA	  
degradation	  happens	  inside	  the	  cell.	  To	  address	  this	  question,	  an	  experiment	  can	  be	  
designed	   with	   fluorescent	   markers	   specific	   to	   organelles	   like	   Endoplasmic	  
Reticulum,	  Golgi	  bodies	  and	   lysosomes.	  These	  markers	  can	  be	  covalently	  bound	  to	  
the	  DNA	  in	  the	  polyplex	  sample	  and	  once	  they	  are	  inside	  the	  cell	  their	  colocalization	  
with	  MB	  can	  be	  measured	  and	  monitored.	  
Another	  question	  that	  remained	  unanswered	  in	  chapter	  3	  is	  the	  induction	  pathway	  
for	   cytosolic	   nuclease	   activation.	   One	   of	   the	   conclusions	   of	   chapter	   3	   is	   that	  
membrane	   permeability	   facilitated	   by	   polycationic	   polymer	   is	   not	   related	   to	  
nuclease	   activation.	   Experiments	   can	   be	   designed	   that	   tests	   other	   polymer	  
characteristic	   like	   charge	   per	   particle	   and	   how	   that	   relates	   to	   nuclease	   activation	  
and	   ultimately	   gene	   expression.	   This	   experiment	   can	   help	   in	   selecting	   optimum	  
charge/particle	   to	   get	  minimum	  nuclease	   activation	  and	   in	   turn	  getting	  maximum	  
expression.	  
The	  aim	  of	  chapter	  4	  is	  to	  improve	  our	  understanding	  of	  cytosolic	  nucleases.	  In	  this	  
study,	   high-­‐throughput	   sequencing	  was	   used	   to	   fingerprint	   cytosolic	   nucleases	   as	  
well	   as	   S1	   nuclease.	   With	   the	   help	   of	   high-­‐throughout	   sequencing,	   previously	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unreported	   labile	   sites	   were	   found	   that	   were	   susceptible	   to	   S1	   nuclease.[14-­‐16]	  
Interestingly,	   the	   most	   susceptible	   cut	   region	   for	   S1	   nuclease	   overlaps	   with	   the	  
susceptible	  region	  of	  cytosolic	  nucleases,	  consistent	  with	  the	  hypothesis	  that	  S1	  type	  
nuclease	   are	   part	   of	   the	   cytosolic	   nuclease	   milieu.	   No	   significant	   homology	   was	  
observed	   between	   these	   labile	   sequencing	   suggesting	   that	   these	   nucleases	   are	  
promiscuous	   in	   nature.	   Additionally,	   gel	   results	   indicate	   that	   S1	   and	   cytosolic	  
nuclease	  are	  more	  likely	  to	  cleave	  supercoiled	  DNA	  than	  the	  linear	  form	  of	  the	  DNA.	  
A	   lot	   of	   work	   has	   been	   dedicated	   to	   improve	   nucleic	   acid	   sequence	   to	   make	   it	  
nuclease	  resistant	  but	  as	  many	  of	  these	  sites	  lie	  in	  indispensable	  functional	  parts	  of	  
pDNA,	  there	  is	  a	   limit	  to	  DNA	  sequence	  optimization.	  Understanding	  labile	  regions	  
where	   DNA	   gets	   degraded	   can	   help	   design	   novel	   polymer	   vector	   systems	   that	  
protect	  these	  sites	  and	  ultimately	  improving	  the	  downstream	  gene	  expression.	  	  
This	   study	   can	   be	   improved	   by	   sequencing	   the	   transported	   DNA	   itself	   by	   high-­‐
throughput	   sequencing.	   By	   sequencing	   the	   transported	   DNA	   and	   using	   other	  
polymer	   used	   in	   nucleic	   acid	   delivery,	   this	   experiment	   can	   answer	   questions	   and	  
concerns	   raised	   in	   chapter	   4.	   	   There	   are	   studies	   showing	   that	   once	   the	   pDNA	   is	  
nicked	   it	   becomes	   non-­‐functional	   in	   terms	   of	   gene	   expression.	   [17]	   Sequencing	  
experiments	  are	  very	  well	  poised	   to	   test	   this	  hypothesis.	  One	  way	  sequencing	  can	  
address	  this	  hypothesis	  is	  by	  separating	  nuclear	  extract	  from	  cytosolic	  extract,	  and	  
then	   sequencing	   the	   transported	   pDNA	   in	   each	   fraction.	   If	   the	   sequencing	   shows	  
that	   nuclear	   fraction	   pDNA	   is	   less	   degraded	   as	   compared	   cytosolic	   fraction	   pDNA	  
then	  it	  will	  support	  the	  above	  hypothesis.	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Degradation	   pattern	   for	   L-­‐PEI	   and	   jetPEITM	   like	   polymers	   that	   facilitate	   good	  
transgene	  expression	  can	  be	  used	  as	  gold	  standards.	  New	  polymer	  candidates	  can	  
then	  be	  quickly	  compared.	  The	  shortlisted	  candidates	  can	  then	  be	  checked	  using	  in	  
cell	  MB	  experiments	  to	  measure	  their	  efficacy	  before	  moving	  onwards	  with	  in-­‐vivo	  
animal	  studies.	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Chapter	  6	  
The	  Endocutter*:	  A	  Gastrointestinal	  Medical	  Device	  That	  Cuts	  Clots,	  
Cuts	  Cost	  and	  Saves	  Lives	  
	  
6.1 Abstract	  
A	   major	   problem	   in	   the	   endoscopic	   treatment	   of	   upper	   gastrointestinal	   (GI)	  
bleeding	  is	  the	  removal	  of	  blood	  clots	  inside	  the	  stomach.[1-­‐3]	  The	  ineffectiveness	  of	  
existing	  methods	   to	   remove	  blood	   clots	   quickly	   during	   active	   bleeding	   events	   has	  
led	   to	   the	   development	   of	   the	   Endocutter.	   This	   device	   is	   designed	   to	   be	   used	   in	  
conjunction	  with	   the	  endoscope’s	   existing	   suction	  power,	   chopping	  up	  blood	   clots	  
and	  similar	  stomach	  content	  before	  they	  enter	  the	  narrow	  instrument	  channel.	  The	  
device	   is	   effective	   in	   facilitating	   the	   removal	   of	   blood	   clots	   in	   a	   short	   time	   span,	  
reducing	   procedure	   risk	   by	   limiting	   the	   number	   of	   endoscope	   reinsertions,	   and	  
eliminating	   the	   need	   to	   perform	   second	   endoscopy	   procedures.	   Furthermore,	   the	  
Endocutter	  aims	   to	  be	   cost-­‐effective	  by	   reducing	  patient	   length	  of	   stay	  and	  saving	  
the	   hospital	   $2,000	   -­‐	   $3,000	   per	   procedure.[4]	   Most	   importantly,	   the	   Endocutter	  
aims	  to	  decrease	  mortality	  rates	  by	  reducing	  the	  number	  of	  second	  endoscopies.	  
*A	   team	   of	   four	   engineers	   invented	   Endocutter:	   Rahul	   Rattan,	   Tareef	   Jafferi,	   Zachary	   T.	   Weingarden	   and	   Raghunath	   Sai	  
Katragadda.	   Apart	   from	  working	   in	   a	   collaborative	   team,	  my	   individual	   responsibility	   included	   prior	   art	   and	   patentability	  
analysis,	  medical	  device	  standard	  research,	  reimbursement	  and	  FDA	  approval	  analysis.	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6.2 Problem	  Description	  
During	   an	   episode	   of	   upper	   GI	   bleeding,	   an	   endoscope	   is	   passed	   through	   the	  
patient’s	   esophagus	   and	   into	   the	   GI	   tract	   for	   a	   visual	   assessment	   of	   the	   bleeding	  
location,[2]	   this	   procedure	   is	   called	   gastroduodenoscopy.	   A	   major	   problem	   in	  
endoscopic	   management	   of	   upper	   GI	   bleeding	   is	   the	   difficulty	   to	   identify	   the	  
bleeding	   source,	   which	   is	   often	   obscured	   by	   overlying	   blood	   and	   clots.[1-­‐3]	  	  
Traditional	   efforts	   of	   removing	   blood	   clots	   are	   via	   lavage	   (i.e.	   using	   large	   bore	  
gastric	  tubes	  or	  suction	  through	  large	  channel	  therapeutic	  endoscopes).	  [1,	  2]	  These	  
methods	   often	   fail	   to	   dislodge	   blood	   clots	   that	   are	   adherent	   to	   the	   base	   of	   the	  
bleeding	   site.	   	   Another	   method	   is	   to	   remove	   clots	   mechanically	   with	   a	   snare.[2]	  	  
Physicians	  are	  generally	  reluctant	  to	  use	  this	  latter	  technique	  because	  of	  the	  risk	  of	  
induced	   bleeding.[2]	   A	   clot	   dissociating	   composition	   comprising	   of	   hydrogen	  
peroxide	   and	   a	   surfactant	   can	   also	   be	   used;[3]	   however,	   this	   process	   is	   time-­‐
consuming	   and	   the	   delay	   in	   treatment	   can	   lead	   to	   serious	   consequences.	   	   These	  
problems	   have	   fueled	   the	   search	   for	   quicker	   and	   cost-­‐effective	   ways	   to	   remove	  
blood	  clots	  from	  stomach	  during	  gastroduodenoscopy. 
6.3 Objective	  Statement	  
The	   Endocutter	   is	   an	   accessory	   that	   is	   compatible	   with	   any	   large	   instrumental	  
endoscope.	   The	   device	   is	   to	   be	   used	   in	   conjunction	  with	   the	   endoscope’s	   existing	  
suction	   power,	   chopping	   up	   blood	   clots	   and	   similar	   stomach	   content	   before	   they	  
enter	  the	  narrow	  instrument	  channel.	   	  It	  consists	  of	  a	  motor	  with	  a	  spinning	  blade	  
shaft	  encased	  in	  a	  clear	  polycarbonate	  shell	  that	  can	  be	  attached	  at	  the	  distal	  end	  of	  
the	  endoscope	  and	  powered	  via	  wiring	  through	  the	  instrument	  channel.	  	  The	  blade	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is	  recessed	  and	  surrounded	  by	  the	  shell	  in	  order	  to	  protect	  the	  stomach	  lining	  from	  
contact	  with	  the	  blade.	  The	  motor	  is	  sufficiently	  small	  to	  be	  placed	  on	  the	  end	  of	  the	  
endoscope	  while	  preserving	  the	  visual	  field	  and	  use	  of	  the	  instrument	  channel.	  The	  
Endocutter	  allows	  the	  physician	  to	  quickly	  locate	  the	  bleeding	  site	  without	  the	  need	  
for	  repeated	  endoscope	  reinsertions	  or	  extended	  patient	  stay.	  
6.4 Prototype	  of	  the	  Final	  Design	  
The	   final	   prototype	  has	   been	  designed	   to	  maintain	   functionality	   of	   the	   endoscope	  
while	  ensuring	  safety	  and	  effectiveness.	   	  The	  CAD	  models	  of	   the	  prototype	  (Figure	  
6.9.1)	  are	  designed	  using	  the	  software	  CATIA	  V5R17.	  	  The	  prototype	  is	  comprised	  of	  
five	   components	   integrated	   in	   the	   complete	   design.	   These	   components	   are	   the	  
protective	   polycarbonate	   casing,	   rubber	   attachment,	   electric	   motor,	   blade	  
connector,	   and	   blade.	   	   The	   wiring	   for	   the	   prototype	   includes	   male	   and	   female	  
connectors	   soldered	   to	   the	   wires,	   allowing	   them	   to	   be	   passed	   through	   the	  
instrument	  channel	  of	  the	  endoscope.	  	  The	  end	  terminals	  of	  the	  wires	  are	  connected	  
to	  a	  switch	  that	  is	  integrated	  with	  a	  battery.	   	  The	  physician	  can	  power	  the	  battery-­‐
operated	   motor	   using	   this	   switch.	   	   The	   prototype	   is	   30	   mm	   long	   with	   an	   outer	  
diameter	   of	   14.6	   mm	   (similar	   in	   diameter	   to	   dual-­‐channel	   endoscopes).	   	   The	  
polycarbonate	  casing	  is	  25	  mm	  long,	  1	  mm	  thick,	  and	  transparent	  to	  maximize	  the	  
field	  of	  vision.	   	  The	  motor	  holder	  has	  an	   inner	  diameter	  of	  6	  mm	  and	  a	   curvature	  
angle	   of	   270	   degrees	   to	   secure	   the	  motor	   in	   place.	   	   It	   is	  mounted	   on	   a	   stem	   that	  
spans	   the	  15	  mm	  motor	  holder.	   	   The	  motor	   itself	   is	   6	  mm	   in	  diameter,	   15	  mm	   in	  
length,	  and	  is	  placed	  3	  mm	  from	  the	  tip	  of	  the	  casing.	  	  The	  blade	  is	  connected	  to	  the	  
shaft	  using	  a	  blade	  connector	  placed	  over	  the	  shaft.	  	  The	  blade	  has	  dimensions	  of	  10	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mm	   in	   length,	   1	   mm	   in	   width,	   and	   0.1	   mm	   in	   thickness	   and	   is	   passed	   over	   the	  
spindle	  and	  glued	  using	  industrial	  stainless	  steel	  adhesive.	   	  A	  rubber	  attachment	  is	  
fixed	  over	  the	  other	  end	  of	  the	  casing	  and	  secures	  the	  prototype	  at	  the	  distal	  end	  of	  
the	  endoscope.	  
	  
Figure	  6.1.	  Below	  are	  CAD	  representations	  of	  the	  polycarbonate	  attachment	  with	  the	  
motor	  in	  place.	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6.5 Intellectual	  Property	  
6.5.1 Prior	  Art	  
An	  exhaustive	  patent	  search	  revealed	  no	  endoscopic	  attachments	  or	  accessories	  that	  
incorporated	   a	  micro-­‐motor.	   	   Searches	   for	   similar	   endoscope	   attachments	   or	   clot	  
removal	  methods	  yielded	  the	  following	  patents	  and	  patent	  applications:	  
6.5.1.1. 	  Endoscopic	  apparatus	  with	  integrated	  hemostasis	  device	  [5]	  (Application	  
No.10/955,908)	  	  
6.5.1.2. Multichannel	  endoscope[6]	  (Patent	  No.	  4146019)	  
6.5.1.3. Clot	  dissolving	  method[7]	  (Patent	  No.	  5846567)	  
6.5.1.4. Method	   and	   apparatus	   for	   removing	   blood	   clots	   and	   other	   objects[8]	  
(Patent	  	  	  	  No.	  5947995)	  	  
6.5.1.5. Method	  and	  associated	  device	  for	  removing	  clot[9]	  (Patent	  No.	  5520635)	  	  
	  
There	   are	   no	   existing	   patents	   that	   include	   the	   features	   of	   the	   Endocutter.	   	   It	   can	  
therefore	  be	  concluded	  that	  there	  is	  little	  risk	  for	  patent	  infringement.	  
6.5.2 Patentability	  Analysis	  
This	  device	  is	  patentable	  as	  it	  meets	  these	  three	  criteria:	  
6.5.2.1. Novel:	  This	  is	  the	  first	  device	  to	  incorporate	  a	  motorized	  cutting	  	  tool	  with	  
an	  endoscope	  for	  gastroduodenoscopy	  procedures.	  
6.5.2.2. 	  Non-­‐obvious:	   This	   device	   is	   specifically	   designed	   to	   use	   mechanical	  
power	  and	  suction	  while	  still	  preserving	  the	  functions	  of	  an	  endoscope.	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6.5.2.3. Utility:	   This	   device	   presents	   a	  method	   that	   efficiently	   removes	   clots	   and	  
improves	  the	  overall	  effectiveness	  of	  the	  procedure.	  
Utility	  patent	  for	  Endocutter	  was	  filed	  in	  December	  2011.	  	  
6.6 Applicable	  Standards	  
Applicable	   standards	   have	   been	   divided	   into	   the	   following	   components	   (Table	  
6.10.1):	  
6.6.1. Process	  standards:	  	  These	  standards	  specify	  the	  controls	  and	  methods	  to	  be	  
used	   to	   manage	   all	   aspects	   of	   a	   manufacturing	   business,	   including	   design	  
requirements	  and	  evaluation	  of	  potential	  design	  hazards.	  
6.6.2. Standard	  testing	  methods:	  	  These	  standards	  specify	  material	  safety	  tests	  and	  
acceptance	  criteria	  that	  must	  be	  satisfied	  for	  a	  biocompatible	  device.	  
6.6.3. Performance	   standards:	   	   These	   standards	   describe	   performance	   attributes	  
for	  the	  device.	  
	  
Table	  6.1.	  Standards	  applicable	  to	  the	  Endocutter.	  
Process	  standards	   Standard	  testing	  methods	   Performance	  standards	  
ISO	  10993:	  2003	   ISO	  10993-­‐1:2003	   ISO	  8600-­‐6:2005	  
ISO	  14971:2007	   IEC	  60601	   ISO	  15223:2000	  
ISO	  14937:2000	   	   ISO	  15225:2000	  
ISO	  11137-­‐1:2006	   	   ISO	  11607-­‐2:2006	  
EN	  ISO	  14155-­‐1,2:2003	   	   CEN/TR	  15133:2005	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6.7 FDA	  Regulatory	  Pathway	  
The	   Endocutter	   falls	   under	   876:4300,[10]	   endoscopic	   electrosurgical	   unit	   and	  
accessories.	  	  It	  is	  a	  class	  II	  device	  and	  non-­‐exempt	  for	  GMP.[10]	  The	  submission	  type	  
would	   be	   510(k)	   premarket	   approval,	   where	   the	   device	   must	   be	   compared	   to	  
previously	  marketed	  devices	  to	  support	  the	  substantial	  equivalency	  claims.[10]	  To	  
prove	   substantial	   equivalence,	   it	   must	   be	   shown	   that	   the	   device	   has	   the	   same	  
intended	   use	   as	   a	   predicate	   or	   does	   not	   raise	   new	   questions	   of	   safety	   and	  
effectiveness.	  	  
Predicate	  devices	  for	  substantial	  equivalence	  are:	  
6.7.1. X-­‐SIZERS	  Catheter	  System:	  [11]	  This	  device	  is	  a	  cardiovascular	  device	  used	  
to	  mechanically	  remove	  clots	  from	  blood	  vessels,	  aided	  with	  suction,	  making	  
it	   substantially	   equivalent,	   as	   the	   Endocutter	   clears	   clots	   by	   using	  
mechanical	  methods	  and	  suction.	  
6.7.2. Auto-­‐Band	  Ligator:	  [12]	  This	  device	  is	  an	  attachment	  to	  the	  endoscope	  tip.	  	  It	  
has	   a	   number	   of	   bands	   that	   can	   be	   ejected	   and	   snapped	   around	   blood	  
vessels,	   veins,	   or	   arteries	   that	   have	   burst.	   	   This	   device	   is	   substantially	  
equivalent,	  as	  it	  is	  also	  an	  endoscope	  attachment.	  
As	   Endocutter	   is	   a	   potential	   license	   out	   technology	   the	   team	   has	   decided	   to	   not	  
pursue	  FDA	  regulatory	  pathway,	  as	  it	  will	  not	  add	  much	  value	  to	  the	  final	  product.	  
6.8 Conclusion	  and	  Future	  Directions	  
Exit	  strategy	  for	  Endocutter	  is	  a	  potential	  license	  out.	  Currently,	  I	  am	  trying	  to	  find	  
potential	  licensees	  for	  Endocutter	  with	  the	  help	  of	  Office	  of	  Technology	  Transfer	  at	  
the	  University	  of	  Michigan.	  The	  prototyping	  for	  Endocutter	  has	  come	  to	  an	  end	  as	  of	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February	   2012	   and	   at	   the	   present	  moment	   there	   are	   no	   ongoing	   negotiations	   for	  
Endocutter	  with	  potential	  licensees.	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